Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Bromodifluoroacetyl chloride | 3832-48-2 | C2BrClF2O | 193.37 | BROMODIFLUOROACETYL CHLORIDE; Bromodifluoroacetyl chloride 97%; Bromodifluoroacetylchloride97%; acetyl chloride, bromodifluoro- |
Bromodifluoroacetyl bromide | 1796-12-9 | C2Br2F2O | 237.82 | BROMODIFLUOROACETYL BROMIDE; Bromodifluoroacetyl bromide 97%; Bromodifluoroacetylbromide97% |
Bromodeoxyuridine (BrdU) | 59-14-3 | C9H11BrN2O5 | 307.1 | BrdU; Bromodeoxyuridine; Broxuridine; NSC 38297 |
Bromocriptine | 25614-03-3 | C32H40BrN5O5 | 654.61 | (5'-a2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3'; 2-bromo-alpha-ergocryptine; 2-bromo-alpha-ergokryptin; 2-bromo-alpha-ergokryptine; 2-bromoergocryptine; (5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-erg |
Bromoconduritol | 42014-74-4 | C6H9O3Br | 209.04 | 6-Bromo-3,4,5-trihydroxy cyclohex-1-ene; 6-Bromo-4-cyclohexene-1,2,3-triol |
Bromocholine bromide | 28508-20-5 | C5H13Br2NO | 262.971 | |
BROMOCHLOROFLUOROACETIC ACID | 354-03-0 | C2HBrClFO2 | 191.38 | BROMOCHLOROFLUOROACETIC ACID |
BROMOCHLOROACETONITRILE | 83463-62-1 | C2HBrClN | 154.39 | bromochloro-acetonitril; Bromochloromethyl cyanide; BROMOCHLOROACETONITRILE; BROMOCHLOROACETONITRILE 100MG NEAT; bcan |
BROMOCHLOROACETIC ACID | 5589-96-8 | C2H2BrClO2 | 173.39 | RARECHEM AL BO 2372; BROMOCHLOROACETIC ACID; BCAA; bromochloro-aceticaci; chlorobromoaceticacid; Branched Chain Amino Acid |
Bromobutide | 74712-19-9 | C15H22BrNO | 312.25 | 2-bromo-3,3-dimethyl-n-(1-methyl-1-phenylethyl)-butanamid; 2-bromo-3,3-dimethyl-n-(1-methyl-1-phenylethyl)butanamide; s-4347; s47; SUMIHERB; BROMOBUTIDE; bromobutide (bsi, draft e-iso, draft f-iso); 2-bromo-3,3-dimethyl-N-N-(alpha-alpha-dimethylbenzyl) bu |
Bromobenzene-d5 | 4165-57-5 | C6BrD5 | 162.04 | Bromobenzene D5; Bromo(2H5)benzene |
BROMOBENZENE (13C6) | 112630-77-0 | C6H5Br | 163.06 | BROMOBENZENE (13C6); BROMOBENZENE-13C6, 99 ATOM % 13C; Benzene-13C6, bromo- |
Bromo-acetic acid decyl ester | 5436-93-1 | C12H23BrO2 | 279.21 | Decylbromoacetate; decyl2-bromoacetate; Bromo-aceticaciddecylester; 5436-93-1; Bromoaceticacid,decylester; Decylbromoacetate# |
BROMO-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ACETIC ACID METHYL ESTER | 138219-39-3 | C8H14BrNO4 | 268.11 | BROMO-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ACETIC ACID METHYL ESTER |
Brominated polystyrene | 88497-56-7 | (C8H5Br3)n | 0 | BROMO PS; BROMOPOLYSTYRENE; BROMOPOLYSTYRENE RESIN; COPOLYMER OF STYRENE AND DIVINYLBENZENE, BROMINATED; 4-BROMO POLYSTYRENE RESIN; N,N,N-TRIMETHYL-AMINOMETHYL POLYSTYRENE BROMIDE; POLYSTYRENE CROSSLINKED WITH DIVINYLBENZENE, BROMINATED; POLYSTYRENE-BR |
Bromhexine Related Compound 2 HCl | 32193-43-4 | C14H22BrCl3N2 | 404.61 | |
Bromhexine Impurity D | 132004-28-5 | C14H21BrN2 | 297.24 | |
Bromhexine Impurity A | 50739-76-9 | C7H7Br2NO | 280.95 | 2-Amino-3,5-dibromo-benzenemethanol |
Bromhexine Impurity (N-(2-Nitrobenzyl)-N-cyclohexyl-N-methylamine) | 80638-08-0 | C14H20N2O2 | 248.33 | N-Cyclohexyl-N-methyl-2-nitrobenzenemethanamine; Einecs 279-522-8; N-(2-Nitrobenzyl)-N-methylcyclohexanamine |
Bromfenac Sodium Sesquihydrate | 120638-55-3 | C30H28Br2N2Na2O9 | 766.347 | disodium 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate trihydrate |
Bromfenac Sodium Salt | 91714-93-1 | C15H11BrNO3.Na | 356.15 | AHR 10282R; AHR10282R; AHR-10282R |
Bromfenac Lactam | 91713-91-6 | C15H10BrNO2 | 316.16 | 7-(4-Bromobenzoyl)-1,3-dihydro-2H-indol-2-one; AHR 10240 |
Bromfenac Impurity (7-(4-bromobenzoyl)indoline-2,3-dione) | 241825-88-7 | C15H8BrNO3 | 330.14 | AHR 11652 |
BRL-15572 | 193611-72-2 | C25H27ClN2O.2HCl | 479.87 | |
BRL 52537 hydrochloride | 112282-24-3 | C18H24Cl2N2O.HCl | 391.77 | (±)-1-(3,4-Dichlorophenyl)acetyl-2-(1-pyrrolidinyl)methylpiperidine hydrochloride |
BRL 50481 | 433695-36-4 | C9H12N2O4S | 244.27 | 3-(N,N-Dimethylsulfonamido)-4-methylnitrobenzene, 5-Nitro-2-N,N-trimethylbenzenesulfonamide; |
BRL 44408 MALEATE | 118343-19-4 | C17H21N3O4 | 331.37 | 2-[(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)METHYL]-2,3-DIHYDRO-1-METHYL-1H-ISOINDOLE MALEATE; 2-[2H-(1-METHYL-1,3-DIHYDROISOINDOLE)METHYL]-4,5-DIHYDROIMIDAZOLE MALEATE; BRL 44408 MALEATE; 2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole; B |
BRL 44408 Maleate | 681806-46-2 | C17H21N3O4 | 331.37 | 2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole maleate |
BRL 15572 hydrochloride | 1173022-77-9 | C25H27ClN2O.HCl | 443.42 | 3-[4-(4-Chlorophenyl)piperazin-1-yl]-1,1-diphenyl-2-propanol hydrochloride |
BRL 15572 | 734517-40-9 | C25H27ClN2O | 406.95 | 1-(Diphenylmethyl)-2-(4-(3-chlorophenyl)-1-piperazinyl)ethanol;193611-72-2 (HCl) |
Brivudine Impurity ((E)-5-(2-Bromovinyl)uracil ) | 69304-49-0 | C6H5BrN2O2 | 217.02 | 5-[(1E)-2-Bromoethenyl]-2,4(1H,3H)-pyrimidinedione |
Brivudine | 69304-47-8 | C11H13BrN2O5 | 333.138 | brivudin, RP-101, RP 101; RP101; BvdU,(E)-5-2-bromovinyl)-2'-deoxyuridine; |
Brivaracetam acid | 943986-67-2 | C11H19NO3 | 213.27 | Brivaracetam Impurity B; (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanoic acid |
Brivaracetam (alfaR, 4S)-Isomer | 357336-99-3 | C11H20N2O2 | 212.29 | |
Brivaracetam (alfaR, 4R)-Isomer | 357337-00-9 | C11H20N2O2 | 212.29 | |
Brivanib alaninate | 649735-63-7 | C22H24FN5O4 | 441.45 | BMS-582664 |
Brivanib | 649735-46-6 | C19H19FN4O3 | 370.37756 | BMS-540215 |
BRITE 338733 | 503105-88-2 | C27H35O2N3 | 433.59 | BCP0008025; 2-(4-(5-ethylfuran-2-yl)-6-(2,2,6,6-tetramethylpiperidin-4-ylamino)pyridin-2-yl)-4-methylphenol;2-(6-(2,2,6,6-tetramethylpiperidin-4-ylamino)-4-(5-ethylfuran-2-yl)pyridin-2-yl)-4-methylphenol |
Britannilactone | 33620-72-3 | C15H22O4 | 266.33 | Desacetylinulicin |
Britanin | 33627-28-0 | C19H26O7 | 366.41 | Britannin; [(3aS,5R,5aS,6S,8S,8aS,9S,9aR)-9-acetyloxy-8-hydroxy-5,8a-dimethyl-1-methylidene-2-oxo-4,5,5a,6,7,8,9,9a-octahydro-3aH-azuleno[6,5-b]furan-6-yl] acetate |
Brinzolamide-d5 | 1217651-02-9 | C12H16N3O5S3D5 | 388.58 | (4R)-(Ethylamino-d5)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide; AL-4682-d5; Azopt-d5 |
Brinzolamide Related Compound C | 154127-19-2 | C12H21N3O5S3 | 383.51 | (S)-Brinzolamide; (S)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide; AL 4862 |
Brinzolamide Related Compound B | 404034-55-5 | C10H17N3O5S3 | 355.46 | (4R)-4-Amino-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide; AL 8520; N-Desethyl Brinzolamide |
Brinzolamide Related Compound A | 154127-42-1 | C10H16N2O6S3 | 356.44 | (S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide; (4S)-1,1-dioxide-3,4-dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide; 2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide,3,4- |
Brinzolamide | 138890-62-7 | C12H21N3O5S3 | 383.51 | AL-4862; AL 4862; AL4862; Brinzolamide; trade names Azopt, Alcon Laboratories, Befardin, Fardi Medicals |
Brinazarone | 89622-90-2 | C25H32N2O2 | 392.54 | |
Brimonidine-d4 D-Tartrate | 1316758-27-6 | C11H6D4BrN5·C4H6O6 | 446.25 | 5-Bromo-N-(4,5-dihydro-1H-imidazol-d4-2-yl)-6-quinoxalinamine D-Tartrate |
Brimonidine-d4 | 1184971-51-4 | C11H6D4BrN5 | 296.18 | 5-Bromo-N-(4,5-dihydro-1H-imidazol-d4-2-yl)-6-quinoxalinamine; 5-Bromo-6-(2-imidazolin-d4-2-ylamino)quinoxaline; AGN-190342-d4; UK-14304-d4 |
Brimonidine Tartrate Impurity 1 | 182627-95-8 | C11H10BrN5O2 | 324.14 | Brimonidine-2,3-dione; 5-Bromo-6-[(4,5-dihydro-1H-imidazol-2-yl)amino]-1,4-dihydro-2,3-quinoxalinedione |
Brimonidine Tartrate | 70359-46-5 | C15H16BrN5O6 | 442.22 | Brimonidine L-Tartrate; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine L-Tartrate; 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline; UK-14304-18; AGN-190342-LF |
Brimonidine Related Impurity 3 | 135306-56-8 | C9H5N3S | 187.22 | Quinoxaline 6-Isothiocyanate; 6-Isothiocyanatoquinoxaline |
Brimonidine Related Impurity 2 | 151110-15-5 | C11H8BrN5 | 290.12 | 4,5-Didehydro Brimonidine; 5-Bromo-N-1H-imidazol-2-yl-6-quinoxalinamine; Brimonidine EP Imprurity F |
Brimonidine Related Compound (6-Aminoquinoxaline) | 6298-37-9 | C8H7N3 | 145.17 | 6-Amino-quinoxaline; (Quinoxalin-6-yl)amine; NSC 41810 |
Brimonidine Related Compound (5-Bromo-6-Aminoquinoxaline) | 50358-63-9 | C8H6BrN3 | 224.06 | 6-Amino-5-bromoquinoxaline; 5-Bromoquinoxalin-6-amine |
Brimonidine impurity II | 91147-43-2 | C11H11N5 | 213.24 | N-(4,5-Dihydro-1H-imidazol-2-yl)-6-quinoxalinamine; UK 41511 |
Brimonidine Impurity I | 842138-74-3 | C9H7BrN4S | 283.15 | 5-Bromoquinazolin-6-ylthiourea; N-(5-bromo-6-quinoxalinyl)thioure; Thiourea,N-(5-broMo-6-quinoxalinyl)-; (5-Bromo-6-quinoxalinyl)thiourea |
Brimonidine Impurity H | 91147-46-5 | C11H10ClN5 | 247.69 | UK 14819; 5-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine |
Brimonidine D-tartrate | 79570-19-7 | C11H10BrN5.C4H6O6 | 442.22100 | |
Brimonidine | 59803-98-4 | C11H10BrN5 | 292.13 | UK 14,304; UK14,304; UK-14,304; UK14304; Brimonidine; AGN 190342; AGN-190342; AGN1903425-bromo-n-(4,5-dihydro-1h-imidazol-2-yl)-6-quinoxalinamin; |
Brilliant Sulfaflavine | 2391-30-2 | C19H14N2O5S.Na | 404.37 | CI NO 56205; CI 56205; BRILLIANT ACID YELLOW 8G; BRILLIANT SULFAFLAVINE; BRILLIANT SULFOFLAVINE; Brilliant Sulphaflavine; BRILLIANT SULPHO FLAVINE FFA; LISSAMINE FLAVINE |
Brilliant Green (C.I. 42040) | 633-03-4 | C27H34N2O4S | 482.64 | |
Brilliant cresyl blue zinc chloride double salt | 51716-96-2 | C34H40Cl4N6O2Zn | 771.92 | BRILLIANT CRESYL BLUE ALD; BRILLIANT CRESYL BLUE ZINC CHLORIDE DOUBLE SALT; BRILLIANT BLUE C; CI NO 51010; CRESYL BLUE; CRESYL BLUE BBS |
Brilliant Carmine 6B | 5281-04-9 | C18H14N2O6S | 424.44 | |
Brilliant Blue G | 6104-58-1 | C47H48N3O7S2·Na | 832.04 | Acid Blue 90; CBBG; Coomassie Brilliant Blue G-250; NSC 328382 |
Brilacidin | 1224095-98-0 | C40H50F6N14O6 | 936.9 | PMX30063; PMX-30063; PMX 30063; 4-N,6-N-bis[3-[5-(diaminomethylideneamino)pentanoylamino]-2-[(3R)-pyrrolidin-3-yl]oxy-5-(trifluoromethyl)phenyl]pyrimidine-4,6-dicarboxamide |
Brij52 | 9004-95-9 | C56H114O21 | 1123.49000 | Polyethylene glycol hexadecyl ether, Polyoxyethylene (2) cetyl ether |
Brij30 | 9002-92-0 | C58H118O24 | 1199.54000 | Polyethylene glycol dodecyl ether |
Brigatinib | 1197953-54-0 | C29H39ClN7O2P | 584.10 | AP26113 |
Briciclib | 865784-01-6 | C19H21Na2O10PS | 518.38 | ON-013105; ON013105; ON 013105; ON 014185; ON014185; ON-014185 |
Briciclib | 865783-99-9 | C19H23O10PS | 474.42 | Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate);ON-014185;(E)-5-[[(2,4,6-Trimethoxystyryl)sulfonyl]methyl]-2-methoxyphenyl dihydrogen phosphate;[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl] |
Breyniaionoside A | 823182-23-6 | C19H32O9 | 404.456 | (4S,5R)-4-hydroxy-4-[(E)-4-hydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]-3,3,5-trimethylcyclohexan-1-one |
Brexpiprazole-d8 | 1427049-21-5 | C25H19N3O2SD8 | 441.63 | |
Brexpiprazole Impurity 9 | 31570-97-5 | C9H7NO2 | 161.16 | 5-Hydroxyquinolin-2(1H)-one; 5-Hydroxy-2(1H)-quinolone; 5-Hydroxycarbostyril; NSC 134652 |
Brexpiprazole Impurity 10 | 15116-41-3 | C16H15NO2 | 253.30 | m-Cinnamanisidide; N-(3-Methoxyphenyl)-3-phenylpropenamide |
Brexpiprazole dihydrochloride | 913612-38-1 | C25H27N3O2S.2HCl | 506.49 | 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-2(1H)-Quinolinone dihydrochloride;7-[4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one dihydrochloride |
Brexpiprazole | 913611-97-9 | C25H27N3O2S | 433.58 | 7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one; OPC 34712 |
Brevilin A | 16503-32-5 | C20H26O5 | 346.4 | 6-O-Angeloylplenolin |
brevifolin carboxylic acid | 18490-95-4 | C13H8O8 | Brevifolic acid | |
Bretylium | 59-41-6 | C11H17BrN+ | 243.16338;g/mol | Bretylium;Bretyliumtolsylate;Bretylum;59-41-6;UNII-RZR75EQ2KJ;C11H17BrN |
Brequinar sodium | 96201-88-6 | C23H14F2NO2Na | 397.35 | 6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium; Dup 785 |
Brequinar | 96187-53-0 | C23H15F2NO2 | 375.375 | Brequinar; Bipenquinate; DUP 785; NSC 368390. |
Bremelanotide Acetate | 1607799-13-2 | C52H72N14O12 | 1085.22 | (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid;acetic acid Breme |
Bremelanotide | 189691-06-3 | C50H68N14O10 | 1025.182 | PT-141 |
Brefeldin C | 73899-78-2 | C16H24O3 | 0 | Brefeldin C; (1R,2E,6S,10E,11aS,14aR)-1,6,7,8,9,11a,12,13,14,14a-Decahydro-1-hydroxy-6-methyl-4H-cyclopent[f]oxacyclotridecin-4-one |
Brefeldin A | 20350-15-6 | C16H24O4 | 280.36 | Ascotoxin; Synergisidin; Decumbin; Nectrolide; (1R,2R,3E,7S,11E,13S,15S)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one |
Brecanavir | 313682-08-5 | C33H41N3O10S2 | 703.82 | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[1,3-benzodioxol-5-ylsulfonyl(2-methylpropyl)amino]-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate; |
BRD9539 | 1374601-41-8 | C24H21N3O3 | 399.4 | BRD-9539; BRD 9539 |
BRD7552 | 1137359-47-7 | C33H33N3O15 | 711.63 | |
BRD73954 | 1440209-96-0 | C16H16N2O3 | 284.31 | |
BRD7116 | 329059-55-4 | C28H36N2O4S | 496.66 | BRD-7116; 2,2,3,3-tetramethyl-N-[4-[4-[(2,2,3,3-tetramethylcyclopropanecarbonyl)amino]phenyl]sulfonylphenyl]cyclopropane-1-carboxamide |
BRCA1-IN-1 | 1622262-74-1 | C27H33F2N4O6P | 578.54 | [(3S)-1,1-difluoro-3-[3-(1H-indol-3-yl)propanoylamino]-4-oxo-4-[[2-oxo-2-(4-phenylbutylamino)ethyl]amino]butyl]phosphonic acid |
Brazilin | 474-07-7 | C16H14O5 | 286.3 | Natural Red 24 |
Braylin | 6054-10-0 | C15H14O4 | 258.3 | N'-[(Z)-indol-3-ylidenemethyl]-1-(4-methoxyphenyl)-5-oxopyrrolidine-3-carbohydrazide |
Brassylic acid dimethyl ester | 1472-87-3 | C15H28O4 | 272.38000 | |
Brassinolide | 72962-43-7 | C28H48O6 | 480.68 | Brassin lactone |
Brassinin | 105748-59-2 | C11H12N2S2 | 236.36 | Methyl (1H-indol-3-ylmethyl)carbamodithioate |
Brassinazole | 224047-41-0 | C18H18ClN3O | 327.8 | Brassinazole |
Brassidic acid | 506-33-2 | C22H42O2 | 338.57 | 13-TRANSDOCOSENOIC ACID; 13TR-DOCOSENOIC ACID; BRASSIDIC ACID; DELTA 13 TRANS DOCOSENOIC ACID; TRANS-13-D-DOCOSENOIC ACID; TRANS-13-DOCOSENOIC ACID |
Brassicin | 6743-96-0 | C22H22O12 | 478.40 | Isorhamnetin 7-glucoside; isorhamnetin 7-O-beta-D-glucopyranoside |
Brasofensine | 171655-91-7 | C16H20Cl2N2O | 327.26 | 3beta-(3,4-Dichlorophenyl)-1alphaH,5alphaH-tropane-2alpha-carboxaldehyde (E)-(O-methyloxime); Brasofensine [INN]; Brasofensine; BMS 204756; BMS-204756; BMS204756; UNII-1YP2S94RVH; CID9554198; NS 2214 |
Br-ANT-ATP | 1350521-49-1 | C17H20BrN6O14P3 (free acid) | 705.2 (free acid) | 2'- / 3'- O- (5- Bromoanthraniloyl)adenosine- 5'- O- triphosphate, sodium salt |
Brandioside | 133393-81-4 | C37H48O20 | 812.771 | 2'-O-Acetylpoliumoside; [5-acetyloxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
Brain natriuretic peptide (1-32) (human) | 124584-08-3 | C143H244N50O42S4 | 3464.05 | BNP-32 (human) |
B-Raf inhibitor 1 dihydrochloride | 1191385-19-9 | C26H21Cl3N8 | 551.86 | 1,5-Isoquinolinediamine, N1-(4-chlorophenyl)-6-methyl-N5-[3-(9H-purin-6-yl)-2-pyridinyl]-, hydrochloride (1:2) |
B-Raf inhibitor 1 | 1093100-40-3 | C26H19ClN8 | 478.94 | |
B-Raf inhibitor | 1315330-11-0 | C29H31F3N6O2 | 552.59 | Benzamide, N-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[(6-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]- |
BRAF inhibitor | 918505-61-0 | C22H18F2N4O3S | 456.47 | 2-Propanesulfonamide, N-[2,4-difluoro-3-[[5-(3-pyridinyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]phenyl]- |
B-Raf IN 1 | 950736-05-7 | C29H24F3N5O | 515.53 | |
BRACO 19 trihydrochloride | 1177798-88-7 | C35H43N7O2.3HCl | 703.14 | N,N'-[9[[4-(Dimethylamino)phenyl]amino]-3,6-acridinediyl]bis-1-pyrrolidinepropanamide trihydrochloride |
BQU57 | 1637739-82-2 | C16H13F3N4O | 334.1 | |
BQR695 | 1513879-21-4 | C19H20N4O3 | 352.39 | BQR-695; NVP-BQR695; CS-8070; HY-18748; 2-[[7-(3,4-dimethoxyphenyl)quinoxalin-2-yl]amino]-N-methylacetamide |
BQCA | 338747-41-4 | C18H15NO4 | 309.32 | 1-(4-Methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid; 1,4-Dihydro-1-[(4-methoxyphenyl)methyl]-4-oxo-3-quinolinecarboxylic Acid |
BQ-3020 | 143113-45-5 | C96H140N20O25S | 2006.35 | Endothelin receptor antagonist; Acetyl-(Ala 11,15)-ET 1 (6-21) |
BQ-123 | 136553-81-6 | C31H42N6O7 | 610.7 | BQ123 |
BQ 788 sodium salt | 156161-89-6 | C34H50N5NaO7 | 663.78 | N-[(cis-2,6-Dimethyl-1-piperidinyl)carbonyl]-4-methyl-L-leucyl-1-(methoxycarbonyl)-D-tryptophyl-D-norleucine sodium salt |
bpV(pic) potassium hydrate | 148556-27-8 | C6H4NO7V·2K·2H2O | 367.3 | Bisperoxovanadium(pic) |
bpV(phen) potassium hydrate | 171202-16-7 | C12H8N2O5V·K+(H2O)3 | 404.3 | Bisperoxovanadium(phen); Potassium Bisperoxo(1,10-phenanthroline) oxovanadate (V) |
bpV(HOpic) potassium salt | 722494-26-0 | C6H4NO8V·2K | 347.2 | Bisperoxovanadium(HOpic) |
BPTU | 870544-59-5 | C23H22F3N3O3 | 445.43 | BMS compound 16; N-[2-[2-(1,1-Dimethylethyl)phenoxy]-3-pyridinyl]-N'-[4-(trifluoromethoxy)phenyl]urea |
BPTES | 314045-39-1 | C24H24N6O2S3 | 524.68 | |
BPR1K653 | 1192754-07-6 | C30H30Cl2N6O2 | 541.04 | BPR1K653; BPR1K 653; BPR1K-653 |
BPR1J-340 | 1395051-72-5 | C29H34N8O3 | 542.632 | BPR1J-340; BPR1J 340; BPR1J340. |
BPR1J-097 | 1327167-19-0 | C27H28N6O3S | 516.62 | BPR1J-097 |
BPOC REAGENT | 31140-37-1 | C24H22O5 | 390.43 | 2-(4-BIPHENYL)-PROP-2-YL-4-METHOXYCARBONYLPHENYL CARBONATE; 2-(4-BIPHENYLYL)-PROP-2-YL 4'-METHOXYCARBONYLPHENYL CARBONATE; 2-(4-BIPHENYLYL)-PROP-2-YL 4-METHOXYCARBONYLPHENYL CARBONATE; BIPHENYLISOPROPYL-4-METHOXYCARBONYL-PHENYLCARBONATE; BPOC REAGENT; BPO |
BPO-27 racemate | 1314873-02-3 | C26H18BrN3O6 | 548.34 | BPO-27 (racemate); CHEMBL1831075; BPO-27 racemat |
BPIQ-II hydrochloride | 171179-37-6 | C15H10BrN5·HCl | 376.6 | PD 158294 |
BPIQ-I | 174709-30-9 | C16H12BrN5 | 354.2 | PD 159121 |
BPIPP | 325746-94-9 | C22H16BrN3O3 | 450.28 | 5-(3-Bromophenyl)-5,11-dihydro-1,3-dimethyl-1H-indeno[2',1':5,6]pyrido[2,3-d]pyrimidine-2,4,6(3H)-trione |
BPH715 | 1059677-23-4 | C17H31NO7P2 | 423.38 | BPH-715;3-(Decyloxy)-1-(2-hydrogen phosphonato-2-phosphonoethyl)pyridin-1-ium;Bisphpshonate-715;[2-(3-Decoxypyridin-1-ium-1-yl)-1-phosphonoethyl]-hydroxyphosphinate;BPH-715;GTPL3196;GTPL-3196;Hydrogen (2-(3-(decyloxy)pyridin-1-ium-1-yl)-1-phosphonoethyl)p |
BPH-652 | 157124-84-0 | C16H16K3O7PS | 500.63 | BMS-187745; BPH-652; CHEMBL351151; BMS 188745 Potassium Salt; DNC009027; KB-75764; tripotassium;4-(3-phenoxyphenyl)-1-phosphonatobutane-1-sulfonate |
BPD-Ring B | 143986-17-8 | C42H44N4O8 | 732.83 | BPD-B; Benzoporpyrin Ring B derivative;23H,25H-Benzo[b]porphine-9,13- dipropanoic acid, 19-ethenyl-1,22a-dihydro-1,2-bis(methoxycarbonyl)-8,14,18, 22a-tetramethyl-, dimethyl ester |
BPC-157 | 137525-51-0 | C62H98N16O22 | 1419.556 | BPC 157; Bepecin |
BP-1-102 | 1334493-07-0 | C29H27F5N2O6S | 626.595 | 4-(N-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid |
BP 554 maleate | 1221401-95-1 | C20H24N2O3.C4H4O4 | 456.48 | 1-[3-(3,4-Methylenedioxyphenoxy)propyl]-4-phenyl-piperazine maleate |
Bovine albumin | 9048-46-8 | |||
Botiacrine | 4774-53-2 | C20H24N2OS | 340.48236;g/mol | S-[2-(dimethylamino)ethyl]9,9-dimethylacridine-10-carbothioate;Botiacrine;Botiacrinum[INN-Latin];Botiacrino[INN-Spanish];UNII-032WJR708Q;Mo876 |
Bosutinib Isomer | 1391063-17-4 | C26H29Cl2N5O3 | 530.46 | 4-[(3,5-Dichloro-4-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile; Bosutinib isomer 4; PF-06651481; PF-06651481-00 |
Bosutinib | 380843-75-4 | C26H29Cl2N5O3 | 530.45 | SKI606; SKI 606; SK-I606. Bosutinib; Brand name: Bosulif. |
Bostrycin | 21879-81-2 | C16H16O8 | 336.29 | Rhodosporin |
Bosentan-d4 | 1065472-77-6 | C27H25N5O6SD4 | 555.65 | 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy-d4)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide; p-tert-Butyl-N-[6-(2-hydroxyethoxy-d4)-5- (o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide; Actelion-d4; Ro 47-0203-d4 |
Bosentan Related Compound 3 | 150727-06-3 | C25H24ClN5O4S | 526.02 | N-[6-Chloro-5-(2-methoxyphenoxy)-(2,2-bipyrimidine)4-4-yl]-(1,1-dimethylethyl)-benzenesulfonamide; 4-tert-Butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzeneSulfonamide |
Bosentan Related Compound 2 | 6292-59-7 | C10H15NO2S | 213.30 | 4-tert-Butylbenzenesulfonamide; 4-(1,1-Dimethylethyl)benzenesulfonamide; p-tert-butyl-Benzenesulfonamide; NSC 9911 |
Bosentan Impurity D | 174227-14-6 | C25H25N5O5S | 507.57 | O-Deshydroxyethyl Bosentan; N-[1,6-Dihydro-5-(2-methoxyphenoxy)-6-oxo[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide; 4-tert-Butyl-N-[6-hydroxy-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide |
Bosentan hydrate | 157212-55-0 | C27H29N5O6S.H2O | 569.63 | Ro 47-0203 |
Bosentan | 147536-97-8 | C27H29N5O6S | 551.61 | Ro 47-0203 |
Boscialin | 129277-03-8 | C13H22O3 | 226.316 | (E)-4-[(1S,4S,6R)-1,4-dihydroxy-2,2,6-trimethylcyclohexyl]but-3-en-2-one |
Boscalid | 188425-85-6 | C18H12Cl2N2O | 343.21 | Nicobifen; Endura |
Bortezomib-d5 | 1133706-15-6 | C19H20BN4O4D5 | 389.28 | |
Bortezomib USP Impurity G | 1132709-14-8 | C19H25BN4O4 | 384.243 | (1S,2S)-Bortezomib; ((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid |
Bortezomib Pinanediol Ester | 205393-22-2 | C29H39BN4O4 | 518.46 | N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide; |
Bortezomib Impurity H | 1446194-56-4 | C19H24N4O2 | 340.43 | (S)-N-(1-(isopentylaMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
Bortezomib Impurity G | 289472-81-7 | C19H24N4O3 | 356.43 | (S)-Hydroxy Des(boric Acid) Bortezomib; N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-Pyrazinecarboxamide |
Bortezomib Impurity F | 73058-37-4 | C15H15N3O3 | 285.31 | 3-Phenyl-2-[(pyrazine-2-carbonyl)-amino]-propionic Acid Methyl Ester; N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester; N-(2-Pyrazinylcarbonyl)-L-phenylalanine Methyl Ester |
Bortezomib Impurity B | 114457-94-2 | C14H13N3O3 | 271.28 | Bortezomib Impurity B is used for the synthesis of Bortezomib. |
Bortezomib Impurity A | 289472-80-6 | C14H14N4O2 | 270.29 | N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide; N-[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]pyrazinecarboxamide; (S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide; 2-PyrazinecarboxaMide, N-[(1S)-2-aMino-2-oxo-1-(phenylMet |
Bortezomib Impurity 9 | 1194235-41-0 | C28H34BN5O5 | 531.42 | N-(2-Pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-methylbutyl]-L-phenylalaninamide ; ((R)-3-Methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butyl)boronic Acid |
Bortezomib Impurity 4 | 862894-96-0 | C19H22N4O3 | 354.41 | N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib; (S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
Bortezomib Impurity 2 (SR-Isomer, Bortezomib Impurity E) | 289472-78-2 | C19H24N4O3 | 356.43 | |
Bortezomib Impurity 13 | 886979-81-3 | C19H24N4O4 | 372.43 | 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-; N-((S)-1-(((S)-1-hydroperoxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
Bortezomib Impurity 12 | 886979-78-8 | C19H24N4O4 | 372.43 | (R)-Hydroperoxy Des(boric Acid) Bortezomib; N-((S)-1-(((R)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- |
Bortezomib Impurity 10 | 390800-88-1 | C57H69B3N12O9 | 1098.69 | 2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- |
Bortezomib Impurity (R,S-Isomer) | 1132709-16-0 | C19H25BN4O4 | 384.25 | (1S,2R)-Bortezomib; B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; N-(2-Pyrazinecarbonyl)-D-phenylalanine-D-leucine boronic anhydride |
Bortezomib Impurity (R,R-Isomer) | 1132709-15-9 | C19H25BN4O4 | 384.25 | (1R,2R)-Bortezomib; B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid |
Bortezomib | 179324-69-7 | C19H25BN4O4 | 384.24 | PS-341; PS 341; PS341; LDP 341; LDP-341 ;LDP341; MLN341; MLN-341; MLN 341. US brand name: VELCADE. |
Borreriagenin | 249916-07-2 | C10H14O5 | 214.2 | Morindacin |
Borrelidin | 7184-60-3 | C28H43NO6 | 489.6 | Treponemycin, U 78548, C2989 |
Boronicacid, B-(2-chloro-5-hydroxyphenyl)- | 913835-71-9 | C6H6 B Cl O3 | 172.37404 | 2-CHLORO-5-HYDROXYBENZENEBORONIC ACID; 2-CHLORO-5-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-5-HYDROXYBENZENEBORONIC ACID 98; 2-Chloro-5-hydroxybenzeneboronic acid 98% |
Boronic acid,B-phenyl-, dimethyl ester | 13471-35-7 | C8H11 B O2 | ||
Boronic acid,B-bicyclo[2.2.1]hept-2-en-2-yl- | 871333-98-1 | C7H11 B O2 | 137.97 | 2-NORBORNEN-2-YLBORONIC ACID; BICYCLO[2.2.1]HEPT-2-EN-2-YLBORONIC ACID; Bicyclo[2.2.1]hept-2-en-2-ylboronic acid 95% |
Boronic acid,B,B'-(2,5-dihexyl-1,4-phenylene)bis- | 131117-66-3 | C18H32 B2 O4 | 334.07 | 2,5-BIS(HEXYL)-1,4-BENZENEBIS(BORONIC ACID); 2,5-DIHEXYLBENZENE-1,4-BIS(BORONIC ACID); RARECHEM AH PB 0009; (2,5-Dihexyl-1,4-phenylene)bis-boronic acid |
Boronic acid, 1,3-benzodioxol-4-yl- (9CI) | 361456-68-0 | C7H7BO4 | 165.93908 | 361456-68-0; 2,3-METHYLENEDIOXYPHENYLBORONICACID; Benzo[d][1,3]dioxol-4-ylboronicacid; 1,3-benzodioxol-4-ylboronicacid; Boronicacid,1,3-benzodioxol-4-yl-; 1,3-BENZODIOXOLE-4-BORONICACID |
Boronic acid, (5-chloro-3-thienyl)- (9CI) | 199659-23-9 | C4H4 B Cl O2 S | 162.4 | 5-CHLOROTHIOPHENE-3-BORONIC ACID; AKOS BRN-1127; 5-chlorothiophen-3-yl-3-boronic acid |
Boronic acid, (1-methyl-4-piperidinyl)- (9CI) | 706748-53-0 | C6H14BNO2 | 142.99186 | |
Boron trifluoride-piperidine complex | 592-39-2 | C5H11BF3N | 152.954 | Boron trifluoride-piperidine complex; Piperidinium trifluoroborate |
BORON TRIFLUORIDE-PHENOL COMPLEX (1:2) | 462-05-5 | C6H6BF3O | 161.92 | BORON TRIFLUORIDE-PHENOL COMPLEX (1:2); BORON TRIFLUORIDE PHENOL COMPLEX (BF3 ABOUT 30%); Boron trifluoride phenol complex compound |
Boron trifluoride-methanol solution | 373-57-9 | CH4BF3O | 99.85 | |
Boron trifluoride tetrahydrofuran complex | 462-34-0 | 139.91 | BORON TRIFLUORIDE TETRAHYDROFURAN COMPLEX; trifluoro(tetrahydrofuran)boron; BORON TRIFLUORIDE TETRAHYDROFURANE; Boron, trifluoro(tetrahydrofuran)-, (T-4)-; Boron trifluoride tetrahydrofuran complex 95%; Borontrifluoridetetrahydrofurancomplex95% | |
Boron trifluoride phenol complex | 106951-44-4 | BF3.C6H6O | 161.92 | Phenol, reaction products with boron trifluoride; Boron trifluoride phenol complex; Boron fluoride, diphenylate; Boron trifluoride phenol (1:2) complex; Boron trifluorodiphenyl |
Boromycin | 34524-20-4 | C45H73BNO15·H | 879.88 | NSC 121380 |
BoroGly-(+)-Pinanediol-HCl | 877314-87-9 | C11H20 B N O2 . Cl H | 245.55400 | BoroGly-(+)-Pinanediol-HCl; Borogly-(+)-pinanediol-hydrochloride |
BORNYL SALICYLATE | 560-88-3 | C17H22O3 | 274.35 | BORNYL SALICYLATE; 2-hydroxy-,1,7,7-trimethylbicyclo[2.2.1]hept-2-ylester,endo-benzoicaci; endo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl salicylate; Einecs 209-213-5 |
Bornyl isovalerate | 76-50-6 | C15H26O2 | 238.37 | 2-Bornyl 3-methylbutyrate; 3-methyl-,1,7,7-trimethylbicyclo(2.2.1)hept-2-ylester,endo-butanoicaci; 3-methyl-,1,7,7-trimethylbicyclo[2.2.1]hept-2-ylester,endo-butanoicaci; 3-methyl-,1,7,7-trimethylbicyclo[2.2.1]hept-2-ylester,endo-Butanoicacid; Bornyl este |
Bornyl acetate | 76-49-3 | C12H20O2 | 1,7,7-Trimethylbicyclo(2.2.1)heptan-2-ol acetate; 1,7,7-Trimethylbicyclo(2.2.1)heptan-2-yl acetate, endo-; 2-Camphanol acetate; | |
Borneol | 464-45-9 | C10H18O | 154.25 | BORNYL ALCOHOL;FEMA 2157; |
Borneol | 507-70-0 | C10H18O | 154.25 | 1,7,7-Trimethyl-bicyclo(2.2.1)heptan-2-ol, endo-; 1,7,7-trimethyl-endo-Bicyclo[2.2.1]heptan-2-ol; 2-Bornanol, endo-; 2-endo-Borneol; 2-endo-Bornylalcohol; 2-hydroxy-camphan; 2-Hydroxycamphane; 7,7-trimethyl-endo-bicyclo(2.2.1)heptan-2-o |
Bornaprine | 20448-86-6 | C21H31NO2 | 329.49 | 2-Phenylbicyclo[2.2.1]heptane-2-carboxylic acid 3-(diethylamino)propyl ester; 3-(Diethylamino)propyl 2-phenyl-2-norbornanecarboxylate; Sormodren |
bornane | 464-15-3 | C10H18 | 138.25 | 1,7,7-Trimethylbicyclo[2.2.1]heptane |
Borin | 31029-61-5 | C5H5 B | 75.9042;g/mol | borinine; Borin; Borinine; 31029-61-5; BORABENZENE; HE027339 |
Boric acid tris(4-chlorophenyl) ester | 7359-58-2 | C18H12BCl3O3 | 393.46 | TRIS(4-CHLOROPHENYL) BORATE; BORIC ACID TRIS(4-CHLOROPHENYL) ESTER; Boricacidtrischlorophenylester |
Boric acid (H3B3O6) | 13460-51-0 | B3H3 O6 | 128.89904 | Trihydroxyboroxine; 2,4,6-trihydroxy-1,3,5,2,4,6-trioxatriborinane; 13460-51-0; AC1L3EWP; BORICACID(H3B3O6); CTK0H7086 |
Boric acid | 11113-50-1 | H3BO3 | 61.83 | Boric acid; Borsrenatliche |
Borazine,1,3,5-trimethyl- | 1004-35-9 | C3H12 B3 N3 | 122.5805 | 1,3,5-TRIMETHYLBORAZINE; Borazine,1,3,5-trimethyl-; N,N',N''-Trimethylborazine; Trimethylborazine; N,N',N"1 |
Borax 5-hydrate | 12179-04-3 | Na2B4O7.5(H2O) | 291.29 | Borax 5-hydrate; Sodium tetraborate 5-hydrate |
Borate(1-),tetrakis(pentafluorophenyl)-, lithium (1:1) | 2797-28-6 | C24B F20 . Li | 760.1 | [LI(C6F5)4B] NOET2; LITHIUM TETRAKIS(PENTAFLUOROPHENYL)-BORATE DIETHYLETHER COMPLEX; LITHIUM TETRAKIS(PENTAFLUOROPHENYL)BORATE ETHERATE; LITHIUM TETRAKIS(PENTAFLUOROPHENYL)BORATE-ETHYL ETHER COMPLEX; LITHIUM TETRAKIS(PENTAFLUOROPHENYL)BORATE ETHYL ETHERAT |
Borate(1-),tetrakis(cyano-kC)-, sodium (1:1) | 623575-91-7 | C4B N4 . Na | ||
Borate(1-),tetrakis(cyano-kC)-, potassium (1:1) | 261356-49-4 | C4B N4 . K | 153.9789;g/mol | potassium; tetracyanoboranuide; Potassiumtetracyanoborate; 261356-49-4; SCHEMBL1466551; MolPort-035-766-861 |
Borate(1-),tetraethyl-, sodium (1:1) | 15523-24-7 | C8H20 B . Na | 150.05 | SODIUM TETRAETHYLBORATE; TetraethylborateSodium; Sodium tetraethylborate, pure, 97%; Sodiumtetraethylborate,min.98%; steb; SODIUM TETRAETHYLBORATE (SN-CONTENT <1PPM)) |
Borapetoside B | 104901-05-5 | C27H36O12 | 552.568 | methyl (2S,4aS,6S,6aR,9R,10aS,10bS)-2-(furan-3-yl)-9-hydroxy-6a,10b-dimethyl-4-oxo-6-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4,4a,5,6,6a,9,10,10a,10b-decahydro-2H-benzo[f]isochromene-7-carboxylate |
BORANE-PIPERAZINE | 55235-17-1 | C4H10BN2 | 96.9466;g/mol | boron;piperazine;BORANE-PIPERAZINE;CTK1G8917;BORANE/PIPERAZINECOMPLEX;HE351932 |
Borane-methylsulfide complex | 13292-87-0 | C2H9BS | 75.97 | |
BORANE-DIISOPROPYLAMINE | 55124-35-1 | |||
Borane-d3 | 13763-62-7 | BD3 | 16.85 | BORANE-D3; Borane-d3, 1M in tetrahydrofuran; Borane-d3, 1M in tetrahydrofuran, packaged under Argon in resealable ChemSealTM bottles; Borane-d3, 1M in tetrahydrofuran; Borane-d3, 1M in tetrahydrofuran, packaged under Argon in reseala |
Borane,dibromomethyl- (7CI,8CI,9CI) | 17933-16-3 | CH3 B Br2 | 185.6535 | dibromo(methyl)borane; Methylborondibromide; Borane,dibromomethyl-(7CI,8CI,9CI); 17933-16-3; CH3BBr2; Methyldibromoborane |
borane ammonia complex | 13774-81-7 | 30.86 | Ammoniaborane; Ammonia-borane(1/1); Boron,amminetrihydro-,(T-4)-; BORANE-AMMONIA; BORANE AMMONIA COMPLEX; BORANE-AMMONIA COMPLEX, TECH., 90%; BORINE AMMONIA COMPOUND | |
Borage oil from Borago officinalis seeds | 84012-16-8 | |||
Bopindolol malonate | 82857-38-3 | C23H28N2O3·C3H4O4 | 484.5 | Bopindolol Malonate; AC1LCS45; SCHEMBL348872; CTK8F8315; HE393689; LS-120081; D01794; Wandonorm |
Bopindolol Malonate | 62658-64-4 | C26H32N2O7 | 484.54 | Bopindolol hydrogen malonate;Sandonorm;Wandonorm;2-Propanol, 1-((1,1-dimethylethyl)amino)-1-((2-methyl-1H-indol-4-yl)oxy)-, benzoate (ester), (+-)-, propanedioate (1:1) (salt);[1-(Tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl] benzoate propa |
BOP sodium salt | 1947348-42-6 | C25H28N3O7SNa | 537.56 | N-(Benzenesulfonyl)-L-prolyl-L-O-(1-pyrrolidinylcarbonyl)tyrosine sodium salt |
BoNT-IN-1 | 694443-03-3 | C23H20N4O3 | 400.43 | 2-Methyl-7-{[(4-methyl-2-pyridinyl)amino](2-nitrophenyl)methyl}-8-quinolinol; |
Bongkrekic acid | 11076-19-0 | C28H38O7 | 486.6 | Flavotoxin A |
Bongardol | 123690-76-6 | C36H64O3 | 544.9 | Octacosanoic acid 2-(4-hydroxyphenyl)ethyl ester |
Bone meal | 68409-75-6 | 0 | ||
Bonducellpin D | 197781-85-4 | C22H28O7 | 404.45 | (3bS,3b1R,5aR,6S,6aR,10S,10aS,10bS)-6a,10-dihydroxy-7,7,10a-trimethyl-4-oxo-3b,3b1,5a,6,6a,7,8,9,10,10a,10b,11-dodecahydro-4H-phenanthro[3,2-b:10,1-b'c']difuran-6-yl acetate;(+)-Bonducellpin D |
Bonducellpin C | 197781-84-3 | C15H21N3O15 | 483.34 | methyl (1S,4aR,6S,6aR,7S,11aS,11bS)-1-acetoxy-4a,6-dihydroxy-4,4,11b-trimethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydrophenanthro[3,2-b]furan-7-carboxylate |
Bonducellin | 83162-84-9 | C17H14O4 | 282.29 | (3E)-7-hydroxy-3-[(4-methoxyphenyl)methylidene]chromen-4-one |
Bometolol Hydrochloride | 65023-16-7 | C25H33ClN2O7 | 508.99 | 5-[3-[2-(3,4-dimethoxyphenyl)ethylamino]-2-hydroxypropoxy]-8-(2-oxopropoxy)-3,4-dihydro-1H-quinolin-2-one;hydrochloride |
Bombiprenone | 21978-49-4 | C43H70O | ||
Bombinakinin-GAP | 573671-91-7 | C145H219N39O39S3 | 3228.75 | |
Bombinakinin M | 509151-65-9 | C100H159N31O24 | 2179.55 | Maximakinin |
bolenol | 16915-78-9 | C20H32O | 0 | bolenol; (17S)-19-Norpregn-5-en-17-ol |
Boldine | 476-70-0 | C19H21NO4 | 327.37 | 5,6,6aS,7-tetrahydro-1,10-dimethoxy-6-methyl-4H-dibenzo[de,g]quinoline-2,9-diol;(+)-(S)-Boldine 2,9-Dihydroxy-1,10-dimethoxyaporphine; |
Boldenone undecylenate | 13103-34-9 | C30H44O3 | 452.67 | Boldenone 10-Undecenoate; Ba 29038 |
Bohemine | 189232-42-6 | C18H24N6O | 340.42 | 3-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]propan-1-ol; 6-benzylamino-2-(3-hydroxypropylamino)-9-isopropylpurine; bohemine |
Boc-Valine,NCA | 141468-55-5 | C11H17NO5 | 243.25638;g/mol | tert-butyl(4S)-2,5-dioxo-4-propan-2-yl-1,3-oxazolidine-3-carboxylate; 141468-55-5; Boc-Valine,NCA; Boc-L-Val-NCA; BOC-VAL-NCA; SCHEMBL2132635 |
Boc-Phe-NCA | 142955-51-9 | C15H17 N O5 | 291.301 | Boc-Phe-NCA |
Boc-Orn(Dnp)-OH | 82518-61-4 | C16H22N4O8 | 398.37 | Nalpha-Boc-ndelta-2,4-dinitrophenyl-L-ornithine; Boc-Orn(Dnp)-OH |
Boc-NH-PEG(5)-COOH(22atoms) | 391684-36-9 | |||
Boc-Lys(Tos)-OH | 13734-29-7 | C18H28N2O6S · C12H23N | 581.82 | Boc-Lys(Tos)-OH |
Boc-L-Ornithine Methyl Ester HCl | 748150-93-8 | C11H22N2O4. HCl | 283.31 | Boc-L-Ornithine Methyl Ester HCl; methyl (2S)-5-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate ; |
BOC-L-DPA(BOC)-OH | 88971-40-8 | C13H24N2O6 | 304.34 | RARECHEM EM WB 0105; L-ALANINE, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-; BOC-L-DPA(BOC)-OH; Boc-L-Dap(Boc)-OH |
BOC-L-DAB(BOC) | 34404-27-8 | C14H26N2O6 | 318.37 | BOC-L-DAB(BOC); (S)-2,4-BIS-TERT-BUTOXYCARBONYLAMINO-BUTYRIC ACID |
Boc-L-beta-homoalanine | 158851-30-0 | C9H17NO4 | 203.24 | (S)-3-((tert-Butoxycarbonyl)amino)butanoic acid; Boc-beta-HoAla-OH; Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-, (3S)- |
BoC-L-Ala-nitrile | 130013-83-1 | C8H14N2O2 | 170.21 | (S)-N-BOC-ALANINE-NITRILE; N-[(1S)-1-Cyanoethyl]-carbamic acid 1,1-dimethylethyl ester; BOC-L-ALA-NITRILE; Boc-Ala-Nitrile; Carbamic acid, [(1S)-1-cyanoethyl]-, 1,1-dimethylethyl ester (9CI) |
BOC-HYP-OH | 331442-12-7 | C10H17NO5 | 231.25 | RARECHEM EM WB 0136; N-BOC-TRANS-4-HYDROXY-L-PROLINE; N-BOC-L-TRANS-4-HYDROXYPROLINE; N-BOC-L-4-HYDROXYPROLINE; N-BOC-4-HYDROXY-L-PROLINE; N-ALPHA-T-BUTOXYCARBONYL-TRANS-4-HYDROXY-L-PROLINE; N-ALPHA-TERT-BUTYLOXYCARBONYL-L-4-HYDROXYPROLINE; N-ALPHA-T-BOC- |
BOC-GRR-AMC | 113866-14-1 | C29H44N10O7 | 644.72 | T-BUTYLOXYCARBONYLGLYCYL-L-ARGINYL-L-ARGININE 4-METHYLCOUMARYL-7-AMIDE; BOC-GRR-AMC; BOC-GLY-ARG-ARG-MCA; BOC-GLY-ARG-ARG-AMC; TERT-BUTYLOXYCARBONYL-GLYCYL-L-ARGINYL-L-ARGININE 4-METHYLCOUMARYL-7-AMIDE |
Boc-Glutamic,5-benzyl ester NCA | 160803-29-2 | C11H15NO7 | 273.2393;g/mol | [(3S)-2,6-dioxooxan-3-yl]-[(2-methylpropan-2-yl)oxycarbonyl]carbamicacid; Boc-Glutamic,5-benzylesterNCA; ZINC238791468; 160803-29-2 |
Boc-D-Cyclopentylglycine | 156881-63-9 | C12H21NO4 | 243.3 | BOC-D-CYCLOPENTYL GLYCINE; BOC-D-CYCLOPENTYLGLYCINE 98%; N-tert-Butoxycarbonyl-D-Cyclopentylglycine |
BM 15.766 | 86621-94-5 | C22H25ClN2O2.H2O4S | 482.982 | |
BLZ945 | 953769-46-5 | C20H22N4O3S | 398.48 | |
Blumenol B | 36151-01-6 | C13H22O3 | 226.3 | (4S)-4-Hydroxy-4-[(3R)-3-hydroxybutyl]-3,5,5-trimethyl-2-cyclohex en-1-one |
Blumeatin B | 79995-67-8 | C17H16O7 | 332.3 | Dihydroquercetin 7,4'-dimethyl ether |
Blumeatin | 118024-26-3 | C16H14O6 | 302.28 | 5,3',5'-Trihydroxy-7-methoxyflavanone; 2-(3,5-Dihydroxyphenyl)-5-hydroxy-7-methoxy-3,4-dihydro-2H-1-benzopyran-4-one |
Bistriazole Ketone (1,3-Bis(1H-1,2,4-triazole-1-yl)propan-2-one) | 98414-56-3 | C7H8N6O | 192.18 | 1,3-Bis(1H-1,2,4-triazol-1-yl)-2-propanone; |
Bistachybotrysin E | 2231761-98-9 | C47H64O9 | 773.02 | |
Bispyridoxine | 19203-56-6 | C16H20N2O5 | 320.35 | 5-Hydroxy-2-[[3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridyl]methyl]-6-methyl-3,4-pyridinedimethanol; Pyridoxine Dimer |
Bisphenol-MCyanateEster | 127667-44-1 | |||
Bisphenol -S /Phenolsulfonic acid resin | 71832-81-0 | |||
BISPHENOL F DIGLYCIDYL ETHER | 2095-03-6 | C19H20O4 | 312.36 | 2-((4-[4-(2-Oxiranylmethoxy)benzyl]phenoxy)methyl)oxirane; Benzene, 1,1'-methylenebis[4-[(2-oxiranyl)methoxy]-; Bis[4-[(oxiran-2-yl)methoxy]phenyl]methane; Oxirane, 2,2'-[methylenebis(4,1-phenyleneoxymethylene)]bis-; BFDGE; BIS(4-GLYCIDYLOXYPHENYL)METHANE |
Bisphenol F bis(2,3-dihydroxypropyl) ether | 72406-26-9 | C19H24O6 | 348.39 | |
Bisphenol F | 1333-16-0 | C13H12O2 | 200.23318 | Bis(hydroxyphenyl) methane; HYDROXYPHENYLMETHYLPHENOL; methylenebis-Phenol; Dihydroxydiphenylmethane, isomer mixture |
bis-(1-Phenylpentane-1,3-dionato-O,O')copper | 15443-06-8 | C22H22CuO4 | 413.95368;g/mol | copper;(Z)-3-oxo-1-phenylpent-1-en-1-olate;EINECS239-456-2;AC1NUMXZ;Bis(1-phenylpentane-1,3-dionato-O,O')copper;copper(Z)-3-oxo-1-phenylpent-1-en-1-olate |
BIS(1-METHOXY-2-PROPYL)MALEATE | 102054-10-4 | C12H20O6 | 260.28 | BIS(1-METHOXY-2-PROPYL)MALEATE; BIS(2-METHOXY-1-METHYLETHYL) MALEATE; 2-Butenedioic acid (2Z)-, bis(2-methoxy-1-methylethyl) ester; BIS-(METHOXYMETHYL)ETHYL MALEATE |
Bis-(1H,1H-perfluorooctyl)amine | 3145-68-4 | C16H5F30N | 781.1697 | |
Boceprevir | 394730-60-0 | C27H45N5O5 | 519.687 | EBP 520; EBP-520; EBP520; SCH-503034; SCH503034; SCH 503034 trade name: Victrelis. |
Boc-D-phe(3,4-OH2)-OH | 30033-24-0 | C14H19NO6 | 297.30376;g/mol | (2S)-3-(3,4-dihydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoicacid;Boc-3,4-dihydroxy-L-phenylalanine;30033-24-0;Boc-D-phe(3,4-OH2)-OH;N-Boc-DOPA;N-Boc-(L)-Dopa |
Boc-D-Lys(Z)-OH | 76477-42-4 | C19H28N2O6 | 380.44 | Boc-D-Lys(Z)-OH |
BOC-D-Leucine monohydrate | 16937-99-8 | 249.3 | N-(TERT-BUTOXYCARBONYL)-D-LEUCINE; N-ALPHA-T-BOC-D-LEUCINE; BOC-D-LEU-OH; BOC-D-LEUCINE; L-LEUCINE-5,5,5-D3, N-T-BOC DERIV.H20 98; N-T-BOC-D-LEUCINE | |
Boc-DL-cyclopropylglycine | 54256-41-6 | C10H17NO4 | 215.24 | Boc-DL-Cyclopropylglycine; N-Boc-2-Cyclopropylglycine; 2-(tert-Butoxycarbonylamino)-2-cyclopropylacetic acid |
Boc-DL-cyclopentylglycine | 35264-06-3 | C12H21NO4 | 243.29 | 2-cyclopentyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]aceticacid; Boc-DL-cyclopentylglycine; 35264-06-3; 2-((tert-Butoxycarbonyl)amino)-2-cyclopentylaceticacid; SCHEMBL3372810; MolPort-019-990-192 |
Boc-Diethylglycine | 35264-04-1 | C11H21NO4 | 231.28874 | Boc-Diethylglycine |
BOC-D-FMK | 634911-80-1 | C11H18FNO5 | 263.26 | Caspase Inhibitor III; Boc-Asp(OMe)-fluoromethyl ketone; Boc-Asp(OMe)-FMK; methyl 5-fluoro-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxopentanoate |
Boc-Dab(Alloc)-OH (dicyclohexylammonium) salt | 327156-92-3 | C25H45N3O6 | 483.64 | N-Boc-N-Alloc-L-2,4-diaminobutyric acid (dicyclohexylammonium) salt, N-Alloc-N-Boc-L-2,4-diaminobutyric acid (dicyclohexylammonium) salt |
Bismuth tribromophenate | 5175-83-7 | C18H6BiBr9O3 | 1198.36 | XEROFORM; TRIS(2,4,6-TRIBROMOPHENOXY)BISMUTHINE; 2,4,6-tribromo-phenobismuth(3++)salt; bismuthtris(2,4,6-tribromophenoxide); BISMUTH TRIBROMOPHENATE; BISMUTHTRIBROMOPHENATE,POWDER |
Bismuth telluride(Bi2Te3) | 1304-82-1 | Bi2Te3 | 800.76 | bismuthsesquitelluride; bismuthtelluride(bi2te3); bismuthtelluride,undoped; bismuthtritelluride; tellurobismuthite; tellururedebismuth; BISMUTH TELLURIDE; BISMUTH (III) TELLURIDE |
Bismuth Subsalicylate | 14882-18-9 | C7H5BiO4 | 362.09 | |
Bis(diisopropylamino)chlorophosphine | 56183-63-2 | C12H28ClN2P | 266.79 | BIS(DIISOPROPYLAMINO)CHLOROPHOSPHINE; BIS(DI-I-PROPYLAMINO)CHLOROPHOSPHINE; bis(diisopropylamino)chlorophosphane; Bis-(diisopropylamino)-chlorphosphin; Bis(diisopropylamino)phosphanylchloride; Bis(N,N-diisopropylamino)chlorophosphine; Chlorbis(diisopropyl |
Biperiden | 514-65-8 | C21H29NO | 311.46 | Akineton; Biperiden; KL 373; KL-373; KL373 |
Bioymifi | 1420071-30-2 | C22H12BrN3O4S | 494.32 | DR5 Activator |
BGB-3111 | 1633350-06-7 | C27H29N5O3 | 471.55 | 2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; SCHEMBL16208602; BDBM249900 |
BGB-283 | 1446090-77-2 | C25H17F3N4O3 | 478.31 | UNII-8762XZS5ZF; 8762XZS5ZF; BGB-283; Compound 2.2b; Beigene-283; GTPL8958;5-[[(1R,1aS,6bR)-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one |
b-Galactosylceramides - from bovine brain | 85305-88-0 | c.a. 750 | Ceramide b-D-galactosides; Cerebrosides | |
BFH772 | 890128-81-1 | C23H16F3N3O3 | 439.4 | 6-[[6-(hydroxymethyl)-4-pyrimidinyl]oxy]-N-[3-(trifluoromethyl)phenyl]-1-naphthalenecarboxamide; BFH-772; BFH 772; BFH772; 1-Naphthalenecarboxamide, 6-((6-(hydroxymethyl)-4-pyrimidinyl)oxy)-N-(3-(trifluoromethyl)phenyl)- |
BFF 122 | 1152314-49-2 | C17H19FN4O4 | 362.36 | (S)-9-(4-Amino-piperazin-1-yl)-8-fluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid |
BFCAs-1 | 585531-74-4 | C32H60N4O8 | 628.84 | |
BF 738735 | 1436383-95-7 | C21H19FN4O3S | 426.47 | 2-Fluoro-4-[2-methyl-8-[[[3-(methylsulfonyl)phenyl]methyl]amino]imidazo[1,2-a]pyrazin-3-yl]phenol; BF738735; BF-738735 |
Berubicin Hydrochloride | 293736-67-1 | C34H36ClNO11 | 670.1 | RTA-744;WP 769; (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-phenylmethoxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride |
Berubicin | 677017-23-1 | C34H36ClNO11 | 633.65 | RTA 744; RTA-744; RTA744; WP 769; WP769; WP-769 |
Berteroin | 4430-42-6 | C7H13NS2 | 175.3 | 5-Methylthiopentyl isothiocyanate; 1-isothiocyanato-5-(methylthio)-pentane |
BENZYL-D7 CHLORIDE | 59502-05-5 | C7ClD7 | 133.63 | ALPHA-CHLOROTOLUENE-D7; BENZYL CHLORIDE (D7); BENZYL-D7 CHLORIDE; alpha-bromo(2H7)toluene; BENZYL-D7 CHLORIDE, 99+ ATOM % D; Benzene-d5, (chloromethyl-d2)- |
Benzyl-D7 Bromide | 35656-93-0 | C7D7Br | 178.08 | Benzyl bromide-d7 |
Benzyl-d7 Alcohol | 71258-23-6 | C7HD7O | 115.18 | (D5)phenyl(D2)methanol |
Benzyl-d5 Bromide | 71258-22-5 | C7H2BrD5 | 176.07 | 2,3,4,5,6-pentadeuteriobenzyl bromide |
Benzylchlorodimethylsilane | 1833-31-4 | C9H13ClSi | 184.74 | BENZYLCHLORODIMETHYLSILANE; BENZYLDIMETHYLCHLOROSILANE; benzylchlorodimethyl-silan; chlorodimethyl(phenylmethyl)-silan; Dimethylchlorobenzylsilane; Benzyldimethylchlorisilane |
Boc-D,L-5,5,5-trifluoroleucine | 409333-67-1 | C11H18F3NO4 | 0 | 5,5,5-trifluoro-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoicacid; Boc-D,L-5,5,5-trifluoroleucine; boc-5,5,5-trifluoro-dl-leucine; 409333-67-1; 2-[(tert-butoxycarbonyl)amino]-5,5,5-trifluoro-4-methylpentanoicacid; SCHEMBL13602877 |
Boc-D,L-4,4,4-trifluorovaline | 409333-54-6 | C10H16F3NO4 | 271.23 | Boc-D,L-4,4,4-trifluorovaline |
Boc-Aminomalonic acid | 119881-02-6 | C8H13 N O6 | 219.19192 | Boc-Aminomalonic acid |
Boc-Ala-Gly-OH | 28782-78-7 | C10H18N2O5 | 246.26 | BOC-ALA-GLY-OH; N-[N-[(1,1-dimethylethoxy)carbonyl]-L-alanyl]glycine |
Boc-ACPC-OH | 88950-64-2 | C9H15NO4 | Boc-ACPC-OH | |
Boc-6-isothiocyanatohexylamine | 347890-44-2 | C12H22N2O2S | 258.38 | Tert-Butyl N-(6-isothiocyanatohexyl)carbamate |
BOC-5-METHYL-DL-TRYPTOPHAN | 142847-21-0 | C17H22N2O4 | 318.37 | BOC-5-METHYL-DL-TRYPTOPHAN; N-BOC-5-METHYL-DL-TRYPTOPHAN |
BoC-5-bromo-L-tryptophan | 75816-20-5 | C16H19BrN2O4 | 383.24 | BOC-5-BROMO-L-TRYPTOPHAN |
BoC-5-bromo-D-tryptophan | 114873-17-5 | C16H19BrN2O4 | 383.24 | BOC-5-BROMO-D-TRYPTOPHAN |
BoC-5-bromo-DL-tryptophan | 67308-26-3 | C16H19BrN2O4 | 383.24 | 2-[(tert-butoxycarbonyl)amino]-3-(5-bromo-1H-indol-3-yl)propanoic acid |
Boc-4-tert-butyl-D-Phe-OH | 250611-12-2 | C18H27NO4 | 321.41 | Boc-4-tert-butyl-D-phenylalanine |
Boc-4-(4-Hydroxyphenyl)-(3s,4s)-3-Piperidinol | 257938-67-3 | C16H23NO4 | 293.35812 | Boc-4-(4-Hydroxyphenyl)-(3s,4s)-3-Piperidinol; BOC-4-(4-HYROXYPHENYL)-(3S,4S)-3-PIPERIDINOL; (3R,4R)-3-Hydroxy-4-(4-hydroxyphenyl)piperidine-1-carboxylicacidtert-butylester; 1-Piperidinecarboxylicacid,3-hydroxy-4-(4-hydroxyphenyl)-,1,1-dimethylethylester, |
BOC-1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID | 123311-18-2 | C11H19NO4 | 229.27 | BOC-1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID |
BOC-(3S,4S)-4-AMINO-3-HYDROXY-5-(4'-PHENYL)PHENYLPENTANOIC ACID | 669713-94-4 | C22H27NO5 | 385.457 | |
BOC-(+/-)-CIS-3-AMINOCYCLOHEXANE-1-CARBOXYLIC ACID | 334932-13-7 | C12H21NO4 | 243.3 | 3-(BOC-AMINO)CYCLOHEXANECARBOXYLIC ACID; BOC-(+/-)-CIS-3-AMINOCYCLOHEXANE-1-CARBOXYLIC ACID; BOC-CIS-3-AMINOCYCLOHEXANE CARBOXYLIC ACID; BOC-CIS-1,3-AMINOCYCLOHEXANE CARBOXYLIC ACID; BOC-1,3-CIS-ACHC-OH; CIS-3-(BOC-AMINO)CYCLOHEXANECARBOXYLIC ACID |
BO3482 | 198013-53-5 | C14H20N2NaO5S2 | 383.44 | (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[2-hydroxyethyl(methyl)carbamothioyl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;sodium |
BNTX maleate | 864461-31-4 | C27H27NO4·C4H4O4 | 545.59 | 7-Benzylidenenaltrexone maleate |
Bnlm | 1380296-82-1 | C20H19ClN2O2 | 386.83 | |
BNC105P | 945771-96-0 | C20H19Na2O10P | 496.315 | BNC105P; BNC 105P; BNC-105P |
BNC-105 | 945771-74-4 | C20H20O7 | 372.373 | BCN-105; BCN105; BCN 105. |
BMY 7378 | 21102-95-4 | C22H31N3O3.2HCl | 458.42 | |
BMY 45778 | 152575-66-1 | C26H18N2O5 | 438.44 | [3-(4,5-Diphenyl[2,4'-bioxazol]-5'-yl)phenoxy]acetic acid |
Bmy 42393 | 136451-58-6 | C25H21NO4 | 399.45 | SCHEMBL675089; AC1L304B; CHEMBL117835;2-[3-[2-(4,5-diphenyl-1,3-oxazol-2-yl)ethyl]phenoxy]acetic acid |
BMX-IN-1 | 1431525-23-3 | C29H24N4O4S | 524.59 | N-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide BMX-IN-1 1431525-23-3 GTPL9269 SCHEMBL17052523 BDBM102620 CS-1295 HY-80002 Example 1-14 [ WO2014063054] W-6056 N-[5-[9-[4-(methanesulfonami |
BMT-145027 | 2018282-44-3 | C23H14ClF3N4 | 438.83 | 3-[4-chloro-3-(trifluoromethyl)phenyl]-4-cyclopropyl-6-phenyl-2H-pyrazolo[3,4-b]pyridine-5-carbonitrile |
BMS-986205 | 1923833-60-6 | C24H24ClFN2O | 410.917 | (2R)-N-(4-chlorophenyl)-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide |
BMS-986165 | 1609392-27-9 | C20H19D3N8O3 | 425.47 | Tyk2-IN-4; BMS 986165; BMS986165 |
BMS-986158 | 1800340-40-2 | C30H33N5O2 | 495.62 | 2-[3-(3,5-dimethyltriazol-4-yl)-5-[(S)-oxan-4-yl(phenyl)methyl]pyrido[3,2-b]indol-7-yl]propan-2-ol; BMS 986158; BMS986158 |
BMS-986142 | 1643368-58-4 | C32H30F2N4O4 | 572.60 | BMS-986142; BMS986142 |
BMS-986141 | 1478711-48-6 | C27H23N5O5S2 | 561.6 | Unii-W530irz40G |
BMS-986120 | 1478712-37-6 | C23H23N5O5S2 | 513.59 | BMS-986120; BMS 986120; BMS986120; 4-(4-(((6-methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzofuran-4-yl)oxy)methyl)-5-methylthiazol-2-yl)morpholine |
BMS-983970 | 1584713-87-0 | C26H26F4N4O3 | 518.5 | BMS-983970 |
BMS-955829 | 1375751-08-8 | C22H14F2N2O2 | 376.36 | (4R,5R)-5-(2,5-difluorophenyl)-4-(5-(phenylethynyl)pyridin-3-yl)oxazolidin-2-one |
BMS-935177 | 1231889-53-4 | C31H26N4O3 | 502.56 | BMS-935177; BMS935177 |
BMS-919373 | 1272353-82-8 | C25H20N6O2S | 468.54 | 5-(5-phenyl-4-((pyridin-2-ylmethyl)amino)quinazolin-2-yl)pyridine-3-sulfonamide |
BMS-911543 | 1271022-90-2 | C23H28N8O | 432.532 | BMS 911543 |
BMS-908662 | 870603-16-0 | C24H19ClN4O4 | 462.89 | methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxoisoindolin-1-yl)-1H-benzo[d]imidazol-2-yl)carbamate;XL-281 |
BMS-906024 | 1401066-79-2 | C26H26F6N4O3 | 556.509 | BMS-906024; BMS 906024; BMS906024. |
BMS-863233 HCl | 1169562-71-3 | C14H13Cl2N3O2 | 289.72 | BMS-863233; BMS863233; BMS 863233; XL-413; XL413; XL 413. |
BMS-856 | 863382-83-6 | C29H25ClN2O5 | 516.97 | UNII-7IQ5DK4G01; 7IQ5DK4G01; 2-((3-chloro-4-hydroxybenzoyl)amino)-N-(2-(2-methoxyphenyl)ethyl)-5-phenoxy-Benzamide |
BMS-833923 | 1059734-66-5 | C30H27N5O | 473.57 | BMS 833923; XL139; N-[2-methyl-5-(methylaminomethyl)phenyl]-4-[(4-phenylquinazolin-2-yl)amino]benzamide |
BMS-794833 | 1174046-72-0 | C23H15ClF2N4O3 | 468.845 | BMS794833; BMS 794833. |
BMS-791325 HCl | 958002-36-3 | C36H46ClN5O5S | 696.304 | Beclabuvir hydrochloride |
BMS-779788 | 918348-67-1 | C28H29ClN2O3S | 509.061 | XL-652; 2-[2-[2-(2-chlorophenyl)propan-2-yl]-1-[4-(3-methylsulfonylphenyl)phenyl]imidazol-4-yl]propan-2-ol |
BMS779333 | 1095181-60-4 | C19H17F3N2O4 | 394.35 | BMS-779333;Benzonitrile, 4-((3aR,4S,6R,6aS,8aS,8bR)-octahydro-4-hydroxy-6-methyl-7-oxo-3a,6-epoxy-3ah-pyrano(2,3,4-cd)isoindol-8(4H)-yl)-2-(trifluoromethyl)- |
BMS-777607 | 1025720-94-8 | C25H19ClF2N4O4 | 512.893 | BMS-777607 |
BMS-777607 | 1196681-44-3 | C25H19ClF2N4O4 | 512.898 | BMS 777607; BMS777607. |
BMS-754807 | 1001350-96-4 | C23H24FN9O | 461.505 | BMS754807; BMS 754807. |
BMS-740808 | 280118-23-2 | C31H27F3N6O3 | 588.58 | 1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-[2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]phenyl]phenyl]-3-(trifluoromethyl)-4,5-dihydropyrazolo[3,4-c]pyridin-7-one; BMS 740808; BMS-740808; BMS740808; UNII-LDD74E663F |
BMS711939 | 1000998-62-8 | C22H20ClFN2O6 | 462.86 | Glycine, N-((5-((2-(4-chlorophenyl)-5-methyl-4-oxazolyl)methoxy)-2-fluorophenyl)methyl)-N-(methoxycarbonyl)-; BMS-711939;2-[[5-[[2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methoxy]-2-fluorophenyl]methyl-methoxycarbonylamino]acetic acid |
BMS-707035 | 729607-74-3 | C17H19FN4O5S | 410.42 | |
BMS695735 | 1054315-48-8 | C26H31ClFN7O | 512.02 | 2(1H)-Pyridinone, 4-((2-(4-chloro-1H-pyrazol-1-yl)ethyl)amino)-3-(5-(1-(3-fluoropropyl)-4-piperidinyl)-7-methyl-1H-benzimidazol-2-yl)-;(3Z)-4-[2-(4-chloropyrazol-1-yl)ethylamino]-3-[6-[1-(3-fluoropropyl)piperidin-4-yl]-4-methyl-1,3-dihydrobenzimidazol-2-y |
BMS694153 | 1050381-35-5 | C35H45FN8O3 | 644.79 | BMS-694153;(R)-N-(1-([1,4'-bipiperidin]-1'-yl)-3-(7-methyl-1H-indazol-5-yl)-1-oxopropan-2-yl)-4-(8-fluoro-2-oxo-1,4-dihydroquinazolin-3(2H)-yl)piperidine-1-carboxamide;(R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1 |
BMS-687453 | 1000998-59-3 | C22H21ClN2O6 | 444.87 | BMS-687453; BMS 687453; BMS687453. |
BMS-6690514 | 859853-30-8 | C19H24N6O2 | 368.441 | |
BMS-663749 | 864953-33-3 | C23H25N4O9P | 532.44 | UNII-667A5745M0; SCHEMBL2688950; CHEMBL2219875;(3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-1-yl)methyl dihydrogen phosphate |
BMS-663068 Tris | 864953-39-9 | C29H37N8O11P | 704.62 | Fostemsavir Tris; Fostemsavir tromethamine |
BMS-663068 | 864953-29-7 | C25H26N7O8P | 583.49 | Fostemsavir |
BMS-645737 | 651744-16-0 | C20H20N8O | 388.43 | BMS645737; BMS 645737; BMS-645737. |
BMS-641988 | 573738-99-5 | C20H20F3N3O5S | 471.451 | Ethanesulfonamide. |
BMS639623 | 675122-44-8 | C25H32FN7O2 | 481.57 | BMS-639623;Urea, N-((1R,2S)-3-((3S)-3-((4-fluorophenyl)methyl)-1-piperidinyl)-2-hydroxy-1-methylpropyl)-N'-(3-(1-methyl-1H-tetrazol-5-yl)phenyl)-;1-[(2R,3S)-4-[(3S)-3-[(4-fluorophenyl)methyl]piperidin-1-yl]-3-hydroxybutan-2-yl]-3-[3-(1-methyltetrazol-5-yl |
BMS-639432 | 1204222-85-4 | C21H25ClO7 | 424.87 | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)-hydroxymethyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol |
BMS-626529 | 701213-36-7 | C24H23N7O4 | 473.493 | BMS 626529; BMS626529 |
BMS-599626 Hydrochloride | 873837-23-1 | C27H28ClFN8O3 | 567.01 | AC480; BMS-599626 HCl |
BMS-593214 | 1004551-40-9 | C31H27N3O4 | 505.56 | BMS593214; BMS 593214; BMS-593214. |
BMS587101 | 509083-77-6 | C26H20Cl2N4O4S | 555.43 | BMS-587101;5-[[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]methyl]thiophene-3-carboxylic acid |
BMS585248 | 619331-12-3 | C22H18FN7O3 | 447.43 | BMS-585248;1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-(4-fluoro-7-(1H-1,2,3-triazol-1-yl)-1H-pyrrolo(2,3-c)pyridin-3-yl)-;1-(4-Benzoylpiperazin-1-yl)-2-[4-fluoro-7-(triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]ethane-1,2-dione |
BMS-582949 hydrochloride | 912806-16-7 | C22H27ClN6O2 | 442.94 | BMS 582949 hydrochloride;4-((5-((Cyclopropylamino)carbonyl)-2-methylphenyl)amino)-5-methyl-n-propylpyrrolo(2,1-f)(1,2,4)triazine-6-carboxamide |
BMS582949 | 623152-17-0 | C22H26N6O2 | 406.49 | 4-[[5-[(Cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide;BMS-582949;PS-540446;PS540446 |
BMS-566419 | 566161-24-8 | C28H30FN5O2 | 487.57 | BMS-566419; BMS 566419; BMS566419. |
BMS-564929 | 627530-84-1 | C14H12ClN3O3 | 305.71 | 4-[(7R,7aS)-7-hydroxy-1,3-dioxo-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazol-2-yl]-2-chloro-3-methylbenzonitrile; |
BMS561392 | 611227-74-8 | C27H32N4O4 | 476.57 | |
BMS-554417 | 468741-42-6 | C28H30ClN7O2 | 532.04 | 3-[4-[(2Z)-2-[4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxopyridin-3-ylidene]-7-methyl-1,3-dihydrobenzimidazol-5-yl]piperazin-1-yl]propanenitrile; |
BMS-538203 | 543730-41-2 | C12H12FNO5 | 269.23 | |
BMS538158 | 543730-36-5 | C15H16FNO5 | 309.29 | BMS-538158;Acetamide, 2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)-N-((4-fluorophenyl)methyl)-N-methoxy-;(2Z)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)-N-[(4-fluorophenyl)methyl]-N-methoxyacetamide |
BMS-536924 | 468740-43-4 | C25H26ClN5O3 | 479.965 | |
BMS-520 | 1236188-38-7 | C23H17F3N4O4 | 470.41 | 1-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid |
BMS-509744 | 439575-02-7 | C32H41N5O4S2 | 623.83 | |
BMS-505130 | 468715-83-5 | C19H21N3O4 | 355.39 | 3-((1S,2S)-2-((dimethylamino)methyl)cyclopropyl)-1H-Indole-5-carbonitrile |
BMS-505130 | 859230-84-5 | C19H21N3O4 | 355.39 | UNII-E892TW82D9; E892TW82D9;1H-Indole-5-carbonitrile, 3-((1S,2S)-2-((dimethylamino)methyl)cyclopropyl)-, (2Z)-2-butenedioate (1:1) |
BMS-5 | 1338247-35-0 | C17H14Cl2F2N4OS | 431.29 | BMS-5; LIMKi 3; BMS 5; C17H14Cl2F2N4OS; CHEMBL2141887 |
BMS-488043 | 452296-83-2 | C22H22N4O5 | 422.44 | 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione; |
BMS480404 | 533889-36-0 | C22H18Cl2O5 | 433.28 | BMS-480404;(2S)-2-[2,3-bis[(2-chlorophenyl)methoxy]phenyl]-2-hydroxyacetic acid;Benzeneacetic acid, 2,3-bis((2-chlorophenyl)methoxy)-alpha-hydroxy-, (alphaS)- |
BMS-433796 | 935525-13-6 | C21H20F2N4O4 | 430.15 | (2S)-2-[[(2S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]amino]-N-[(5S)-3-methyl-4-oxo-5H-2,3-benzodiazepin-5-yl]propanamide; BMS-433796; UNII-R1E8M783K2; 935525-13-6; CHEMBL247361; R1E8M783K2; ZINC28899741; (alphaS)-N-[(1S)-2-[[(5S)-4,5-Dihydro-3-methyl-4- |
BMS-419437 | 333389-24-5 | C23H30N4O4S2 | 490.64 | N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]-2-[4-[(1,3-dihydroxypropan-2-ylamino)methyl]phenyl]acetamide; |
BMS-394136 | 343246-73-1 | C24H21Cl2FN4O | 471.35 | [(7R)-7-(3,4-dichlorophenyl)-5-methyl-1,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl]-[(2S)-2-(4-fluorophenyl)pyrrolidin-1-yl]methanone; |
BMS-378806 | 357263-13-9 | C22H22N4O4 | 406.43 | BMS-806 |
BMS-36313 | 384829-65-6 | C28H40N6O5 | 540.66 | (2S,3R)-3-[[(3R)-1-carbamimidoylpiperidin-3-yl]methyl]-4-oxo-1-[4-(6-phenylhexanoyl)piperazine-1-carbonyl]azetidine-2-carboxylic acid |
BMS358233 | 601519-75-9 | C25H25ClN6O2S | 509.02 | BMS-358233;6-Benzothiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-methyl-2-((((2R)-tetrahydro-2-furanyl)methyl)amino)-4-pyrimidinyl)amino)-;N-(2-chloro-6-methylphenyl)-2-[[6-methyl-2-[[(2R)-oxolan-2-yl]methylamino]pyrimidin-4-yl]amino]-1,3-benzothi |
BMS-354326 | 708258-16-6 | C28H40N4O5 | 512.65 | CHEMBL306448; BDBM50144532;(2S,3R)-4-oxo-1-((4-(1-oxo-6-phenylhexyl)-1-piperazinyl)carbonyl)-3-(2-(3-piperidinyl)ethyl)- 2-Azetidinecarboxylic acid, |
BMS-351 | 1370001-71-0 | C15H12F3N3 | 291.28 | 4-(4-methylpyridin-3-yl)-1-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazole |
BMS-347070 | 197438-73-6 | C18H15BrO4S | 407.28 | (3Z)-3-[(4-bromophenyl)-(4-methylsulfonylphenyl)methylidene]oxolan-2-one; BMS-347070; BMS 347070; BMS347070; UNII-0CKM4H090C; 0CKM4H090C; SCHEMBL6882900; SCHEMBL6882905 |
BMS-345541 | 445430-58-0 | C14H17N5 | 255.32 | |
BMS-344577 | 288079-93-6 | C31H37N7O5 | 587.67 | N5-[[[(3S)-Hexahydro-2-oxo-1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-azepin-3-yl]imino][(2-methyl-5-benzofuranyl)amino]methyl]-N2,N2-dimethyl-2,5-pyridinedicarboxamide; (S,E)-N2,N2-dimethyl-N5-(N'-(2-methylbenzofuran-5-yl)-N-(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl |
BMS-337197 | 267645-83-0 | C24H34N5OP | 489.532 | BMS-337197; BMS 337197; BMS337197. |
BMS-317180 | 295337-71-2 | C26H30N5O2P | 463.539 | BMS-317180; BMS317180; BMS 317180. |
BMS303141 | 943962-47-8 | C19H15Cl2NO4S | 424.30 | |
BMS-3 | 1338247-30-5 | C17H12Cl2F2N4OS | 429.27 | N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-cyclopropanecarboxamide |
BMS-284640 | 230640-88-7 | C15H19N3O2 | 273.33 | (1R,3R)-N-(diaminomethylidene)-3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethylcyclopropane-1-carboxamide;BMS-284640; BMS 284640; BMS284640; UNII-XP87V064PV; CHEMBL51879; XP87V064PV; SCHEMBL13285838; BDBM50104844 |
BMS-279700 | 240814-54-4 | C21H22ClN7 | 407.899 | (S)-N-(2-chloro-6-methylphenyl)-2-(3-methylpiperazin-1-yl)imidazo[1,5-a]pyrido[3,2-e]pyrazin-6-amine; BMS279700; BMS 279700; BMS-279700 |
BMS-275183 | 355113-98-3 | C43H59NO16 | 845.936 | BMS 275183. |
BMS-265246 | 582315-72-8 | C18H17F2N3O2 | 345.34 | |
BMS-248360 | 254737-87-6 | C36H45N5O5S | 659.84 | 2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-[(3,3-dimethyl-2-oxopyrrolidin-1-yl)methyl]phenyl]-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide; BMS-248360; BMS 248360; BMS248360; UNII-EEP77N970Y; CHEMBL11706; EEP77N970Y; SCHEMBL4764 |
BMS-247243 | 307316-55-8 | C36H41Cl2N5O8S3 | 838.83 | (6R,7R)-7-[[2-[4-[(E)-3-(carboxylatomethylamino)-3-oxoprop-1-enyl]-2,5-dichlorophenyl]sulfanylacetyl]amino]-3-[[2,6-dimethyl-1-[3-(4-methylmorpholin-4-ium-4-yl)propyl]pyridin-1-ium-4-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyla |
BMS-243117 | 225521-80-2 | C20H21ClN4O2S | 416.92 | 2-(tert-butylcarbamoylamino)-N-(2-chloro-6-methylphenyl)-1,3-benzothiazole-6-carboxamide; BMS-243117; UNII-MBE6KWV0QI |
BMS-229724 | 221914-85-8 | C27H25Cl2F3O5S | 589.45 | 4-[4-[2-[2-[bis(4-chlorophenyl)methoxy]ethylsulfonyl]ethoxy]phenyl]-1,1,1-trifluorobutan-2-one; 4-(4-(2-(2-(bis(4-chlorophenyl)methoxy)ethylsulfonyl)ethoxy)phenyl)-1,1,1-trifluoro-2-butanone; BMS 229724; BMS-229724; BMS229724 |
BMS-214662 mesylate | 474010-58-7 | C25H25N5O6S3 | 585.72 | (R)-2,3,4,5-Tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-Benzodiazepine-7-carbonitrile monohydrochloride, (R)-7-Cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzod |
BMS-214662 | 195987-41-8 | C25H23N5O2S2 | 489.612 | ARQ-171. |
BMS-214662 | 195981-08-9 | C25H23N5O2S2 | 489.61 | (3R)-3-benzyl-1-(1H-imidazol-5-ylmethyl)-4-thiophen-2-ylsulfonyl-3,5-dihydro-2H-1,4-benzodiazepine-7-carbonitrile; 7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine; ARQ171; ARQ 171; ARQ-171 |
BMS-212122 | 194213-64-4 | C43H36F6N4O2 | 754.76 | 9-[4-[2,5-dimethyl-4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]benzimidazol-1-yl]butyl]-N-(2,2,2-trifluoroethyl)fluorene-9-carboxamide; BMS-212122; BMS212122; BMS 212122; UNII-0Z473OO6GB |
BMS-210285 | 344607-69-8 | C24H25ClF2N2O5S | 526.98 | N-[5-[(1R)-2-[[(1R)-2-(3-chlorophenyl)-1-[4-(difluoromethoxy)phenyl]ethyl]amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulfonamide |
BMS-196085 | 170686-10-9 | C24H26F2N2O5S | 492.54 | BMS-196085; UNII-FM0D5L3W03; BDBM50106829; N-[5-[(1R)-2-[[(1R)-1-[4-(difluoromethoxy)phenyl]-2-phenylethyl]amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulfonamide |
BMS-195270 | 202822-23-9 | C15H9ClF3N3O2 | 355.7 | 2-(5-chloro-2-hydroxyphenyl)-5-[2-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-one; BMS-195270; BMS 195270; BMS195270; UNII-20UM0T170J; CHEMBL13637; SCHEMBL5754043; 20UM0T170J |
BMS-194449 | 170686-12-1 | C24H24F4N2O6S | 544.52 | BMS-194449; BMS 194449; (R)-N-(5-(2-((bis(4-(difluoromethoxy)phenyl)methyl)amino)-1-hydroxyethyl)-2-hydroxyphenyl)methanesulfonamide |
BMS-193885 salt | 679839-66-8 | C33H42N4O6.C3H6O3 | 680.79 | dimethyl 4-[3-[3-[4-(3-methoxyphenyl)piperidin-1-yl]propylcarbamoylamino]phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate;2-hydroxypropanoic acid; 186185-03-5; 1,4-dihydro-4-[3-[[[[3-[4-(3-methoxyphenyl)-1-piperidinyl]propyl]amino]carbonyl]ami |
BMS-193885 | 186185-03-5 | C33H42N4O6 | 590.71 | dimethyl 4-[3-[3-[4-(3-methoxyphenyl)piperidin-1-yl]propylcarbamoylamino]phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; BMS 193885; 679839-66-8 BMS-193885; BMS193885 |
BMS-193884 | 176960-47-7 | C20H17N3O4S | 395.43 | BMS-193884; 7ON53PV45J; SCHEMBL4204130; BDBM50091105; N-(3,4-dimethyl-1,2-oxazol-5-yl)-2-[4-(1,3-oxazol-2-yl)phenyl]benzenesulfonamide |
BMS-192364 | 202822-21-7 | C15H9ClF3N3O2 | 355.7 | 2-(5-chloro-2-hydroxyphenyl)-5-[4-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-one; BMS-192364; BMS 192364; BMS192364; UNII-1NC8D8P7QF |
BMS-191095 | 166095-21-2 | C22H21ClN4O2 | 408.88 | (3R,4S)-4-[4-chloro-N-(1H-imidazol-2-ylmethyl)anilino]-3-hydroxy-2,2-dimethyl-3,4-dihydrochromene-6-carbonitrile BMS-191095 CHEMBL11594 SCHEMBL8896325 ZINC3821976 BDBM50409914 |
BMS-188494 | 191866-32-7 | C28H39O11PS | 614.645 | 1-[bis(2,2-dimethylpropanoyloxymethoxy)phosphoryl]-4-(3-phenoxyphenyl)butane-1-sulfonic acid; BMS-188494; BMS 188494; BMS188494; UNII-F4W2579G7P |
BMS-187308 | 153624-15-8 | C21H25N3O3S | 399.51 | BMS-187308; UNII-7K0YU35900; CHEMBL106684; 7K0YU35900; SCHEMBL6767698; BDBM50068674; 2-[2-amino-4-(2-methylpropyl)phenyl]-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide |
BMS-187071 | 161302-39-2 | C32H49N3O6 | 571.75 | BMS 187071; BMS-187071; (3-((3-((2,3,3-Trimethyl-2(S)-2-hydroxy-1-oxobutyl)amino)-2-hydroxy-4-phenylbutyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamic acid, 1,1-dimethylethyl ester; [3-[[3-[(2,3,3-Trimethyl-2(S)-2-hydroxy-1-oxobutyl)amino]-2-hydroxy-4 |
BMS-186511 | 167467-53-0 | C26H27N5O5 | 685.902 | BMS186511; BMS 186511; BMS-186511. |
BMS-186318 | 161302-40-5 | C36H54N4O9 | 686.85 | BMS-186318; BMS 186318; 12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-13,13-dimethyl-3-((4-(2-(4-morpholinyl)-2-oxoethoxy)phenyl)methyl)-11-oxo-9-(phenylmethyl)-, 1,1-dimethylethyl ester, (3S,4R,8R,9S)-; BMS-186318 analog 19; 12-Oxa-2,6,10-triazat |
BMS-180048 | 171171-42-9 | C26H34N6O7S | 574.65 | Avitriptan fumarate; Bms-180048; 3-(3-(4--(5-methoxy-4-pyrimidinyl)-1-piperazinyl)propyl)-N-methyl-1H-indole-5-methanesulfonamide fumarate |
BMS CCR2 22 | 445479-97-0 | C28H34F3N5O4S | 593.66 | N-[2-[[2-[(4-methylsulfanylbenzoyl)amino]cyclohexyl]amino]-2-oxoethyl]-2-(propan-2-ylcarbamoylamino)-5-(trifluoromethyl)benzamide; |
BMS 986188 | 1776115-10-6 | C30H31BrO4 | 535.5 | MS-986188; BMS 986188 |
BMS 986187 | 684238-37-7 | C31H34O4 | 470.61 | 3,4,5,6,7,9-Hexahydro-3,3,6,6-tetramethyl-9-[4-[(2-methylphenyl)methoxy]phenyl]-1H-xanthene-1,8(2H)-dione |
BMS 986122 | 313669-88-4 | C16H15BrClNO3S2 | 448.8 | BMS-986122; BMS986122; 2-(3-bromo-4-methoxyphenyl)-3-[(4-chlorophenyl)sulfonyl]-thiazolidine |
BMS 986020 | 1257213-50-5 | C29H26N2O5 | 482.5 | BMS-986020; BMS986020 |
BMS 961 | 185629-22-5 | C23H26FNO4 | 399.45 | BMS 961; BMS961; BMS-961; 3-Fluoro-4-[[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-2-naphthalenyl)acetyl]amino]-benzoic acid |
BMS 903452 | 1339944-47-6 | C21H19Cl2FN4O4S | 513.37 | 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one |
BMS 795311 | 939390-99-5 | C33H23F10NO3 | 671.52 | N-[(1R)-1-[3-(Cyclopropyloxy)-4-fluorophenyl]-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide |
BMS 753 | 215307-86-1 | C21H21NO4 | 351.4 | 4-[[(2,3-Dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)carbonyl]amino]benzoic acid |
BMS 747158-02; Flurpiridaz (18F); Flurpiridaz F 18 | 863887-89-2 | C18H22ClFN2O3 | 367.83300 | |
BMS 688521 | 893397-44-9 | C26H19Cl2N5O4 | 536.37 | 6-[(5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4,4]non-7-yl]-3-pyridinecarboxylic acid; BMS-688521; BMS688521; SCHEMBL5392413 |
BMS 605541 | 639858-32-5 | C19H17F2N5OS | 401.43 | N-Cyclopropyl-2,4-difluoro-5-[[[2-(2-pyridinylamino)-5-thiazolyl]methyl]amino]benzamide |
Blood group H tetraose type II | 1352644-16-6 | C26H45NO20 | 691.63 | Fuca-2Galb-4GlcNAcb-3Gal |
BMS 493 | 215030-90-3 | C29H24O2 | 404.50 | BMS-493 |
Blood Group H type I trisaccharide | 137739-90-3 | C20H35NO15 | 529.49 | Fuca1-2Galb1-3GlcNAc |
BMS 453 | 166977-43-1 | C27H24O2 | 380.48 | BMS 189453; 4-[(1E)-2-(5,6-Dihydro-5,5-dimethyl-8-phenyl-2-naphthalenyl)ethenyl]-benzoic acid |
BMS 433771 | 380603-10-1 | C20H21N5O2 | 363.41 | 1-cyclopropyl-1,3-dihydro-3-((1-(3-hydroxypropyl)-1H-benzimidazol-2-yl)methyl)-2H-Imidazo(4,5-c)pyridin-2-one |
BMS 345541 trifluoroacetate salt | 547757-23-3 | C14H17N5·2CF3COOH | 483.4 | IKK Inhibitor III |
BMS 309403 | 300657-03-8 | C31H26N2O3 | 474.6 | Adipocyte FABP Inhibitor; A-FABP Inhibitor; ALBP Inhibitor; aP2 Inhibitor; FABP4 Inhibitor; Fatty Acid Binding Protein 4 Inhibitor |
BMS 299897 | 290315-45-6 | C24H21ClF3NO4S | 511.94 | 4-[2-[(1R)-1-(N-(4-chlorophenyl)sulfonyl-2,5-difluoroanilino)ethyl]-5-fluorophenyl]butanoic acid; 4-(2-((1R)-1-(((4-chlorophenyl)sulfonyl)-2,5-difluoroanilino)ethyl)-5-fluorophenyl)butanoic acid; BMS 299897; BMS-299897; 290315-45-6; 2-[(1R)-1-[[(4-Chlorop |
BMS 270394 | 262433-54-5 | C23H26FNO4 | 399.46 | (R)-3-fluoro-4-(2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)acetamido)benzoic acid; 3-fluoro-4-[[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)acetyl]amino]benzoic acid |
BMS 262084 | 253174-92-4 | C18H31N7O5 | 425.48 | (2S,3R)-1-[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]-3-[3-(diaminomethylideneamino)propyl]-4-oxoazetidine-2-carboxylic acid; BMS-262084; BMS 262084; BMS262084; CHEMBL71037; UNII-I0IR71971G; I0IR71971G; BDBM50120368; DNC004491 |
BMS 214428 | 216508-01-9 | C33H40N6O4 | 584.71 | dimethyl 4-[3-[[N-cyano-N'-[3-(4-phenylpiperidin-1-yl)propyl]carbamimidoyl]amino]phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; UNII-6774Z74TWN; 6774Z74TWN |
BMS 195614 | 253310-42-8 | C29H24N2O3 | 448.51 | 4-[[[5,6-Dihydro-5,5-dimethyl-8-(3-quinolinyl)-2-naphthalenyl]carbonyl]amino]benzoic acid |
BMS 191011 | 202821-81-6 | C16H10ClF3N3O3 | 370.71 | 3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-one; BMS-191011; BMS 191011; BMS191011; UNII-LW7MXS978N; Bms-a |
BMS 183920 | 153072-33-4 | C26H19N5O3 | 449.47 | Bms 183920; Bms-183920; CHEMBL305365; 2-Cyclopropyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)oxy)-4-quinolinecarboxylic acid; 4-Quinolinecarboxylicacid, 2-cyclopropyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]oxy]- |
BMS 182874 Hydrochloride | 1215703-04-0 | C17H20ClN3O3S | 381.88 | 5-(dimethylamino)-N-(3,4-dimethylisoxazol-5-yl)naphthalene-1-sulfonamide hydrochloride |
BMS 182874 | 153042-42-3 | C17H19N3O3S | 345.417 | 5-Ddins; Bms 182874; CHEMBL267458; 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide |
BMS 182264 | 127749-54-6 | C15H19N5 | 269.35 | CHEMBL19169; N-Cyano-N'-(4-cyanophenyl)-N''-1,2,2-trimethylpropylguanidine |
BMS 181168 | 123259-91-6 | C15H19F3N4O | 328.34 | Bms181168;1-((1-(2-(trifluoromethyl)pyrimidin-4-yl)piperidin-4-yl)methyl)pyrrolidin-2-one |
BMS 181101 | 146479-45-0 | C20H26Cl2FN5O | 442.36 | BMS 181101; AC1L42ZR; SCHEMBL4356376; DTXSID40163380; 5-fluoro-3-[3-[4-(5-methoxypyrimidin-4-yl)piperazin-1-yl]propyl]-1H-indole Dihydrochloride |
BMS 180680 | 142654-34-0 | C19H17N7O10S2 | 567.51 | SQ 84,100;PA 1806;(2R-(2alpha,3alpha(Z)))-3-((((1-(2-Amino-4-thiazolyl)-2-((2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino)-2-oxoethylidene)amino)oxy)methyl)-6,7-dihydroxy-2-quinoxalinecarboxylic acid |
Triazoledione | 153707-88-1 | C23H28ClN5O3 | 457.96 | BMS 180492; UNII-3508097W2U |
BMS 180448 | 144264-47-1 | C20H18ClN5O2 | 395.85 | trans-N-(4-chlorophenyl)-N'-cyano-N''-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)- Guanidine |
BMP-22 | 1306684-90-1 | C22H39O3P | 382.52 | BMP22; BMP 22 |
BMN-673 8R,9S | 1207456-00-5 | C19H14F2N6O | 380.35 | Talazoparib (8R,9S); (8R,9S)-BMN-673; BMN673 (8R,9S); BMN 673 (8R,9S) |
BML-284 | 853220-52-7 | C19H18N4O3 | 350.37 | BML 284; 2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine; 4-N-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine |
BML-278 | 120533-76-8 | C24H25NO4 | 391.5 | BML 278; BML278 |
BML-277 | 516480-79-8 | C20H14ClN3O2 | 363.80 | Chk2 Inhibitor II; 2-[4-(4-chlorophenoxy)phenyl]-3H-benzimidazole-5-carboxamide; |
BML-258 HCl | 1072443-89-0 | C21H33N7O5 | 313.8627 | BML258; BML 258; BML-258; SK1I. |
BML-244 | 104062-70-6 | C11H21NO3 | 215.293 | BML-244; BML-244; BML-244. |
BML-210 | 537034-17-6 | C20H25N3O2 | 339.43 | CAY10433; N1-(2-aminophenyl)-N8-phenyloctanediamide; N-(2-aminophenyl)-N'-phenyl-octanediamide; |
BML 111 | 78606-80-1 | C8H16O5 | 192.21 | (5S,6R)-Methyl 5,6,7-trihydroxyheptanoate; methyl (5S,6R)-5,6,7-trihydroxyheptanoate |
BMI-1026 | 477726-77-5 | C34H60N3O7PS | 280.291 | BMI-1026; BMI 1026; BMI1026 |
BMH-21 | 896705-16-1 | C21H22N4O2 | 362.43 | |
B-Methoxy-9-BBN solution | 38050-71-4 | C9H17BO | 152.04 | 9-Methoxy-9-borabicyclo[3.3.1]nonane |
b-Maltosyl azide | 51970-30-0 | C12H21N3O10 | 367.3 | 4-O-a-D-Glucopyranosyl-b-D-glucopyranosyl azide |
BM-212 | 146204-42-4 | C23H25Cl2N3 | 414.37 | BM-212; UNII-U9HSU4GZWL; BM212; 1-[[1,5-bis(4-chlorophenyl)-2-methylpyrrol-3-yl]methyl]-4-methylpiperazine; 1-{[1,5-Bis(4-chlorophenyl)-2-methylpyrrol-3-yl]methyl}-4-methylpiperazine; U9HSU4GZWL |
BM152054 | 213411-84-8 | C22H18N2O4S3 | 470.58 | 5-[[4-[2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl]methyl]-1,3-thiazolidine-2,4-dione; BM 15.2054; BM-15.2054; BM15.2054 |
BM 567 | 284464-77-3 | C18H28N4O5S | 412.5 | BM567; BM-567 |
Blue dextran (MW 2000000) - from Leuconostoc spp | 87915-38-6 | (C6H10O5)n | ||
BLUE DEXTRAN | 9049-32-5 | 0 | REACTIVE BLUE 2-DEXTRAN; BLUE DEXTRAN; BLUE DEXTRAN 2000; BLUE DEXTRAN LOADING SOLUTION; CIBACRON BLUE 3GA-DEXTRAN; DEXTRAN BLUE | |
BLUE 203 | 98660-18-5 | C34H41N3O3 | 0 | BLUE 203; 4-b]pyridin-5(7H)-one, 7-[4-(diethylamino)-2-(hexyloxy)phenyl]-7-(1-ethyl-2-methyl-1H-indol-3-yl)-Furo[3 |
BLU9931 | 1538604-68-0 | C26H22Cl2N4O3 | 509.38 | BLU9931; BLU-9931; BLU 9931. |
BLU-554 | 1707289-21-1 | C24H24Cl2N4O4 | 503.38 | SCHEMBL16668287; EX-A841; MFCD30496704; N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino]oxan-4-yl]prop-2-enamide; BLU554 |
b-L-Rhamnopyranosyl nitromethane | 30627-99-7 | C7H13NO6 | 207.18 | 2,6-Anhydro-1,7-dideoxy-1-nitro-L-glycero-L-galacto-heptitol |
Blood-coagulationfactor VII | 9001-25-6 | 0 | FACTOR VII (HUMAN); FACTOR VII; COAGULATION FACTOR VII, HUMAN; COAGULATION FACTOR VII, HUMAN PLASMA; CONVERTIN, HUMAN; NATIVE HUMAN PLASMA FACTOR VIII; NATIVE HUMAN FACTOR VII; PROCONVERTIN | |
Blood-coagulationfactor IX | 9001-28-9 | 0 | ahf-b; antihemophilicfactorb; bloodcoagulationfactorix; plasmathromboplastincomponent; ptc(bloodcoagulationfactor); PTC, HUMAN; PLASMA THROMBOPLASTIN COMPONENT, HUMAN; CHRISTMAS FACTOR | |
Blood Group H type II trisaccharide-sp-biotin | 870891-89-7 | C39H67N5O18S | 926.04 | Fuca1-2Galb1-4GlcNAc-b-1-O(CH2)3NHCO(CH2)5NH-biotin |
Blood group H pentaose type II | 30517-76-1 | C32H55NO25 | 853.77 | Fuca-2Galb-4GlcNAcb-3Galb-4Glc |
Blood Group H disaccharide | 146076-26-8 | C12H22O10 | 326.3 | Fuc-(a1,2)-Gal; 2-O-(a-L-Fucopyranosyl)-D-galactopyranose; H-Disaccharide |
Blood Group B type III/IV tetrasaccharide | 1352644-06-4 | C26H45NO20 | 691.63 | Gala1-3(Fuca1-2)Galb1-3GalNAc |
Blood Group B trisaccharide, spacer-biotin conjugate | 870891-30-8 | C37H64N4O18S | 884.99 | Gal-a-1,3(Fuc-a-1,2)Gal-b-1-O(CH2)3NHCO(CH2)5NH-biotin; Btri-sp biot |
Blood Group B type II tetrasaccharide | 909890-21-7 | C26H45NO20 | 691.63 | Gala1-3(Fuca1-2)Galb1-4GlcNAc |
Blood Group B type II linear trisaccharide | 77356-46-8 | C20H35NO16 | 545.49 | a-Gal epitope type II; Gala1-3Galb1-4GlcNAc; Linear B-2 trisaccharide; Gal-a-1,3-Gal-b-1,4-GlcNAc; Galili antigen triaose; Xeno antigen type 2; Gala1-3 epitope |
Blood Group B type I tetrasaccharide | 67673-41-0 | C26H45NO20 | 691.63 | Gala1-3(Fuca1-2)Galb1-3GlcNAc |
Blood Group B type I linear trisaccharide | 100850-25-7 | C20H35NO16 | 545.49 | Gala1-3Galb1-3GlcNAc |
Blood Group B trisaccharide | 49777-14-2 | C18H32O15 | 488.44 | Gal-a-1,3(Fuc-a-1,2)Gal; 2-O-(3-O[a-D-Galactopyranosyl]-a-L-fucopyranosyl)-D-galactopyranose |
Blood Group B trisaccharide-(CH2)8COOMe derivative | 65606-80-6 | C28H50O17 | 658.69 | 8-Methoxycarbonyloctyl 2-O-(a-L-fucopyranosyl)-3-O-(a-D-galactopyranosyl)-b-D-galactopyranoside |
Blood Group B pentasaccharide | 72468-43-0 | C30H52O24 | 796.72 | Gala1-3(Fuca1-2)Galb1-4(Fuca1-2)Glc |
Blood Group A type I linear trisaccharide | 886750-14-7 | C22H38N2O16 | 586.54 | GalNAca1-3Galb1-3GlcNAc |
Blood Group A type II linear trisaccharide | 138398-63-7 | C22H38N2O16 | 586.54 | GalNAca1-3Galb1-4GlcNAc |
Blood Group A trisaccharide, spacer-biotin conjugate | 870891-83-1 | C39H67N5O18S | 926.04 | Fuc-(a1,2)-[GalNAc-(a1,3)]-b-Gal-O(CH2)3NHCO(CH2)5NH-biotin |
Blood Group A trisaccharide, N-aminoethyl nonanamide | 170298-33-6 | C31H57N3O16 | 727.79 | GalNAc-a-1,3-(Fuc-a-1,2)Gal-b1-O-(CH2)8CONH(CH2)2NH2; Blood Group A trisaccharide amine derivative |
Blood Group A trisaccharide-(CH2)8COOMe derivative | 68733-37-9 | C30H53NO17 | 699.74 | |
Blood Group A trisaccharide | 49777-13-1 | C20H35NO15 | 529.49 | GalNAc-a-1,3-(Fuc-a-1,2)Gal |
Blood Group A tetrasaccharide (A-Type-6) | 59957-92-5 | C26H45NO20 | 691.63 | GalNAca1-3(Fuca1-2)Galb1-4Glc |
Blood Group A pentasaccharide | 50624-46-9 | C32H55NO24 | 837.77 | GalNAca1-3(Fuca1-2)Galb1-4(Fuca1-3)Glc |
Blonanserin-d5 | 1346599-86-7 | C23H25FN3D5 | 372.54 | 2-(4-[Ethyl-d5)-1-piperazinyl]-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine; Lonasen-d5; AD 5423-d5 |
Blonanserin Impurity 6 | 132810-83-4 | C23H30FN3 | 367.51 | |
Blonanserin Impurity 4 | 132811-84-8 | C21H26FN3 | 339.46 | Blonanserin C; 4-(4-Fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)cycloocta[b]pyridine |
Blonanserin Impurity 2 | 132810-75-4 | C23H31N3 | 349.52 | Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl- |
Blonanserin Impurity 1 | 1648791-23-4 | C29H43N5 | 461.70 | Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- |
Blonanserin | 132810-10-7 | C23H30FN3 | 367.512 | 2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
Blinin | 125675-09-4 | C22H32O6 | 392.49 | 4-[2-[(1S,2R,4aS,7S,8aR)-4a-[(Acetyloxy)methyl]-1,2,3,4,4a,7,8,8a-octahydro-7-hydroxy-5-(hydroxymethyl)-1,2-dimethyl-1-naphthalenyl]ethyl]-2(5H)-furanone; Blinin; 2(5H)-Furanone,4-[2-[(1S,2R,4aS,7S,8aR)-4a-[(acetyloxy)methyl]-1,2,3,4,4a,7,8,8a-octahydro-7 |
blinatumomab | 853426-35-4 | C2367H3577N649O772S19 | 54100 | Blincyto |
b-L-Fucose-1-phosphate bis(cyclohexylammonium) salt | 28553-11-9 | C6H11O8P 2C6H14N | 442.48 | 6-Deoxy-b-L-galactose phosphate |
b-L-Fucopyranosylamine | 103419-79-0 | C6H13NO4 | 163.17 | |
b-L-Fucopyranosyl phosphate | 16562-59-7 | |||
b-Lactose - min 70% b-anomer | 5965-66-2 | C12H22O11 | 342.30 | 4-O-(b-D-Galactopyranosyl)-b-D-glucopyranose |
Bletilol B | 147235-17-4 | C27H26O7 | 462.49 | (-)-Bletilol B |
Bletilloside A | 2292159-89-6 | C29H36O15 | 624.59 | |
Bleomycin sulfate | 9041-93-4 | C55H84N17O21S3·xH2SO4 | 1415.6 (free base) | Blexane |
Bleomycin B2 | 9060-10-0 | C55H84N20O21S2 | 1425.52 | Bleomycin B2; BLEMOYCIN BZ; Dehydrophleomycin D1; N1-[4-[(Aminoiminomethyl)amino]butyl]bleomycinamide; N1-[4-[[Amino(imino)methyl]amino]butyl]bleomycinamide; Phleomycin D2; Zhengguanmycin B2 |
Bleomycin A5 hydrochloride | 55658-47-4 | C57H89CuN19O21S2.3HCl | 1477.02 | |
Bleomycin a2 | 11116-31-7 | C55H84N17O21S3 | 1415.55 | BLEOMYCIN A2; Bleomycinamide, N1-[3-(dimethylsulfonio)propyl]-; BLEMOYCIN AZ; Bleogin; N1-[3-(Dimethylsulfonio)propyl]bleomycinamide; Pingyangmycin A2; Zhengguangmycin A2; Einecs 234-356-5 |
Bleomycin | 11056-06-7 | C55H84N17O21S3 | 1415.55 | N1-(3-(dimethylsulfonio)propyl)bleomycinamide) (Bleomycin A2);Bleocin;Blenoxane;Pingyangmyvin A2;3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]a |
Bleaching earth | 70131-50-9 | H2Al2(SiO3)4-nH2O | 274-324-8 | Bentonite, acid-leached; Bleaching clay; ACTIVATED BLEACHING EARTH; ACTIVATED BLEACHING EARTH CS-1040; Activatedclay/Bleachingclay; Sud Chemie Tonsil Optimum FF; bentonite acid-leached powder; Active clay CS-1055 |
Blasticidin A | 100513-53-9 | C58H107NO23 | 1186.5 | |
b-L-Arabinopyranose | 7296-56-2 | C5H10O5 | 150.1 | |
b-Lactopyranosyl phenylisothiocyanate | 96324-93-5 | C19H25NO11S | 475.47 | |
Black tea extract | 188265-33-0 | C7H8ClN3O4S2 | 297.73912;g/mol | hydrochlorothiazide; Hypothiazide; Dichlotride; Esidrex; Esidrix; Oretic |
Black Ferric Oxide | 1317-61-9 | Fe3O4 | 231.53 | Iron(II,III) oxide |
Black Cohosh P.E. | 1254019-22-1 | C17H16BrNO2S | 378.28344;g/mol | AC1LNXHF; ZINC1064678; ZINC01064678; (2S,5S)-3-(4-bromophenyl)-2-(4-methoxyphenyl)-5-methyl-1,3-thiazolidin-4-one |
BL 1249 | 18200-13-0 | C17H17N5 | 291.35 | 5,6,7,8-Tetrahydro-N-[2-(2H-tetrazol-5-yl)phenyl]-1-naphthalenamine; N-[2-(2H-tetrazol-5-yl)phenyl]-5,6,7,8-tetrahydronaphthalen-1-amine |
BKM120 | 944396-07-0 | C18H21F3N6O2 | 410.39 | 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine; BKM120; buparlisib; NVP-BKM120; 944396-07-0; BKM 120; BKM-120; UNII-0ZM2Z182GD; 1202777-78-3; 944396-07-0; NVP-BKM120; Buparlisib; 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluorome |
BKM120 | 1202777-78-3 | C18H21F3N6O2 | 410.39 | 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine; BKM120; buparlisib; NVP-BKM120; 944396-07-0; BKM 120; BKM-120; UNII-0ZM2Z182GD; 1202777-78-3; 944396-07-0; NVP-BKM120; Buparlisib; 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluorome |
Bisphenol A glycerolate dimethacrylate | 1565-94-2 | C29H36O8 | 512.59 | Bis-gma; BisphenolAglycerolatedimethacrylate; BisphenolAglycidylmethacrylate; Silux; Panaviaopaque; 1565-94-2 |
Bivalirudin Impurity 1 | 72378-50-8 | C6H8N2O4 | 172.14 | |
Bizine | 1591932-50-1 | C18H23N3O | 297.4 | BSM-0353 |
Bizelesin | 129655-21-6 | C43H36Cl2N8O5 | 815.712 | U-77779. |
Bixin | 6983-79-5 | C25H30O4 | 394.5 | 6-Methyl hydrogen (9Z)-6,6'-diapocarotene-6,6'-dioate |
BIX02189 | 1265916-41-3 | C27H28N4O2 | 440.54 | (Z)-3-(((3-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-N,N-dimethyl-2-oxoindoline-6-carboxamide; BIX02189; BIX 02189; BIX-02189 |
BIX-02188 | 1094614-84-2 | C25H24N4O2 | 412.493 | Code name: BIX02188. |
BIX02188 | 334949-59-6 | C25H24N4O2 | 412.493 | |
BIX01294 hydrochloride hydrate | 1808255-64-2 | C28H38N6O2·3HCl·xH2O | 600 | BIX 01294; BIX-01294 |
BIX-01294 | 935693-62-2 | C28H38N6O2 | 490.64 | |
BIX NHE1 inhibitor | 1204329-34-9 | C16H19F3N4O2.HCl | 392.8 | 4-(1-Acetyl-4-piperidinyl)-N-(aminoiminomethyl)-3-(trifluoromethyl)benzamide hydrochloride |
BIX 02565 | 1311367-27-7 | C26H30N6O2 | 458.56 | BIX 02565; CHEMBL1933288; BIX02565; GTPL8039; SCHEMBL1980595; BDBM50360301 |
BIX 02189 | 1094614-85-3 | C27H28N4O2 | 440.54 | N/A |
BIX 02188 | 334951-92-7 | C26H26N4O2 | 426.51 | MEK inhibitor; 1H-Indole-6-carboxamide, 3-[[[3-[(dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-N-methyl-2-oxo-, (3Z)- |
BIX 01294 | 1392399-03-9 | C28H38N6O2.3HCl | 600.02 | BIX 01294 trihydrochloride; BIX-01294; N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine trihydrochloride |
BIX | 101714-41-4 | C9H7NO3S | 209.22 | 2-(3,4-Dihydroxyphenyl)-2-oxoethyl ester thiocyanic acid; Thiocyanic acid,2-(3,4-dihydroxyphenyl)-2-oxoethyl ester |
Bivalirudin | 128270-60-0 | C98H138N24O33 | 2180.29 | Angiomax; Angiox; L-leucine; D-phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl- |
Bitumens | 128683-24-9 | |||
Bitoscanate | 4044-65-9 | C8H4N2S2 | 192.26 | 1,4-Diisothiocyanatobenzene; 1,4-Phenylene diisothiocyanate; |
Bitopertin R enantiomer | 845614-12-2 | C21H20F7N3O4S | 543.46 | RG1678 (R enantiomer); RO4917838 (R enantiomer) |
Bitopertin | 845614-11-1 | C21H20F7N3O4S | 543.46 | RG1678; RO4917838 |
Bitolterol | 30392-40-6 | C28H31NO5 | 461.555 | Bitolterol; Bitolterolum; Bitolterolum[INN-Latin]; 30392-40-6; Bitolterol[INN:BAN]; CHEBI:3133 |
Bithionol sulfoxide | 844-26-8 | C12H6Cl4O3S | 372.05 | Bitin-S |
Bithionol | 97-18-7 | C12H6Cl4O2S | 356.05 | Actamer |
bis-Xylenofluorene | 80850-00-6 | C29H26O2 | 0 | bis-Xylenofluorene |
Bisucaberin | 112972-60-8 | C18H32N4O6 | 400.47 | BISUCABERIN; 6,17-Dihydroxy-1,6,12,17-tetraazacyclodocosane-2,5,13,16-tetrone; Biscaberin |
Bisphenol AF | 1478-61-1 | C15H10F6O2 | 336.23 | 2,2-bis(4-hydroxy-phenyl)-1,1,1,3,3,3-hexafluoropropane; 3,3'-(hexafluoroisopropylidene)diphenol; 4,4'-(2,2,2-trifluoro-1-(trifluoromethyl)ethylidene)bis-pheno; 4,4'-(bis(trifluoromethyl)methylene)di-Phenol; 4,4'-(trifluoro-1-(trifluoromethyl)ethylidene)d |
BISPHENOL A GLYCEROLATE (1 GLYCEROL/ | 4687-94-9 | C27H32O8 | 484.54 | |
Bisoxatin | 17692-24-9 | C20H15NO4 | 0 | bisoxatin; 2,2-Bis(p-hydroxyphenyl)-2H-1,4-benzoxazin-3(4H)-one |
Bisoprolol Phenol Impurity | 62340-37-8 | C12H19NO3 | 225.29 | (±)-Varbian; C-50005-A-BA; H-80/62; Kwd-2033 |
Bisoprolol Impurity E | 1217245-60-7 | C18H29NO3 | 307.44 | Dehydroxy Bisoprolol; 3-[4-[[2-(1-Methylethoxy)ethoxy]Methyl]phenoxy]-N-(1-Methylethyl)-2-propen-1-aMine; 2-Propen-1-amine |
Bisoprolol Hemifumarate | 104344-23-2 | C22H35NO8 | 441.52 | EMD33512; EMD 33512; EMD-33512 |
Bisoprolol fumarate (1:x) | 66722-45-0 | C18H31NO4.xC4H4O4 | 325.448 (free base) | |
Bisoprolol fumarate | 105878-43-1 | C18H31NO4·C4H4O4 | 441.5 | EMD 33512 |
Bisoprolol EP Impurity L | 29122-74-5 | C13H19NO3 | 237.29 | 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzaldehyde; p-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde; H 128/80 |
Bisoprolol EP Impurity L | 1956321-87-1 | C13H20ClNO3 | 273.759 | p-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride; Metoprolol Impurity C (HCl salt form) |
Bisoprolol EP Impurity K | 864544-37-6 | C18H29NO5 | 339.44 | Keto Bisoprolol; 2-Isopropoxyethyl-4-[[(2RS)-2-hydroxy-3-(isopropylaMino)propyl]oxy]benzoate; 4-[2-hydroxy-3-[(1-Methylethyl)aMino]propoxy]-Benzoic Acid 2-(1-Methylethoxy)ethyl Ester |
Bisoprolol EP Impurity G | 1215342-36-1 | C19H33NO5 | 355.48 | rac Des(isopropoxyethyl)-2-isopropoxyethoxymethyl Bisoprolol; 1-[4-[[(2-Isopropoxyethoxy)methoxy]methyl]phenoxy]-3-isopropylamino-2-propanol |
Bisoprolol EP Impurity A | 62572-93-4 | C13H21NO3 | 239.32 | Des(isopropoxyethyl) Bisoprolol; 4-[2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzeneMethanol |
Bisoprolol Acid Impurity | 72570-70-8 | C13H19NO4 | 253.30 | 4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic Acid; 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzoic Acid |
bis-O-(Benzylidene)-D-glucitol | 32647-67-9 | C20H22O6 | 358.39 | bis-O-(Benzylidene)-D-glucitol; (1,3:2,4)Dibenzylidene sorbitol; Dibenzylidene-D-sorbitol |
bis-N-Succinimidyl diglycolic acid | 373614-12-1 | C12H12N2O9 | 328.232 | Bis-N-succinimidyl diglycolic acid, 2,2-Oxydiacetic acid bis-N-succinimidyl ester; DIG(NHS)2 |
Bismuth, granular | 7440-69-9 | Bi | 208.98 | |
bismuth(iii) citrate | 813-93-4 | C6H5BiO7 | 398.08 | BISMUTH(III) CITRATE; BISMUTH CITRATE; Bimuth Potassium Citrate; BISMUTH(III) CITRATE, -325 MESH, 99.99%; Citric acid, bismuth salt; BISMUTHCITRATE,POWDER; BISMUTHCITRATE,POWDER,USP; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) salt (1:1) |
Bismuth vanadate | 14059-33-7 | BiVO4 | 323.92 | |
Bismuth tris(methanesulfonate) | 82617-81-0 | 3(CH3O3S).Bi | 494.26 | Bismuth methanesulfonate; Bismuth tris(methanesulfonate) |
Bismuth trimethyl | 593-91-9 | C3H9Bi | 254.08 | trimethyl-bismut; Trimethyl-bismuthane; Trimethylbismuthine; Trimethylbismutin; BISMUTH TRIMETHYL; TRIMETHYLBISMUTH |
Bismuth Subcitrate Potassium | 880149-29-1 | C12H16BiK5O14 | 788.72 | |
Bismuth strontium calcium copper oxide, (2-2-1-2) | 114901-61-0 | Bi2Sr2CaCu2Ox | 944.44300 | |
Bismuth Sodium Tartrate | 31586-77-3 | C12H12BiO18Na3 | 722.17 | 2,3-dihydroxy-butanedioicaci(r-(r*,r*))-butanedioicacibismuthsodiumsalt; tartaricacid,bismuthsodiumsalt; Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, bismuth sodium salt |
Bismuth Potassium Iodide | 41944-01-8 | BiI7K4 | 1253.70 | Bismuthate(4-),heptaiodo-,tetrapotassium; Tetrapotassiumheptaiodobismuthate; Potassium heptaiodobismuthate; Einecs 255-595-1; Heptaiodobismuthate(4-) potassium |
Bismuth Potassium Citrate | 57644-54-9 | C6H8O7 | 192.12 | Bismuth tripotassium dicitrate; De-Noltab; Bismuth subcitrate |
Bismuth Oxychloride | 7787-59-9 | BiClO | 260.43 | PEARL WHITE; biju; chlorooxo-bismuthin; chlorooxo-Bismuthine; mearlite; BIRON LF-2000; BIRON MTU; BISMUTH OXYCHLORIDE |
Bismuth oxybromide | 7787-57-7 | BiBrO | 304.88 | BISMUTH OXYBROMIDE; bismuth bromide oxide; Bromobismuth oxide |
Bismuth oleate | 52951-38-9 | C36H67BiO4 | 772.9 | BISMUTH OLEATE; bismuth(3+)salt; oleo-bi; bismuth trioleate; 9-Octadecenoic acid (Z)-, bismuth(3+) salt; Einecs 258-270-2 |
BISMUTH NEODECANOATE | 34364-26-6 | C30H57BiO6 | 722.75 | Neodecanoicacid,bismuth(3+)salt; neodecanoicacid,bismuth(3++)salt; BISMUTH NEODECANOATE; BISMUTH(III)NEODECANOATE; bismuth(3+) neodecanoate; BISMUTH NEODECANOATE, TECH; Bismuth(III)neodecanoate,superconductorgrade~60%inneodecanoicacid(15-20%Bi); Bismuth(I |
Bismuth iodate | 13702-39-1 | Bi(IO3)3 | 733.69 | bismuthtriiodate; BISMUTH IODATE; Trisiodic acid bismuth salt |
BISMUTH CHROMATE, (BiO)2Cr2O7 | 37235-82-8 | O12Cr3Bi2 | 765.95 | |
Bismuth carbonate | 5892-10-4 | CBi2O5 | 509.97 | BISMUTH CARBONATE; BISMUTH CARBONATE, BASIC; BISMUTHI SUBCARBONAS; BISMUTH(III) CARBONATE BASIC; BISMUTH(III) CARBONATE OXIDE; BISMUTH CARBONATE OXIDE; BISMUTH SUBCARBONATE; BISMUTH OXYCARBONATE |
Bismuth aluminate hydrate | 308796-32-9 | Al3BiO6 | 771.84 (anhydrous basis) | Aluminum bismuth oxide hydrate |
Bismuth 2-ethylhexanoate | 67874-71-9 | C24H45BiO6 | 638.5909 | Bismuth 2-ethylhexanoate; 2-Ethylhexanoic acid bismuth salt |
Bisjatrochizine chloride | 35558-46-4 | C40H38N2O8Cl2 | 745.66 | |
Bisindolylmaleimide XI hydrochloride | 145333-02-4 | C28H28N4O2·HCl | 489 | BIM XI; Ro 31-0432 |
Bisindolylmaleimide X hydrochloride | 145317-11-9 | C26H24N4O2·HCl | 461 | BIM X; Ro 31-8425 |
Bisindolylmaleimide VIII acetate | 138516-31-1 | C24H22N4O2·C2H4O2 | 458.5 | BIM VIII; Ro 31-7549 |
Bisindolylmaleimide V | 113963-68-1 | C21H15N3O2 | 341.3 | BIM V; Ro 31-6045 |
Bisindolylmaleimide III | 137592-43-9 | C23H20N4O2 | 384.4 | BIM III |
Bisindolylmaleimide II | 137592-45-1 | C27H26N4O2 | 438.52 | 3-(1H-Indol-3-yl)-4-[1-[2-(1-methyl-2-pyrrolidinyl)ethyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione |
Bisindolylmaleimide I hydrochloride | 176504-36-2 | C25H24N4O2·HCl | 449 | |
Bishydroxyphenylbutane | 77-40-7 | C16H18O2 | 242.32 | 4,4'-(1-methylpropylidene)bisphenol; 2,2-BIS(P-HYDROXYPHENYL)BUTANE; 2,2-BIS(4-HYDROXYPHENYL)BUTANE; BISPHENOL B; BISHYDROXYPHENYLBUTANE; P,P'-SEC-BUTYLIDENEDIPHENOL; p,p'-Dihydroxy-2,2-diphenylbutane; 4,4'-(1-Methylpropylidene)diphenol |
Bisegliptin | 862501-61-9 | C18H26FN3O3 | 351.42 | ethyl 4-((2-((2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl)-2-oxoethyl)amino)bicyclo[2.2.2]octane-1-carboxylate |
BIS-DIGLYCERYL POLYACYLADIPATE-2 | 82249-33-0 | |||
Bisdethiobis(methylthio)gliotoxin | 74149-38-5 | C15H20N2O4S2 | 356.455 | (3R,5aS,6S,10aR)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-6,10-dihydro-5aH-pyrazino[1,2-a]indole-1,4-dione |
Bisdemethoxycurcumin | 24939-16-0 | C19H16O4 | 308.33 | BIS-DESMETHOXYCURCUMIN; BIS(4-HYDROXYCINNAMOYL)METHANE; DEMETHOXYCURCUMIN, BIS-; CURCUMIN 3; (1E,6E)-1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; BIS-(PARA-HYDROXYCINNAMOYL)METHANE; CURCUMINIII; 1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione |
Bisdemethoxycurcumin | 33171-05-0 | C19H16O4 | 308.33 | Curcumin III; Didemethoxycurcumin |
Bisdemethoxycurcumin | 52328-96-8 | C19H16O4 | 308.33 | (Z,E,E)-5-Hydroxy-1,7-bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one |
Bisdemethoxyboehmenan | 146918-26-5 | C38H36O10 | 652.70 | |
Bisdehydroneotuberostemonine | 160333-27-7 | C22H29NO4 | 371.477 | 1alpha-Methyl-4alpha-ethyl-5beta,6-butano-7-[(2S,4S)-4-methyl-5-oxotetrahydrofuran-2-yl]-1,2,3abeta,4,5,8bbeta-hexahydro-6H-furo[3,2-e]indole-2-one |
Bis-Cl-ANT-ATP | 1350460-89-7 | C24H24Cl2N7O15P3 (free acid) | 814.3 (free acid) | 2', 3'- O- (Bis- [5- chloroanthraniloyl])adenosine- 5'- O- triphosphate, sodium salt |
Bischloroanthrabenzoxocinone | 866022-28-8 | C28H24O7Cl2 | 542.1 | BABX |
Bis-Br-ANT-ATP | 1350460-91-1 | C24H24Br2N7O15P3 (free acid) | 903.2 (free acid) | 2', 3'- O- (Bis- [5- bromoanthraniloyl])adenosine- 5'- O- triphosphate, sodium salt |
Bisantrene Dihydrochloride | 71439-68-4 | C22H24Cl2N8 | 471.39 | N-[(E)-[10-[(E)-(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine;dihydrochloride; 9,10-anthracenedicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl)hydrazone; bisantrene; bisantrene |
Bisantrene | 78186-34-2 | C22H22N8 | 398.471 | |
bis-ANS potassium salt | 65664-81-5 | C32H22K2N2O6S2 | 672.9 | 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic acid dipotassium salt; Potassium 4,4'-bis(phenylamino)-[1,1'-binaphthalene]-5,5'-disulfonate |
Bisandrographolide C | 160498-02-2 | C40H56O8 | 664.88 | |
Bisandrographolide A | 160498-00-0 | C40H56O8 | 664.88 | Bisandrographolide A |
Bisacurone C | 127214-86-2 | C15H24O3 | 252.354 | (6S)-6-[(1R,4R,5R)-4,5-dihydroxy-4-methylcyclohex-2-en-1-yl]-2-methylhept-2-en-4-one |
Bisacurone | 120681-81-4 | C15H24O3 | 252.354 | (6S)-6-[(1R,4S,5S)-4,5-dihydroxy-4-methylcyclohex-2-en-1-yl]-2-methylhept-2-en-4-one |
Bisacodyl Impurity E | 111664-35-8 | C22H19NO4 | 361.40 | 2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate; 4'-Desacetoxy-2'-Acetoxy Bisacodyl; te; 2,4'-(2-pyridylmethylene)diphenol Diacetate; USP Bisacodyl Related Compound E |
Bisacodyl Impurity D | 10040-45-6 | C18H15NO8S2.2Na | 481.41 | N/A |
Bisacodyl Impurity C | 72901-16-7 | C20H17NO3 | 319.36 | 4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate; 4-[[4-(Acetyloxy)phenyl]-2-pyridinylmethyl]phenol; Desacetyl Bisacodyl; USP Bisacodyl Related Compound C |
Bisacodyl Impurity B | 16985-05-0 | C18H15NO2 | 277.33 | 2,4'-(2-Pyridinyl-2methylene)diphenol; 2-[(4-Hydroxyphenyl)-2-pyridinylmethyl]phenol |
Bisacodyl | 603-50-9 | C22H19NO4 | 361.39 | Bisacodyl, Durolax, Dulcolax, Fenilaxan, Neolax, Ulcolax |
Bisabolol oxide A | 22567-36-8 | C15H26O2 | 238.36 | Bisabolol oxide |
BISABOLENE | 495-62-5 | C15H26 | 206.37 | FEMA 3331; BISABOLENE; 2-methyl-6-(4-methyl-3-cyclohexen-1-ylidene)-2-hepten; 4-(1,5-dimethyl-4-hexenylidene)-1-methyl-cyclohexen; 4-(1,5-dimethyl-4-hexenylidene)-1-methylcyclohexene; 4-(1,5-dimethyl-4-hexenylidene)-1-methyl-Cyclohexene |
Bisabola-3,10-dien-2-one | 61432-71-1 | C15H24O | 220.356 | 1-Bisabolone; 6R,7R-Bisabolone; (6R)-3-methyl-6-[(2S)-6-methylhept-5-en-2-yl]cyclohex-2-en-1-one |
Bisabola-2,10-diene-1,9-dione | 107439-25-8 | C15H22O2 | 234.33 | |
Bis-5,5-nortrachelogenin | 870480-56-1 | C40H42O14 | 746.8 | (3S,3'S,4S,4'S)-4,4'-[(6,6'-Dihydroxy-5,5'-dimethoxy[1,1'-biphenyl]-3,3'-diyl)bis(methylene)]bis[dihydro-3-hydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone |
Bis[rhodium(a,a,a#,a#-tetramethyl-1,3-benzenedipropionic acid)], 96% | 819050-89-0 | 2C16H22O4.Rh2 | 762.512 | |
bis[p-(1,1,3,3-Tetramethylbutyl)phenyl] hydrogen phosphate | 1758-45-8 | C28H43O4P | 474.612 g/mol | |
bis[N,N,N',N'-Tetramethyl-3-(10H-phenothiazin-10-yl)propane-1,3-diamine] fumarate | 3688-62-8 | C42H54N6O4S2 | 771.04596 | (E)-but-2-enedioicacid;N,N,N',N'-tetramethyl-1-phenothiazin-10-ylpropane-1,3-diamine;3688-62-8;BIS[N,N,N',N'-TETRAMETHYL-3-(10H-PHENOTHIAZIN-10-YL)PROPANE-1,3-DIAMINE]FUMARATE;bis[N,N,N',N'-tetramethyl-3-propane-1,3-diamine]fumarate |
bis[N-(2-mercaptophenyl)benzamidato-N,S]zinc | 30429-79-9 | C26H20N2O2S2Zn | 521.9692 | bis[N-(2-mercaptophenyl)benzamidato-N,S]zinc; Zinc 2-benzamidothiophenolate; Noctizer SZ; Pepton 65 |
Bis[bis(trimethylsilyl)amino]tin(II) | 59863-13-7 | C12H36N2Si4Sn | 439.48 | |
BIS[BIS(TRIMETHYLSILYL)AMINO]-GERMANIUM II | 55290-25-0 | C12H36GeN2Si4 | 393.41 | GERMANIUM II BIS[BIS(TRIMETHYLSILYL)AMIDE]; BIS[BIS(TRIMETHYLSILYL)AMINO]-GERMANIUM II; Germanium(II), bis[bis(trimethylsilyl)]amino-; GERMANIUM II BIS(HEXAMETHYLSILYL)AZIDE); germanium ii bis(hexamethyldisilazide |
bis[6-(5,6-dihydrochelerythrinyl)]amine | 165393-48-6 | C42H37N3O8 | 711.76 | |
bis[5-Amino-1,1-dimethylhexyl] hydrogen phosphate | 18864-27-2 | C16H37N2O4P | 352.45 g/mol | |
bis[4-(dimethylamino)phenyl]-[4-(methylamino)phenyl]methanol | 561-41-1 | C24H29N3O | 375.507 | 561-41-1; 4,4'-Bis(dimethylamino)-4''-(methylamino)tritylalcohol; bis[4-(dimethylamino)phenyl][4-(methylamino)phenyl]methanol; Benzenemethanol,a,a-bis[4-(dimethylamino)phenyl]-4-(methylamino)-; EINECS209-218-2; AC1L29OV |
Bis[3-(dimethylamino)propyl] phenylphosphine | 32357-32-7 | C16H29N2P | 280.388622;g/mol | 3-[3-(dimethylamino)propyl-phenylphosphanyl]-N,N-dimethylpropan-1-amine;SCHEMBL10849576;Bis[3-(dimethylamino)propyl]phenylphosphine;3-(3-dimethylamino-propyl-phenyl-phosphanyl)-propyl-dimethyl-amine;3-(3-dimethylaminopropyl-phenylphosphanyl)-N,N-dimethylp |
bis[2-[(2-Aminoethyl)amino]ethanolato][2-[(2-aminoethyl)amino]ethanolato-o](propan-2-olato)titanate | 65380-84-9 | C15H40N6O4Ti | ||
bis-[2,4,5-Trichloro-6-(pentyloxycarbonyl)phenyl]oxalate | 30431-54-0 | C26H24Cl6O8 | 677.18 | BIS[2,4,5-TRICHLORO-6-(PENTYLOXYCARBONYLPHENYL)] OXALATE; BIS(2-CARBOPENTYLOXY-3,4,6-TRICHLOROPHENYL) OXALATE; BIS[3,4,6-TRICHLORO-2-(PENTYLOXYCARBONYL)PHENYL] OXALATE; DIPENTYL O,O'-OXALYL-BIS(3,5,6-TRICHLOROSALICYLATE); ethanedioicacid,bis[3,4,6-trichlo |
bis-[2-(Hydroxymethyl)phenyl] disulfide | 35190-71-7 | C14H14O2S2 | 278.39 | (2-([2-(HYDROXYMETHYL)PHENYL]DISULFANYL)PHENYL)METHANOL; 2,2'-DITHIODIBENZENEMETHANOL; BIS[2-(HYDROXYMETHYL)PHENYL] DISULFIDE; Benzenemethanol, 2,2'-dithiobis- |
bis[2-(acryloyloxy)ethyl] hydrogen phosphate | 40074-34-8 | C10H15O8P | 294.194 | bis[2-(acryloyloxy)ethyl] hydrogen phosphate; 2-Propenoic acid, phosphinicobis(oxy-2,1-ethanediyl) ester; Bispropenoic acid phosphinicobis(oxy-2,1-ethanediyl) ester; Phosphoric acid bis[2-(acryloyloxy)ethyl] ester |
bis-[2-(2-Butoxyethoxy)ethoxy]methane | 143-29-3 | C17H36 O6 | 336.53 | 5,8,11,13,16,19-Hexaoxatricosane; bis(2-(2-butoxyethoxy)ethoxy)-methan; bis(butylcarbitol)formal; butylcarbitolformal; cryoflex; dibutylcarbitolformal; Hexaoxatricosane; 2-(2-Butoxyethoxy)ethyl formal |
Bis[1,3-bis(h2-ethenyl)-1,1,3,3-tetramethyldisiloxane]platinum | 81032-58-8 | C16H36O2PtSi4 | 567.87 | |
Bis[(S,S,S)-DiazaPhos-SPE] | 851770-14-4 | C78H72N8O8P2 | 1311.40 | 2,2,2,2-(1,2-Phenylenebis[(1S,3S)-tetrahydro-5,8-dioxo-1H-[1,2,4]diazaphospholo[1,2-a]pyridazine-2,1,3(3H)-triyl])tetrakis(N-[(1S)-1-phenylethyl]) |
Bis(vinylsulfonylmethyl)ether | 26750-50-5 | C6H10O5S2 | 226.26 | 1,1'-(oxybis(methylenesulfonyl))bis-ethen; 1,1'-[oxybis(methylenesulfonyl)]bis-ethen; bis(vinylsulphonylmethyl)ether; ether,bis((vinylsulfonyl)methyl); BIS(VINYLSULFONYLMETHYL)ETHER; 1,1'-(OXYBIS(METHYLENESULFONYL)BISETHENE); 1-(ethenylsulfonylmethoxymeth |
BIS(TRIPROPYL TIN)OXIDE | 1067-29-4 | C18H42OSn2 | 511.95 | BIS(TRIPROPYL TIN)OXIDE; 1,1,1,3,3,3-hexapropyl-distannoxan; 1,1,1,3,3,3-Hexapropyldistannoxane; Bis(tri-n-propyltin) oxide; Distannoxane, 1,1,1,3,3,3-hexapropyl-; Distannoxane, hexapropyl- |
Bis(triphenylphosphine)palladium(II) chloride | 13965-03-2 | C36H30Cl2P2Pd | 701.91 | DICHLOROBIS(TRIPHENYLPHOSPHINE)PALLADATE (II); DICHLOROBIS(TRIPHENYLPHOSPHINE)PALLADIUM; DICHLOROBIS(TRIPHENYLPHOSPHINE)PALLADIUM(II); BIS(TRIPHENYLPHOSPHINE)PALLADIUM CHLORIDE; BIS-(TRIPHENYLPHOSPHINE)-PALLADIUM DICHLORIDE; BIS(TRIPHENYLPHOSPHINE)PALLADI |
BIS(TRIMETHYLSILYL)DICHLOROMETHANE | 15951-41-4 | C7H18Cl2Si2 | 229.29 | BIS(TRIMETHYLSILYL)DICHLOROMETHANE; DICHLOROBIS(TRIMETHYLSILYL)METHANE |
BIS(TRIMETHYLSILYL)AMIDOHAFNIUM(IV) CHLORIDE | 70969-29-8 | C12H36Cl2HfN2Si4 | 570.17 | HAFNIUM BIS(HEXAMETHYLDISILAZIDE)DICHLORIDE; BIS(TRIMETHYLSILYL)AMIDOHAFNIUM(IV) CHLORIDE; Bis(trimethylsilyl)amidohafnium(IV) chloride, >=95%, 99.99+% metals basis |
bis-(Trifluoromethyl)disulfide | 372-64-5 | C2F6S2 | 202.14 | bis(trifluoromethyl)-disulfid; Di(methyl) disulfide, perfluoro-; di(Trifluoromethyl)disulfide; Disulfide, bis(trifluoromethyl); hexafluorodimethyldisulfide; Perfluorodimethyl disulfide; perfluorodimethyldisulfide; Trifluoromethyl disulfide |
BIS(TRIFLUOROMETHYL)CHLOROPHOSPHINE | 650-52-2 | C2ClF6P | 204.44 | BIS(TRIFLUOROMETHYL)CHLOROPHOSPHINE; Bis(trifluoromethyl)chlorophosphine 97%; Bis(trifluoromethyl)chlorophosphine97%; CHLORO-BIS-TRIFLUOROMETHYLPHOSPHINE |
Bis-(tetramethylammonium)oxalate | 98296-17-4 | |||
bis-(tert-Butyldioxyisopropyl)benzene | 2212-81-9 | C20H34O4 | 338.48 | bis-(tert-Butyldioxyisopropyl)benzene; 1,3-di-(2-tert-Butylperoxyisopropyl)benzene |
BIS(SULFOSUCCINIMIDYL)OXALATE SODIUM SALT | 215597-87-8 | C10H7N2NaO14S2 | 466.28735 | BIS(SULFOSUCCINIMIDYL)OXALATE SODIUM SALT |
Bis(propylcyclopentadienyl)zirconium dichloride | 73364-09-7 | C16H22Cl2Zr | 376.48 | BIS(PROPYLCYCLOPENTADIENYL)ZIRCONIUM(IV) DICHLORIDE; BIS(N-PROPYLCYCLOPENTADIENYL)ZIRCONIUM DICHLORIDE; Bis(propylcyclopentadienyl)zirconium dichloride |
BIS(P-NITROPHENYL) AZIDOPHOSPHONATE | 51250-91-0 | C12H8N5O7P | 365.19 | BIS(P-NITROPHENYL) AZIDOPHOSPHONATE; Di-p-Nitrophenyl phosphorazidate; Phosphorazidic acid bis(4-nitrophenyl) ester |
Bis(phenylsulfonyl)sulfide | 4388-22-1 | C12H10O4S3 | 314.4 | Benzenesulfonic thio anhydride; bis-(Phenylsulfonyl)sulfide |
bis-(Pentamethylcyclopentadienyl)barium | 112379-49-4 | C20H30Ba | 407.79 | Bis(pentamethylcyclopentadienyl)barium |
bis-(Pentafluoropropionyl) peroxide | 356-45-6 | C6F10O4 | 326.045832 | |
Bis(pentafluoroethylsulfonyl)imide | 152894-10-5 | C4HF10NO4S2 | 381.17 | 152894-10-5; Bis(pentafluoroethylsulfonyl)imide; N,N-Bis(pentafluoroethanesulphonyl)imide; 1,1,2,2,2-pentafluoro-N-(1,1,2,2,2-pentafluoroethylsulfonyl)ethanesulfonamide; 1,1,2,2,2-pentafluoro-N-(pentafluoroethanesulfonyl)ethanesulfonamide; Ethanesulfonami |
Bis(p-anisyl)iodonium bromide | 19231-06-2 | C14H14BrIO2 | 421.07 | Bis(4-methoxyphenyl)iodonium Bromide; |
BIS(NEODECANOATE)TIN | 49556-16-3 | C20H38O4Sn | 461.22 | BIS(NEODECANOATE)TIN; TIN II NEODECANOATE; Neodecanoicacid,tin(2+)salt; neodecanoicacid,tin(2++)salt; tin(2+) neodecanoate; BIS(NEODECANOATE)TIN: 85% CONTAINS FREE NEODECANOIC ACID |
bis-(Methylcyclopentadienyl)magnesium | 40672-08-0 | C12H14Mg | 182.54 | BIS(METHYLCYCLOPENTADIENYL)MAGNESIUM; (CH3C5H4)2MG |
Bis(methacryloyloxy)propanol | 1830-78-0 | C11H16O5 | 228.24 | 1830-78-0; Glycerol1,3-Dimethacrylate; Bis(methacryloyloxy)propanol; Glycerol1,3-dimethacrylatecheckCAS; Glyceroldimethacrylate,mixtureofisomers; 2-hydroxypropane-1,3-diylbis(2-methylacrylate) |
Bis(maltolato) oxovanadium(IV) | 38213-69-3 | C12H10O7V | 317.1451;g/mol | bis(maltolato)oxovanadium(IV); Bmov(IV); 38213-69-3; BMOV; Vanadium,bis(3-hydroxy-2-methyl-4H-pyran-4-onato-O3,O4)oxo-,(SP-5-31)-; AC1MHZE4 |
BIS(ISOPROPYLCYCLOPENTADIENYL)TUNGSTEN DICHLORIDE | 90023-13-5 | C16H22Cl2W 10* | 469.09 | BIS(ISOPROPYLCYCLOPENTADIENYL)TUNGSTEN DICHLORIDE; BIS(ISOPROPYLCYCLOPENTADIENYL)TUNGSTEN(IV) DICHLORIDE; BIS(ISOPROPYLCYCLOPENTADIENYL)-TUNGSTEN |
BIS-(IMIDAZOL-2-YL)-METHANE | 64269-81-4 | C7H8N4 | 148.16522 | BIS-(IMIDAZOL-2-YL)-METHANE |
BIS(HYDROXYMETHYL)PHOSPHINIC ACID | 2074-67-1 | C2H7O4P | 126.05 | BIS(HYDROXYMETHYL)PHOSPHINIC ACID; BIS(HYDROXYMETHYL) PHOSPHONIC ACID; dimethylolphosphinic acid |
bis-(Hydrogenated tallow alkyl)dimethylammonium montmorillonite salts | 68911-87-5 | |||
Bis(hexamethylenetriaminepenta(methylenephosphonic acid)) | 34690-00-1 | C17H44N3O15P5 | 685.42 | [[(phosphonomethyl)imino]bis[6,1-hexanediylnitrilobis(methylene)]]tetrakis-Phosphonicacid; bis(hexamethylene)triamine-pentakis(me.-phosphonicac.)sol.; Bishexamethylenetriamine,pentamethylenepentaphosphonicacid; Phosphonicacid,[[(phosphonomethyl)imino]bis[ |
bis(glycinato-N,O)magnesium | 14783-68-7 | C4H8MgN2O4 | 172.42232 | bis-(Glycinato-N,O)magnesium; Magnesium glycinate |
bis(furan-2-yl)-dimethylsilane | 1578-44-5 | C10H12O2Si | 192.287 g/mol | Di-(2-furyl)dimethylsilane; bis(furan-2-yl)-dimethylsilane; AC1L39VQ; Dimethylbis(furan-2-yl)silane; SCHEMBL9793596; HE315036 |
Bis(ethylcyclopentadienyl)iron | 1273-97-8 | C14H18Fe | 242.14 | 1,1'-DIETHYLFERROCENE; BIS(ETHYLCYCLOPENTADIENYL)IRON; Bis(ethylcyclopentadienyl)iron,min.98%; Bis(ethylcyclopentadienyl)iron, min. 98%; 1,1'-Diethylferrocene,98% |
bis-(Dinonyldithiocarbamato-S,S')zinc | 14244-40-7 | C38H76N2S4Zn | 754.692 g/mol | zinc; N,N-di(nonyl)carbamodithioate; EINECS238-120-2; AC1L375Y; SCHEMBL2216269; zincN,N-di(nonyl)carbamodithioate |
bis-(Dichlorosilyl)methane | 18081-42-0 | CH4Cl4Si2 | 214.03 | BIS(DICHLOROSILYL)METHANE |
Bis(dibenzylideneacetone)palladium | 32005-36-0 | C34H28O2Pd | 575.01 | BIS(DIBENZYLIDENEACETONE)PALLADIUM; BIS(DIBENZYLIDENEACETONE) PALLADIUM(0); PALLADIUM (0) BIS(DIBENZYLIDENEACETONE) SALT; PALLADIUM(0) BIS(DIBENZYLIDENEACETONE); PD(DBA)2; Bis(dibenzylideneacetone)palladium(0) Pd(dba)2Pd2(dba)3dba |
Bis(cyclopentadienyl)titanium Dichloride | 1271-19-8 | C10H10Cl2Ti | 248.96 | |
bis-(Cyclopentadienyl)dimethyltitanium | 1271-66-5 | C12H16Ti | 208.13 | PETATIS REAGENT; BIS(CYCLOPENTADIENYL)DIMETHYLTITANIUM; BIS-(CYCLOPENTADIENYL)-DIMETHYLTITANIUM(IV); DIMETHYLTITANOCENE; Bis(cyclopentadienyl)dimethyltitanium, 5 wt% in toluene; petatis; Bis(cyclopentadienyl)dimethyltitanium, 5 WT% solution in toluene; Bi |
Bis(chloromethyl)dichlorosilane | 18076-97-6 | C2H4Cl4Si | 197.952 | dichloro-bis(chloromethyl)silane; BIS(CHLOROMETHYL)DICHLOROSILANE; 18076-97-6; dichlorobis(chloromethyl)silane; SCHEMBL467718; CTK4D7703 |
BIS(BUTYLCYCLOPENTADIENYL)HAFNIUM(IV) DICHLORIDE | 85722-08-3 | C18H26Cl2Hf 10* | 491.8 | |
bis-(Butane-2,3-glycolato)diboron | 230299-23-7 | C8H16B2O4 | 197.832 | Bis(Butane-2,3-Glycolato)Diboron |
Bis(bis(2-hydroxyethyl)ammonium) hydrogen phosphate | 32154-53-3 | C8H25N2O8P | 308.266462;g/mol | bis(2-hydroxyethyl)azanium;hydrogenphosphate;BIS(BIS(2-HYDROXYETHYL)AZANIUM)HYDROGENPHOSPHATE;SCHEMBL1833785;CTK1C6451;LP063799 |
BIS-(BIPYRIDIN)-4'-METHYL-4-CARBOXYBIPY. | 136724-73-7 | C36H29F12N7O4P2Ru | 1014.66 | BIS-(BIPYRIDIN)-4'-METHYL-4-CARBOXYBIPY.; bis(2,2'-bipyridine)-4'-methyl-4-carboxybipyridine-ruthenium n-succinimidyl ester-bis(hexafluorophosphate); ru(bpy)2(mcbpy-o-su-ester)(pf6)2 |
BIS-(BIPYRIDIN)-4 4'-DICARBOXYBIPYRI.-RU | 160525-49-5 | C20H14N4O8.2C10H8N2.Ru | 851.795 | BIS-(BIPYRIDIN)-4 4'-DICARBOXYBIPYRI.-RU; bis(2,2'-bipyridine)-4,4'-dicarboxybipyridine-ruthenium di(n-succinimidyl ester) bis(hexafluorophosphate); ru(bpy)2(dcbpy-di o-su-ester)(pf6)2 |
Bis(benzonitrile)dichloroplatinum(II) | 15617-19-3 | C14H10Cl2N2Pt | 472.23 | DICHLOROBIS(BENZONITRILE)PLATINUM (II); CIS-BIS(BENZONITRILE)DICHLOROPLATINUM(II); BIS(BENZONITRILE)PLATINUM(II) CHLORIDE; BIS(BENZONITRILE)DICHLOROPLATINATE (II); cis-di(benzonitrile)dichloroplatinum(ii); bis(benzonitrile)dichloroplatinumpt41.3%; cis-bis |
Bis(acetylacetonato) Platinum(II) | 15170-57-7 | C10H14O4Pt | 393.29400 | |
Bis(acetonitrile)palladium(II) chloride | 14592-56-4 | C4H6Cl2N2Pd | 259.43 | PALLADIUM(II) CHLORIDE-DIACETONITRILE COMPLEX; PALLADIUM-BIS-ACETONITRIL-DICHLORIDE; PALLADIUM DICHLOROBIS(ACETONITRILE); TRANS-DICHLOROBIS(ACETONITRILE)PALLADIUM; TRANS-BIS(ACETONITRILE)PALLADIUM(II) CHLORIDE; DICHLOROBIS(ACETONITRILE)PALLADIUM(II) |
BIS(ACETONITRILE)(1,5-CYCLOOCTADIENE)RHODIUM(I) TETRAFLUOROBORATE | 32679-02-0 | C12H18BF4N2Rh | 379.99 | |
bis(7)-Tacrine | 224445-12-9 | C33H40N4·2HCl | 565.6 | 1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydro-acridine |
bis(2-methylphenyl)diazene | 584-90-7 | C14H14N2 | 210.274 g/mol | |
bis-(2-Methoxyethoxy)methane | 4431-83-8 | (CH3OCH2CH2O)2CH2 | 164.2 | BIS(2-METHOXYETHOXY)METHANE; Formaldehyde 2-methoxyethyl acetal~2,5,7,10-Tetraoxaundecane; 2,5,7,10-tetraoxaundecane; Formaldehyde2-methoxyethylacetal; Formaldehyde bis(2-methoxyethyl)acetal; 1-methoxy-2-(2-methoxyethoxymethoxy)ethane |
BIS(2-METHACRYLOXYETHYL) PHOSPHATE | 32435-46-4 | C12H19O8P | 322.25 | BIS(2-METHACRYLOXYETHYL) PHOSPHATE; MONOACRYLOXYETHYL PHOSPHATE; 2-Propenoicacid,2-methyl-,phosphinicobis(oxy-2,1-ethanediyl)ester; bis(methacryloyloxyethyl) hydrogen phosphate; Bismethacrylic acid (phosphinicobisoxybisethylene) ester; Bismethacrylic acid |
Biorobin | 17297-56-2 | C27H30O15 | 594.53 | 3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-galactopyranosyl]oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;Kaempferol 3-O-robinoside |
Bioresmethrin | 28434-01-7 | C22H26O3 | 338.45 | (5-benzyl-3-furyl)methyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; (+)-trans-bioresmethrin; (1r)-trans-resmethrin; 1r-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylicacid,(5-benzyl; 1r-trans-resemethrin; 3-furanmeth |
Biopterin-d3 | 1217838-71-5 | C9H18N5O3D3 | 240.24 | 2-Amino-6-[(1R,2S)-1,2-dihydroxypropyl-d3]-4(1H)-pteridinone; (-)-Biopterin-d3; 6-Biopterin-d3; L-Biopterin-d3; L-erythro-Biopterin-d3; NSC 339699-d3; Pterin H B2-d3 |
Biondinin C | 55511-08-5 | C19H24O3 | 300.4 | |
B-IODO-9-BBN, 1.0M SOLUTION IN HEXANES | 70145-42-5 | C8H14BI | 247.91 | |
BIM5078 | 337506-43-1 | C14H10ClN3O4S | 351.8 | |
Biochanin A b-D-glucuronide | 38482-76-7 | C22H20O11 | 460.39 | |
Biochanin A | 491-80-5 | C16H12O5 | 284.26 | 4-Methylgenistein |
Benzylhydrazine hydrochloride | 1073-62-7 | C7H10N2.HCl | 158.63 | |
Benzylhydrazine | 555-96-4 | C7H10N2 | 122.17 | BENZYLHYDRAZINE; 1-Benzylhydrazine; Benzyl hydrazide; benzyl-hydrazin; Hydrazine, (phenylmethyl)-; Hydrazine, benzyl-; Benzylhydazine; BENZYLHYDRAZINE HCI |
Benzyl N-acetyl-6-O-benzyl-a-D-muramic acid methyl ester | 107671-54-5 | C26H33NO8 | 487.54 | N-Acetyl-1,6-bis-O-(phenylmethyl)-a-muramic acid methyl ester; (R)-Phenylmethyl 2-(acetylamino)-2-deoxy-3-O-(2-methoxy-1-methyl-2-oxoethyl)-6-O-(phenylmethyl)-a-D-glucopyranoside |
Benzyl N-acetyl-4,6-O-benzylidene-a-isomuramic acid methyl ester | 104371-52-0 | C26H31NO8 | 485.53 | N-Acetyl-1-O-(phenylmethyl)-4,6-O-(phenylmethylene)-a-isomuramic acid methyl ester; 2-Acetamido-4,6-O-benzylidene-3-O-(L-1-carboxyethyl)-2-deoxy-a-D-glucopyranoside benzyl methyl ester |
Benzyl N-acetyl-4,6-O-benzylidene-a-isomuramic acid | 730911-70-3 | C25H29NO8 | 471.50 | N-Acetyl-1-O-(phenylmethyl)-4,6-O-(phenylmethylene)-a-isomuramic acid |
Benzyl N,N-di-acetyl-b-chitobioside | 19272-52-7 | C23H34N2O11 | 514.52 | GlcNAc-b-1,4-GlcNAc-b-OBn |
bis-(3,4-Dimethylphenyl)iodonium hexafluorophosphate | 67578-25-0 | C16H18I.PF6 | 482.19 | BIS(3,4-DIMETHYLPHENYL)IODONIUM HEXAFLUOROPHOSPHATE |
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)- | 11079-53-1 | C35H52 O4 | 536.78 | 4-HYDROXY-6R-METHYL-1R,3,7S-TRIS(3-METHYL-2-BUTENYL)-5S-(2-METHYL-1-OXOPROPYL)-6R-(4-METHYL-3-PENTENYL)-BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE; HYPERFORIN; Bicyclo[3.3.1]non-3-ene-2,9-dione, 4-hydroxy-6-; methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1- |
BI-882370 | 1392429-79-6 | C28H33F2N7O2S | 569.7 | BI882370; BI 882370 |
BI-847325 | 1207293-36-4 | C29H28N4O2 | 464.56 | BI 847325; BI847325 |
BI-7273 | 1883429-21-7 | C20H23N3O3 | 353.422 | 4-[4-[(dimethylamino)methyl]-3,5-dimethoxyphenyl]-2-methyl-2,7-naphthyridin-1-one; GTPL9146; CHEMBL3823478; EX-A990; AKOS030528616; ZINC575448880 |
BI-6C9 | 791835-21-7 | C23H25N3O4S2 | 471.6 | N-[4-[(4-aminophenyl)thio]phenyl]-4-[[(4-methoxyphenyl)sulfonyl]amino]-butanamide |
BI671800 | 1093108-50-9 | C25H26F3N5O3 | 501.51 | AP-761;5-Pyrimidineacetic acid, 4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]-;2-(4,6-Bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)pyrimidin-5-yl)acetic acid;BI-671800 |
BI605906 | 960293-88-3 | C17H22F2N4O3S2 | 432.51 | BI-605906;3-AMino-4-(1,1-difluoropropyl)-6-(4-Methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxaMide |
BI-4834 | 876371-13-0 | C21H42N4O3S3 | 593.76008 | BI-4834; BI4834; BI 4834. |
Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-D-galactopyranoside | 75263-33-1 | C18H25NO6 | 351.39 | |
Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-b-D-glucopyranoside | 50605-12-4 | C18H25NO6 | 351.39 | BADIG |
Benzyl 2-acetamido-2-deoxy-4,6-O-isopropylidene-a-D-glucopyranoside | 66026-10-6 | C18H25NO6 | 351.39 | |
Benzyl 2-acetamido-2-deoxy-4,6-O-benzylidene-3-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-a-D-galactopyranoside | 86327-84-6 | C36H43NO15 | 729.72 | Phenylmethyl 2-(acetylamino)-2-deoxy-4,6-O-(phenylmethylene)-3-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-a-D-galactopyranoside |
Benzoic acid,3-hydroxy-4-iodo-, methyl ester | 157942-12-6 | C8H7 I O3 | 278.04 | RARECHEM AL BF 0964; METHYL-4-IODO-3-HYDROXY BENZOATE; Methyl 3-hydroxy-4-iodobenzenecarboxylate |
Benzoic acid,3-hydroxy-4-iodo-, ethyl ester | 203187-56-8 | C9H9 I O3 | 292.07 | ETHYL 3-HYDROXY-4-IODOBENZOATE; RARECHEM AL BI 0964; ETHYL 4-IODO 3-HYDROXY BENZOATE |
Benzoic acid,3,4,5-trihydroxy-, 2-hydroxyethyl ester | 68162-50-5 | C9H10 O6 | 214.17200 | |
Benzoic acid,3,3'-[oxybis[(1-oxo-2,1-ethanediyl)imino]]bis[2,4,6-triiodo- | 2618-25-9 | C18H10 I6 N2 O7 | 1127.71 g/mol | IoglycamicAcid;2618-25-9;UNII-ET36GPP4T7;Benzoicacid,3,3'-[oxybis[(1-oxo-2,1-ethanediyl)imino]]bis[2,4,6-triiodo-;Ioglycaminsaeure;Acidoioglicamico |
Benzyl butyrate | 103-37-7 | C11H14O2 | 178.231 | |
Benzyl bromide-,-d2 | 51271-29-5 | C7H7Br | 173.05 | -Bromotoluene-,d2 |
Benzyl 2-oxo-1,2-dihydropyridin-3-ylcarbamate | 147269-67-8 | C13H12N2O3 | 244.25 | BENZYL 2-OXO-1,2-DIHYDROPYRIDIN-3-YLCARBAMATE |
Benzyl 2-acetamido-2-deoxy-6-O-(b-D-galactopyranosyl)-a-D-galactopyranoside | 93496-44-7 | C21H31NO11 | 473.47 | |
Benzyl 2-Acetamido-6-O-(2-Acetamido-2-De Oxy-B-D- | 33401-02-4 | C23H24N2O11 | 504.44 | |
Benzenesulfonicacid, 4-amino-, hydrazide | 5450-86-2 | C6H9 N3 O2 S | ||
Bis-(4-tert-butyl-phenyl)-methanone | 15796-82-4 | C21H26O | 294.43 | 4,4'-DI-T-BUTYLBENZOPHENONE; 4,4'-DI-TERT-BUTYLBENZOPHENONE; BIS-(4-TERT-BUTYL-PHENYL)-METHANONE; 4,4'-Di-butylbenzophenone |
Bis-(4-tert-butylphenyl)-iodonium bis(trifluoromethylsulfonyl)imide | 460731-32-2 | C22H26F6INO4S2 | 673.47 | |
Bis(4-sulfobutyl)ether Disodium Salt | 183278-30-0 | C8H16O7S2Na2 | 334.32 | 4,4'-Oxybis-1-butanesulfonic Acid Disodium Salt; WAS-18 |
BIS(4-NITROPHENYL)PHOSPHORIC ACID SODIUM SALT | 4043-96-3 | C12H8N2NaO8P | 362.16 | BIS(P-NITROPHENYL) PHOSPHATE SODIUM SALT; BIS(PNP)-PHOS NA; BIS(4-NITROPHENYL)PHOSPHORIC ACID SODIUM SALT; BIS(4-NITROPHENYL)PHOSPHATE SODIUM SALT; SODIUM BIS(4-NITROPHENYL)PHOSPHATE; bis(P-nitrophenyl)phosphate sodium |
Bis-(4-methylumbelliferyl)phosphate | 51379-07-8 | C20H15O8P | 414.30 | Bis-MUP; Bis(Mu)-phos |
Bis(4-methylphenyl)methanamine | 55095-22-2 | C15H17N | 211.31 | bis(4-methylphenyl)methanamine; Bis(4-methylphenyl)methanamine; 55095-22-2; SS-3626; Di-p-tolylmethanamine; AC1MC0AK |
bis(4-methylphenyl)diazene | 501-60-0 | C14H14N2 | 210.274 g/mol | |
BIS(4-METHOXYBENZYLIDENE)ACETONE | 2051-07-2 | C19H18O3 | 294.34 | (E,E)-1,5-BIS-(4-METHOXYPHENYL)-1,4-PENTADIEN-3-ON; (E,E)-1,5-BIS(4-METHOXYPHENYL)-1,4-PENTADIEN-3-ONE; DIANISYLIDENE ACETONE; DI-(4,4'-DIMETHOXY)-BENZYLIDENE-ACETONE; BIS(4-METHOXYBENZYLIDENE)ACETONE; (1E,4E)-1,5-BIS(4-METHOXYPHENYL)-1,4-PENTADIEN-3-ONE; |
bis-(4-Isopropylphenyl)iodonium hexafluorophosphate | 69842-76-8 | C18H22I.PF6 | 510.24 | BIS(4-ISOPROPYLPHENYL)IODONIUM HEXAFLUOROPHOSPHATE |
Bis(4-fluorophenyl)phenylphosphine oxide | 54300-32-2 | |||
bis-(4-Dodecylphenyl)iodonium hexaflurorantimonate | 71786-70-4 | C36H58F6ISb | 853.5 | |
Bis(4-dimethylaminodithiobenzil)nickel(II) | 38465-55-3 | C32H30N2S4Ni | 629.54 | BDN |
Bis(4-dimethylamino-cyclohexyl) methane | 13474-64-1 | |||
bis-(4-Diethylaminodithiobenzil)nickel | 51449-18-4 | (C18H19S2)2Ni | 685.65 | 1-[4-(diethylamino)phenyl]-2-phenylethane-1,2-dithione;nickel;bis-(4-Diethylaminodithiobenzil)nickel;51449-18-4;NICKELCOMPLEX182;SCHEMBL9057697 |
bis-(4-(1,1,3,3-Tetramethylbutyl)phenyl) ether | 101-58-6 | C28H42O | ||
Bis-(3-nitrophenyl)-sulfone | 1228-53-1 | C12H8N2O6S | 308.27 | BIS(3-NITROPHENYL)SULFONE; BIS(3-NITROPHENYL)SULPHONE; BIS(M-NITROPHENYL) SULFONE; 3,3'-DINITRODIPHENYLSULFONE; 3,3'-DINITRODIPHENYLSULPHONE; 3-Nitrophenyl sulphone |
BIS-(3-AMINOMETHYLBENZYL)AMIN | 34235-31-9 | C16H21N3 | 255.35804;g/mol | [3-[[[3-(aminomethyl)phenyl]methylamino]methyl]phenyl]methanamine; 34235-31-9; SCHEMBL834002; CTK4H1938; BIS(3-AMINOMETHYLBENZYL)AMIN; BIS(3-AMINOMETHYLBENZYL)AMINE |
BIS(3,5-DI-TERT-BUTYLPHENYL)PHOSPHINE | 287960-85-4 | C28H43P | 410.614781 | BIS(3,5-DI-TERT-BUTYLPHENYL)PHOSPHINE |
BIS(3,5-DI-TERT-BUTYLPHENYL)CHLOROPHOSPHINE | 181257-36-3 | C28H42ClP | 445.059841 | BIS(3,5-DI-TERT-BUTYLPHENYL)CHLOROPHOSPHINE |
BIS(3,5-DI-TERT-BUTYL-4-METHOXYPHENYL)CHLOROPHOSPHINE | 212713-08-1 | C30H46ClO2P | 505.11 | BIS(3,5-DI-TERT-BUTYL-4-METHOXYPHENYL)CHLOROPHOSPHINE; BIS(3,5-DI-TERT-BUTYL-4-METHOXYPHENYL)PHOSPHINOUS CHLORIDE; Bis(3,5-di-t-butyl-4-methoxyphenyl)chlorophosphine,; Bis(3,5-di-t-butyl-4-methoxyphenyl)chlorophosphine,93% |
bis(2-hydroxyethyl)-tetradecan-2-ylazanium chloride | 56167-12-5 | C18H40ClNO2 | 337.969 g/mol | bis(2-hydroxyethyl)-tetradecan-2-ylazanium; chloride; 2,2'-((1-Methyltridecyl)imino)bisethanolhydrochloride; N,N-Bis(beta-hydroxyethyl)-2-aminotetradecanehydrochloride; ETHANOL,2,2'-((1-METHYLTRIDECYL)IMINO)BIS-,HYDROCHLORIDE; AC1L26FV |
bis(2-hydroxyethyl)-octadecan-2-ylazanium chloride | 56167-14-7 | C22H48ClNO2 | 394.075 g/mol | bis(2-hydroxyethyl)-octadecan-2-ylazanium; chloride; 2,2'-((1-Methylheptadecyl)imino)bisethanolhydrochloride; N,N-Bis(beta-hydroxyethyl)-2-aminooctadecanehydrochloride; ETHANOL,2,2'-((1-METHYLHEPTADECYL)IMINO)BIS-,HYDROCHLORIDE; 56167-14-7 |
BIS(2-HYDROXYETHYL)-D8-AMINE | 103691-51-6 | C4H3D8NO2 | 113.18 | BIS(2-HYDROXYETHYL)-D8-AMINE |
bis(2-hydroxyethyl)carbamodithioic acid | 1528-72-9 | C5H11NO2S2 | 181.276 g/mol | 1-hydroxyethyl(oxido)carbamodithioicacid; |
Bis(2-hydroxyethyl)amine-d11 | 1219804-08-6 | |||
BIS(2-HYDROXYETHYL)-1,1,2,2-D4-AMINE | 352431-07-3 | C4H8ClD4NO2 | 145.62 | BIS(2-HYDROXYETHYL)-1,1,2,2-D4-AMINE |
Bis(2-hydroxy-3-carboxyphenyl)methane | 5578-67-6 | C3H4O2 | 72.06 | MDA; MALONDIALDEHYDE; 3,3'-Methylenebissalicylic acid; 3,3'-Methylenedisalicylic acid |
bis-(2-Hexyldecyl) adipate | 57533-90-1 | C38H74O4 | 594.992 g/mol | Bis(2-hexyldecyl)adipate; 57533-90-1; Diisocetyladipate; Hexanedioicacid,bis(2-hexyldecyl)ester; AC1L3QQQ; bis-(2-Hexyldecyl)adipate |
bis(2-hexoxyethyl) hexanedioate | 110-32-7 | C22H42O6 | 402.565 g/mol | |
Bis-(2-ethylhexyl)-succinate | 2915-57-3 | C20H38O4 | 342.51332 | bis(2-ethylhexyl) succinate; Butanedioic acid, bis(2-ethylhexyl) ester; Succinic acid bis(2-ethylhexyl) ester; Ai3-00998; Butanedioic acid, 1,4-bis(2-ethylhexyl) ester; Butanedioic acid, bis(2-ethylhexyl) ester y; Di(2-ethylhexyl)butanedioate |
Bis-(2-ethylhexyl)-phenyl phosphate | 16368-97-1 | C22H39O4P | 398.516 g/mol | bis(2-ethylhexyl)phenylphosphate; Bis(2-ethylhexyl)phenylphosphate; Phosphoricacid,bis(2-ethylhexyl)phenylester; DAFF; DEPP; 16368-97-1 |
bis-(2-Ethylhexyl)chlorendate | 4827-55-8 | C25H36Cl6O4 | 613.269 g/mol | |
bis-(2-Ethylhexyl) carbonate | 14858-73-2 | C17H34O3 | ||
bis-(2-Diphenylphosphino)ethyl ether | 50595-38-5 | C28H28OP2 | 442.47 | BIS(2-DIPHENYLPHOSPHINO)ETHYL ETHER; POP; Polypolyols |
bis-(2-Cyanoethyl)-N,N-diisopropyl phosphoramidite | 102690-88-0 | C12H22N3O2P | 271.3 | bis-(2-Cyanoethyl)-N,N-diisopropyl phosphoramidite; N,N-bis(1-Methylethyl)phosphoramidous acid bis(2-cyanoethyl) ester |
BIS(2-CHLOROETHYL)-D8 ETHER | 93952-02-4 | C4Cl2D8O | 151.06 | BIS(2-CHLOROETHYL)-D8 ETHER; BIS(2-CHLOROETHYL)ETHER (D8); Bis(2-chloroethoxy)-D8 Ether; Ethane-1,1,2,2-D4, 1,1'-oxybis(2-chloro- |
bis(2-chloroethyl)-[2-[(6-chloro-2-methoxyacridin-9-yl)azaniumyl]ethyl]azanium dichloride | 10072-25-0 | C20H24Cl5N3O | 499.689 g/mol | N',N'-bis(2-chloroethyl)-N-(6-chloro-2-methoxyacridin-9-yl)ethane-1,2-diamine; hydrochloride; 10072-25-0; NSC34372; WLN:TC666BNJEGIM2N2G2GLO1&GH2&QH |
bis-(2-Chloroethyl) hydrogen phosphate | 3040-56-0 | C4H9Cl2O4P | 222.992 g/mol | |
BIS(2-CHLOROETHOXY)ETHANE-D12 | 347841-75-2 | C6Cl2D12O2 | 199.14 | BIS(2-CHLOROETHOXY)ETHANE-D12 |
bis(2-CHLORETHYL)SULFONE | 471-03-4 | C4H8O2SCl2 | 191.08 | Mustardsulfone; Bis(2-chloroethyl)sulfone; Yperitesulfone; Hsulfone; Mustardgassulfone; Sulfone,bis(2-chloroethyl) |
bis-(2-Butoxyethyl)adipate | 141-18-4 | C18H34 O6 | 346.52 | ADIPIC ACID BIS(2-BUTOXYETHYL) ESTER; ADIPIC ACID DI(2-BUTOXYETHYL) ESTER; BIS(2-BUTOXYETHYL) ADIPATE; DI(2-BUTOXYETHYL) ADIPATE; DI(BUTOXYETHYL)ADIPATE; Adipic acid, bis(2-butyoxyethyl) ester |
Bis(2-aminophenyl)diselenide, 97% | 63870-44-0 | C12 H12 N2 Se2 | 342.16 | Bis(2-aminophenyl)diselenide |
bis(2-aminoethyl) hydrogen phosphate | 6094-81-1 | C4H13N2O4P | 184.130781 | |
bis(2,6-diisopropylphenyl)carbodiimide | 2162-74-5 | C25H34N2 | 362.56 | BIS(2,6-DIISOPROPYLPHENYL)CARBODIIMIDE; (2,6-diisopropylphenyl)carbodiimide; 2,2',6,6'-Tetraisopropyldiphenylcarbodiimide; bis(2,6-diisopropylphenyl)-carbodiimid; carbod; n,n'-methanetetraylbis(2,6-bis(1-methylethyl)-benzenamin; n,n'-methanetetraylbis(2,6 |
BIS(2,6-DIFLUORO-3-(1-HYDROPYRROL-1-YL)PHENYL)TITANOCENE | 125051-32-3 | 125051-32-3 | ||
bis(2,4-dimethylphenyl)diazene | 29418-25-5 | C16H18N2 | 238.328 g/mol | BIS(2,4-DIMETHYLPHENYL)DIAZENE; 29418-25-5; ST50101162; AC1L1RSL; SCHEMBL11693231; CTK4G3257 |
bis(2,4-dichlorophenyl) chlorophosphate | 14254-41-2 | C12H6Cl5O3P | 406.41 | BIS(2,4-DICHLOROPHENYL) PHOSPHOROCHLORIDATE; BIS(2,4-DICHLOROPHENYL)PHOSPHORYL CHLORIDE; BIS(2,4-DICHLOROPHENYL) CHLOROPHOSPHATE; CHLOROPHOSPHORIC ACID BIS(2,4-DICHLOROPHENYL) ESTER; ChlorophosphoricAcidBis(2,4-dichlorophenyl)Este; Bis(2,4-dichlorophenoxy |
Bis(2,4,6-trimethylphenyl)phosphorus chloride | 67950-05-4 | C18H23P | 304.79 | Chlorodimesitylphosphine |
bis-(2,4,4-Trimethylpentyl)phosphinic acid | 83411-71-6 | C16H35O2P | 290.42 | |
Bis(2,3-epoxypropyl) cyclohex-4-ene-1,2-dicarboxylate(S-182)(CY183) | 21544-03-6 | C14H18O6 | 282.29 | |
bis-(2,3-Dibromopropyl) hydrogen phosphate | 5412-25-9 | C6H11Br4O4P | 497.74 | BIS(2,3-DIBROMOPROPYL) PHOSPHATE; BIS(2,3-DIBROMOPROPYL)PHOSPHORIC ACID; bis(2,3-dibromopropyl) hydrogen phosphate; 1-PROPANOL,2,3-DIBROMO-,HYDROGENPHOSPHATE; Bis(2,3-dibromopropyl)=hydrogen phosphate ester; BIS-BP |
bis(2,3,3,3-tetrachloropropyl) ether | 127-90-2 | C6H6Cl8O | 377.73 | OCTACHLORODIPROPYL ETHER; S 421; 1,1'-oxybis(2,3,3,3-tetrachloro-Propane; ENT 25,456; ent25,456; Ether, bis(2,3,3,3-tetrachloropropyl) |
Bis(2,2-bipyridyl)dichloroOsmium(II) | 15702-72-4 | C20H16Cl2N4Os | 0 | Bis(2,2-bipyridyl)dichloroOsmium(II) |
Bis(2,2,6,6-tetramethyl-1-piperidinyloxy-4-yl) sebacate | 2516-92-9 | C28H50N2O6 | 510.71 | BIS(2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXY)-SEBACATE; 1-Piperidinyloxy, 4,4-(1,10-dioxo-1,10-decanediyl)bis(oxy)bis2,2,6,6-tetramethyl-; Piperidinooxy, 4-hydroxy-2,2,6,6-tetramethyl-, sebazat (2:1); 4,4'-[(1,10-dioxo-1,10-decanediyl)bis(oxy)]bis[2,2,6,6-tetr |
bis(2,2,2-trifluoroethyl) carbonate | 1513-87-7 | C5H4F6O3 | 226.0739 | |
Bis(1-ethyl(3-oxetanil)methyl)ether | 18934-00-4 | C12H22O3 | ||
BIS(1-BUTYLPENTYL) DECANE-1,10-DIYL DIGLUTARATE | 101342-76-1 | C38H70O8 | 654.96 | 5-O-nonan-5-yl 1-O-[10-(5-nonan-5-yloxy-5-oxopentanoyl)oxydecyl] pentanedioate; ETH 469; AC1ND8J0; 30585_FLUKA; ETH-469; ZINC100650269; 5-O-nonan-5-yl 1-O-[10-(5-nonan-5-yloxy-5-oxopentanoyl)oxydecyl] pentanedioate |
Bis(1,5-cyclooctadiene)rhodium(I)trifluoromethanesulfonate | 99326-34-8 | C17H24F3O3RhS | 468.33600 | |
Bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | 35138-22-8 | 406.07 | RHODIUM(I) TETRAFLUOROBORATE 1,5-CYCLOOCTADIENE COMPLEX; BIS(CYCLOOCTA-1,5-DIEN)RHODIUM(I)-TETRAFLUOROBORATE; BIS(1,5-CYCLOOCTADIENE)RHODIUM(I) TETRAFLUOROBORATE; BIS(1,5-CYCLOOCTADIENE)RHODIUM TETRAFLUOROBORATE; BIS(1,5-CYCLOOCTADIEN)RHODIUM(I) TETRAFLUO | |
Bis(1,5-cyclooctadiene)diiridium(I) Dichloride | 12112-67-3 | C16H24Cl2Ir2 | 671.7 | Chloro(1,5-cyclooctadiene)iridium(I)dimer; 12112-67-3; (1Z,5Z)-cycloocta-1,5-diene; iridium; dichloride; Iridium,di-.mu.-chlorobis[(1,2,5,6-.eta.)-1,5-cyclooctadiene]di- |
bis-(1,3-Dimethylbutyl) maleate | 105-52-2 | C16H28O4 | 284.44 | |
bis-(1,2-di-isopropylthio-1,2-ethylenedithiolato)nickel | 863678-76-6 | C16H28 Ni S8 | ||
bis(1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylato-N3,O4)magnesium | 34717-03-8 | C10H6MgN4O8 | 334.4824 | beta-4)-; bis(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylato-n3,o4)-magnesiu(; MAGNESIUM OROTATE; bis(1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylato-N3,O4)magnesium; magnesium oratate; Magnesium Orotate Dihydrate |
Bis(1,2,2,6,6-pentamethyl-4-piperidyl) sebacate | 41556-26-7 | C30H56N2O4 | 508.78 | UV-3765; TINUVIN 765; TINUVIN 292; DECANEDIOIC ACID BIS(1,2,2,6,6-PENTAMETHYLPIPERIDIN-4-YL)ESTER; BIS(1,2,2,6,6-PENTAMETHYL-4-PIPERIDYL) SEBACATE; BIS(1,2,2,6,6-PENTAMETHYL-4-PIPERIDINYL)SEBACATE METHYL 1,2,2,6,6-PENTAMETHYL-4-PIPERIDINYL SEBACATE |
BIS(1,1,2,2,3,3,4,4,4-NONAFLUORO-1-BUTANESULFONYL)IMIDE | 39847-39-7 | C8HF18NO4S2 | 581.2 | |
Bis((3,4-epoxycyclohexyl)methyl)adipate | 3130-19-6 | 366.45 | BIS(3,4-EPOXYCYCLOHEXYLMETHYL) ADIPATE; hexanedioicacid,bis(7-oxabicyclo(4.1.0)hept-3-ylmethylester; Hexanedioicacid,bis(7-oxabicyclo[4.1.0]hept-3-ylmethyl)ester; Bis((3,4-epoxycyclohexyl)methyl)adipat; Adipic acid bis(3,4-epoxycyclohexane-1-ylmethyl) est | |
Bis Valacyclovir | 1356019-51-6 | C14H18N10O4 | 390.36 | Valacyclovir Impurity P (EP), Bis-valaciclovir in USP monograph (impurity K). |
BIS THF Nitro Derivative 2 | 252873-01-1 | C13H13NO7 | 295.24 | (3S,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl 4-Nitrophenyl Ester Carbonic Acid |
BIS THF Nitro Derivative 1 | 288296-64-0 | C13H13NO7 | 295.24 | (3S,3aR,6aS)-Hexahydrofuro[2,3-b]furan-3-yl 4-Nitrophenyl Ester Carbonic Acid |
BIS THF HNS Derivative 3 | 799241-86-4 | C11H13NO7 | 271.22 | |
BIS THF HNS Derivative 2 | 799241-85-3 | C11H13NO7 | 271.22 | 1-[[[[(3S,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl]oxy]carbonyl]oxy]-2,5-pyrrolidinedione |
BIS THF HNS Derivative 1 | 253265-98-4 | C11H13NO7 | 271.22 | 1-[[[[(3S,3aR,6aS)-Hexahydrofuro[2,3-b]furan-3-yl]oxy]carbonyl]oxy]-2,5-pyrrolidinedione |
BIRT 377 | 213211-10-0 | C18H15BrCl2N2O2 | 442.13 | (5R)-5-[(4-Bromophenyl)methyl]-3-(3,5-dichlorophenyl)-1,5-dimethyl-2,4-imidazolidinedione; (R)-5-(4-bromobenzyl)-3-(3,5-dichlorophenyl)-1,5-dimethylimidazolidine-2,4-dione |
Birnessite(Na4(Mn14O27).9H2O) | 12244-32-5 | H2O . 1/9 Mn14 O27 . 4/9 Na | ||
Birinapant | 1260251-31-7 | C42H56F2N8O6 | 806.957 | TL-32711; TL32711; TL 32711. Birinapant |
Biricodar Dicitrate | 174254-13-8 | C34H41N3O7.2C6H8O7 | 987.962 | 1,7-dipyridin-3-ylheptan-4-yl (2S)-1-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid |
Biricodar | 159997-94-1 | C34H41N3O7 | 603.71 | 1,7-dipyridin-3-ylheptan-4-yl (2S)-1-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate; biricodar; Incel; N-(2-oxo-2-(3,4,5-trimethoxyphenyl)acety)piperidine-2-carboxylic acid 1,7-bis(3-pyridyl)-4-heptyl ester; VX 710; VX-710 |
Birch leaves extract | 84012-15-7 | 0 | betula alba extract; BIRCH EXTRACT; birch leaves extract; Birch, Betula alba, ext.; BETULA ALBA BARK EXTRACT; BETULA ALBA LEAF EXTRACT; SILVERBIRCH; COMMONBIRCH | |
biphenyl-4,4'-dicarboxylic acid | 84787-70-2 | C14H10O4 | 0 | SANDELWOOD OIL; SANDALWOOD OIL INDONESIAN; SANDALWOOD OIL EAST INDIAN; SANTALUM ALBUM; Sandalwood,extract; sandelwoodoilfromsantalumalbuml.; FEMA 3005; Sandalwood, ext. |
Biotinyl-Asp-Glu-Val-Asp-aldehyde (pseudo acid) | 178603-73-1 | C28H42N6O12S | 686.73 | Biotinyl-Asp-Glu-Val-Asp-aldehyde (pseudo acid); Biotinyl-Asp-Glu-Val-Asp-CHO |
Biotinyl Tyramide | 41994-02-9 | C18H25N3O3S | 363.47 | Biotin-Phenol; (3aS,4S,6aR)-Hexahydro-N-[2-(4-hydroxyphenyl)ethyl]-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide |
Biotin-X Cadaverine | 916165-67-8 | C23H40F3N5O5S | 555.65 | 5-(((N-(Biotinoyl)amino)hexanoyl)amino)pentylamine, trifluoroacetic acid salt |
Biotin-X 2,4-Dinitrophenyl-X-L-Lysine Succinimidyl Ester | 216453-51-9 | C38H55N9O12S | 861.97 | DNP-X-Biocytin-X SE |
Biotin-VAD-FMK | 1135688-15-1 | C24H38FN5O7S | 559.65 | Biotin-VAD(OMe)-FMK; Biotin-Val-Ala-Asp(OMe)-FMK; bVAD-fmk; Biotin-Val-Ala-Asp(OMe)-Fluoromethylketone |
Biotinoyl tripeptide-1 | 299157-54-3 | C24H38N8O6S | 566.678 | (2S)-2-[[(2S)-2-[[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-6-aminohexanoic acid |
Bianmihuanglong | 83055-99-6 | C16H18N4O7S | 410.40200 | |
Biotin-LC-Hydrazide | 109276-34-8 | C16H29N5O3S | 371.50 | Biotinamidocaproyl hydrazide; (+)-Biotin-LC-Hydrazide; N-(6-Hydrazinyl-6-oxohexyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide |
Biotin-dC-puromycin | 436083-86-2 | C47H69N13O16P2S (free acid) | 1166.14 (free acid) | |
Biotin Alkyne | 773888-45-2 | C13H19N3O2S | 281.37 | Biotin Propargylamide |
Biotin-4-fluorescein | 1032732-74-3 | C33H32N4O8S | 644.7 | B4F |
Biotin Sulfoxide | 23015-53-4 | C10H16N2O4S | 260.31 | |
Biotin Sulfone | 40720-05-6 | C10H16N2O5S | 276.31 | (3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic Acid 5,5-Dioxide; Biotin 5,5-Dioxide; 5-[(1S,2S,5R)-3,3,7-trioxo-3,lambda6-thia-6,8-diazabicyclo[3.3.0]oct-2-yl]pentanoic acid |
BIOTIN METHYL ESTER | 608-16-2 | C11H18N2O3S | 258.34 | |
Biotin Impurity E | 57229-92-2 | C17H22N2O3S | 334.44 | 3'N-Benzyl Biotin; (3aS,4S,6aR)-Hexahydro-2-oxo-3-(phenylmethyl)-H-thieno[3,4-d]imidazole -4-pentanoic Acid |
Biotin Impurity B | 57671-79-1 | C11H16N2O5S | 288.32 | Biotin Diacid; 2-[3-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]propyl]propanedioic Acid2-[3-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]propyl]propanedioic Acid |
Biotin ethylenediamine hydrobromide | 216299-38-6 | C12H23BrN4O2S | 367.3 | N-(2-Aminoethyl)biotinamide hydrobromide; 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-(2-aminoethyl)pentanamide hydrobromide |
Bioallethrin | 584-79-2 | C19H26O3 | 302.41 | Allethrine; 2,2-dimethyl-3-(2-methyl-1-propen-1-yl)-cyclopropanecarboxylic Acid 2-methyl-4-oxo-3-(2-propen-1-yl)-2-cyclopenten-1-yl Ester; Allyl cinerin I; EBT; ENT 17510; Esbiothrine; Exthrin; Matox; NSC 11782; OMS 3045; Pynamin forte; Pyresyn; RU 27436; |
BIO-acetoxime | 667463-85-6 | C18H12BrN3O3 | 398.21 | GSK-3 Inhibitor X; [(E)-[2-(6-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino] acetate |
BIO 5192 | 327613-57-0 | C38H46Cl2N6O8S | 817.78 | AMD 15057; (2S)-2-[[(2S)-1-(3,5-dichlorophenyl)sulfonylpyrrolidine-2-carbonyl]amino]-4-[[(2S)-4-methyl-2-[methyl-[2-[4-[(2-methylphenyl)carbamoylamino]phenyl]acetyl]amino]pentanoyl]amino]butanoic acid |
BIO 1211 | 187735-94-0 | C36H48N6O9 | 708.8 | |
BIO | 667463-62-9 | C16H10BrN3O2 | 356.17 | GSK-3 Inhibitor IX; 6-bromoindirubin-3-oxime; 6-bromo-3-(3-nitroso-1H-indol-2-yl)-1H-indol-2-ol |
Binucleine 2 | 220088-42-6 | C13H11ClFN5 | 291.7 | |
Binimetinib | 606143-89-9 | C17H15BrF2N4O3 | 441.233 | MEK162; MEK-162; ARRY-162; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide |
Binfloxacin | 108437-28-1 | C19H22FN3O3 | 359.39 | 3-Quinolinecarboxylicacid, 7-(1,4-diazabicyclo[3.2.2]non-4-yl)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-;7-(1,4-Diazabicyclo[3.2.2]non-4-yl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;CP73049;CP-73049 |
Bindarit | 130641-38-2 | C19H20N2O3 | 324.37 | AF 2838 |
BINA | 866823-73-6 | C30H30O4 | 454.56 | 3'-[[(2-Cyclopentyl-2,3-dihydro-6,7-dimethyl-1-oxo-1H-inden-5-yl)oxy]methyl]-[1,1'-biphenyl]-4-carboxylic acid; Biphenylindanone A; Biphenyl-indanone A |
BIMU 8 | 134296-40-5 | C19H26N4O2.HCl | 378.9 | 2,3-Dihydro-N-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-3-(1-methylethyl)-2-oxo-1H-benzimidazole-1-carboxamide hydrochloride; N-[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2-oxo-3-propan-2-ylbenzimidazole-1-carboxamide hydrochloride |
Bimosiamose disodium | 187269-60-9 | C46H52Na2O16 | 906.8808 | |
Bimolane | 74550-97-3 | C20H32N6O6 | 452.51 | Bimolane;4,4'-Ethylenebis[1-(morpholinomethyl)-2,6-piperazinedione];AT-1727 |
Bimoclomol | 130493-03-7 | C14H20ClN3O2 | 297.78 | (3Z)-N-(2-hydroxy-3-piperidin-1-ylpropoxy)pyridine-3-carboximidoyl chloride; bimoclomol; bimoclomol, maleate (1:1) |
Bimatoprost | 155206-00-1 | C25H37NO4 | 415.57 | AGN 192024; AGN192024; AGN-192024; Bimatoprost; Lumigan; Latisse; Bimatoprostum; Lumigan. |
BIM-46068 | 201487-53-8 | C17H28ClNO2 | 494.772 | BIM-46068; BIM 46068; BIM46068. |
BIM-46050 | 201487-52-7 | C14H12N6O | 480.7516 | BIM46050; BIM-46050; BIM 46050. |
BIM 23056 | 150155-61-6 | C71H81N11O9 | 1232.49 | |
BIM 23042 | 111857-96-6 | C63H73N11O9S2 | 1192.46 | |
BIM 189 | 142062-55-3 | C56H73ClN14O10 | 1137.73 | |
BIM 187 | 137734-88-4 | C53H76N14O10 | 1069.27 | |
Bilobetin | 521-32-4 | C31H20O10 | 552.5 | 4',5,5'',7,7''-Pentahydroxy-4'''-methoxy-8,3'''-biflavone;5,7-Dihydroxy-8-[2-methoxy-5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenyl]-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
Bilobalide | 33570-04-6 | C15H18O8 | 326.30 | |
BILIVERDIN DIHYDROCHLORIDE | 55482-27-4 | C33H36Cl2N4O6 | 655.57 | BILIVERDIN DIHYDROCHLORIDE; BILIVERDIN HYDROCHLORIDE; BiliverdinHCl |
BILIRUBIN OXIDASE | 80619-01-8 | 0 | EC 1.3.3.5; BILIRUBIN OXIDASE; BILIRUBIN: OXYGEN OXIDOREDUCTASE; bilirubin oxidase from myrothecium verrucaria; BILIRUBIN OXIDASE, FROM MYROTHECIUM SP.; frommyrotheciumspecieslyophilizedpowder0; Oxidase, bilirubin | |
Bilirubin disodium salt | 93891-87-3 | C33H34N4O6.2Na | 628.637 | 2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid disodium salt |
Bilirubin acyl-b-D-glucuronide - Mixture of monoglucuronides | 874448-90-5 | C39H44N4O12 | 760.79 | |
Bilirubin | 635-65-4 | C33H34N4O6 | 2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic Acid | |
Bi-linderone | 1227375-09-8 | C34H32O10 | 600.6 | |
Cranberry Extract | 84082-34-8 | C27H31O16 | 611.53 | BILBERRY EXTRACT; Vaccinium myrtillus, ext.; Bilberry Seed Oil; Blue Tocal Bilberry Seed Oil; Vaccinium Myrtillus; VACCINIUM MYRTILLUS EXTRACT; BILBERRY EXTRACT 25%; BILBERRYFRUITEXTRACT |
BI-Lawsone | 33440-64-1 | C20H10O6 | 346.29 | 2,2'-BIS(3-HYDROXY-1,4-NAPHTHOQUINONE); 2,2'-BI(3-HYDROXY-1,4-NAPHTHOQUINONE); LAWSONE DIMER; LABOTEST-BB LT00452273; BI-LAWSONE; 2,2'-BI(3-HYDROXY-1,4-NAPHTHOQUINONE), 9 8% |
Bilastine Impurity 2 | 1181267-36-6 | C21H31N3O3 | 373.50 | N-Boc 1-(2-Ethyoxyethyl)-2-(4-piperidinyl)-1H-benzimidazole; tert-Butyl 4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate |
Bilastine Impurity 1 | 953071-73-3 | C17H23N3O2 | 301.39 | tert-butyl 4-(1H-benzo[d]iMidazol-2-yl)piperidine-1-carboxylate |
Bilastine | 202189-78-4 | C28H37N3O3 | 463.622 | 2-[4-[2-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]ethyl]phenyl]-2-methylpropanoic acid; Bilaxten |
Bikinin | 188011-69-0 | C9H9BrN2O3 | 273.08 | 4-((5-Bromopyridin-2-yl)amino)-4-oxobutanoic acid; N-(5-Bromo-pyridin-2-yl)-succinamic acid |
Bikaverin | 33390-21-5 | C20H14O8 | 382.32 | Lycopersin; BRN 0358013 |
BIIE 0246 | 246146-55-4 | C49H57N11O6 | 896.05 | (2S)-5-(diaminomethylideneamino)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-2-[[2-[1-[2-oxo-2-[4-(6-oxo-5,11-dihydrobenzo[c][1]benzazepin-11-yl)piperazin-1-yl]ethyl]cyclopentyl]acetyl]amino]pentanamide; BIIE-0246; BIIE 0246; BIIE-0246; C |
BIIB028 | 911398-13-5 | C19H21ClN5O5P | 465.83 | CF3647, 3-Butyn-1-ol, 4-[2-amino-4-chloro-7-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-, dihydrogen phosphate (ester) (9CI) |
BIIB021 | 848695-25-0 | C14H15ClN6O | 318.76 | [6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine; BIIB021; BIIB 021; BIIB-021; CNF-2024; CNF 2024; CNF2024 |
Biguanide | 56-03-1 | C2H7N5 | 101.11048;g/mol | Biguanide; HBIG; 56-03-1; Imidodicarbonimidicdiamide; 1-(diaminomethylidene)guanidine; 1,2,3-triimidodicarbonicdiamide |
BigLEN (rat) | 369377-66-2 | C76H128N24O23 | 1746 | |
BigLEN (mouse) | 501036-69-7 | C78H130N24O22 | 1756.03 | |
Bifonazole Impurity D | 66600-13-3 | C41H33N2Cl | 589.18 | 1,3-Bis[(biphenyl-4-yl)phenylmethyl]-1H-imidazolium Chloride |
Bifonazole Impurity B | 91679-37-7 | C22H18N2 | 310.40 | |
Bifonazole Impurity A | 7598-80-3 | C19H16O | 260.34 | alpha-phenyl[1,1'-biphenyl]-4-methanol; (1,1'-Biphenyl-4-yl)phenylmethanol; Phenyl(biphenyl-4-yl)methanol; (RS)-(Biphenyl-4-yl)phenylmethanol |
Bifonazole | 60628-96-8 | C22H18N2 | 310.39 | Bay H 4502; Bay H-4502; Bay-H-4502; BayH4502 |
Bifeprunox mesylate | 350992-13-1 | C24H23N3O2.CH4O3S | 481.56 | 7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-one mesylate |
Bifenthrin | 82657-04-3 | C23H22ClF3O2 | 422.87 | 2-METHYLBIPHENYL-3YL-METHYL (Z)-(1RS)-CIS-3-(2-CHLORO-3,3,3-TRIFLUOROPROP-1-ENYL)-2,2-DIMETHYL-CYCLOPROPANE CARBOXYLATE; 3-[(1Z)-2-CHLORO-3,3,3-TRIFLUORO-1-PROPENYL]-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID (2-METHYLBIPHENYL-3-YL)METHYL ESTER; BRIGADE(R); |
BIFENOX (FREE ACID) | 53774-07-5 | C13H7Cl2NO5 | 328.10438 | |
Bifendate Impurity G | 79279-08-6 | C18H18O8 | 362.34 | |
Bifendate Impurity E | 205117-47-1 | C19H16O10 | 404.33 | |
Bifendate Impurity B | 128142-41-6 | C18H16O9 | 376.32 | |
Bifendate Impurity A | 1181519-47-0 | C18H14O8 | 358.31 | |
Bifemelane hydrochloride | 62232-46-6 | C18H23NO.HCl | 305.84 | Celeport; Alnert; 4-(2-Benzylphenoxy)-N-methylbutylamine hydrochloride |
Bidwillol A | 161099-42-9 | C21H22O4 | 338.40 | 3-[4-Hydroxy-2-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-2H-1-benzopyran-7-ol; 2H-1-Benzopyran-7-ol,3-[4-hydroxy-2-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]- |
Bidimazium | 21817-73-2 | C26H25N2S+ | 0 | Bidimazium; Bidimazium iodide |
BI-D1870 | 501437-28-1 | C19H23F2N5O2 | 391.41 | BI-D1870; BI-D1870. |
Bicyclomycin benzoate | 37134-40-0 | C19H22N2O8 | 406.4 | Bicozamycin benzoate, FR 2054 |
Bicyclomycin | 38129-37-2 | C12H18N2O7 | 302.3 | Bicozamycin, Aizumycin, Bacteron, CGP 3543E, WS4545, 5879 |
Bicyclol | 118159-48-1 | C19H18O9 | 390.34 | SY 801 |
Bicyclo[2.2.2]octane-1,4-dicarboxylic acid | 711-02-4 | C10H14O4 | 198.216 | |
BICYCLO[2.2.2]OCTANE | 280-33-1 | C8H14 | 110.19676 | BICYCLO[2.2.2]OCTANE |
Bicyclo[2.2.1]heptane-2-carboxylic acid | 824-62-4 | C8H12O2 | 140.18 | Bicyclo[2.2.1]heptane-2-carboxylic acid; Norbornane-2-carboxylic acid |
Bicyclo[2.2.1]heptan-2-ol, 3-(1-piperidinyl)-, (2-endo,3-exo)- (9CI) | 58501-40-9 | C12H21NO | 0 | Bicyclo[2.2.1]heptan-2-ol, 3-(1-piperidinyl)-, (2-endo,3-exo)- (9CI) |
bicyclo[2.2.1]hepta-2,5-dien-7-ol | 822-80-0 | C7H8O | 108.138 g/mol | |
Bicyclo[2.2.1]hept-5-en-2-one | 694-98-4 | C7H8O | 108.14 | |
Bicyclo[2.1.1]hexane(7CI,8CI,9CI) | 285-86-9 | C6H10 | 82.1436 | bicyclo[2.1.1]hexane;Bicyclo[2.1.1]hexane;Bicyclo(2.1.1)hexane;Bicyclo[2.1.1]hexane(7CI,8CI,9CI);285-86-9;AC1Q1GVN |
Bicyclo[2,1,0]pentane | 185-94-4 | C5H8 | 68.117 g/mol | bicyclo[2.1.0]pentane; Bicyclo[2.1.0]pentane; housane; BICYCLO(2.1.0)PENTANE; 185-94-4; BICYCLO[2,1,0]PENTANE |
Bictegravir | 1611493-60-7 | C21H18F3N3O5 | 449.39 | GS-9883; GS 9883; GS9883 |
Bicifadine hydrochloride | 66504-75-4 | C12H15N.HCl | 209.72 | 1-(4-Methylphenyl)-3-azabicyclo[3.1.0]hexane hydrochloride |
Bicifadine | 71195-57-8 | C12H15N | 173.25 | Bicifadine; 1-(4-Methylphenyl)-3-azabicyclo[3.1.0]hexane; 1-p-Tolyl-3-azabicyclo[3.1.0]hexane |
Bicalutamide-d4 | 1185035-71-5 | C18H10D4F4N2O4S | 434.41 | N-[4-Cyano-3-trifluoromethyl)phenyl]- 3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide-d4; ICI-176334-d4; Casodex-d4 |
Bicalutamide Sulfoxide | 945419-64-7 | C18H14F4N2O3S | 414.38 | N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2-methylpropanamide, Bicalutamide sulfoxide; Bicalutamide Related Compound A |
Bicalutamide Sulfide | 90356-78-8 | C18H14F4N2O2S | 398.38 | (+/-)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy-2-methyl-propanamide; (R,S)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy-2-methylpropionamide; Bicalutamide EP Impurity J |
Bicalutamide Related Compound B | 1166228-30-3 | C18H14F4N2O4S | 430.38 | (RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(3-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide, Bicalutamide 3-fluoro isomer; 3-Fluoro-4-desfluoro BicalutaMide; 3-Fluoro-4-desfluoro Bicalutamide |
Bicalutamide Impurity 1 | 90357-53-2 | C12H9F3N2O | 254.21 | N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyl-2-Propenamide; 2-Methyl-N-[(4-cyano-3-trifluoromethyl)phenyl]-propenamide; N-Methacryloyl-4-cyano-3-trifluoromethylaniline |
Bicalutamide Epoxide Impurity | 90357-51-0 | C12H9F3N2O2 | 270.21 | N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide; N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide; (±)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide; 2-Methyloxirane-2-carboxylic acid N-(4-Cyano-3-trifl |
Bicalutamide EP Impurity M | 151262-57-6 | C10H11FO5S | 262.26 | 3-[(4-Fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanoic Acid |
Bicalutamide | 90357-06-5 | C18H14F4N2O4S | 430.37 | ICI 176334; ICI-176334; ICI176334; Abbreviation: CDX. US brand name: Casodex. Foreign brand name: Cosudex. |
BIBX 1382 dihydrochloride | 1216920-18-1 | C18H19ClFN7.2HCl | 460.77 | Falnidamol Dihydrochloride; N8-(3-Chloro-4-fluorophenyl)-N2-(1-methyl-4-piperidinyl)-pyrimido[5,4-d]pyrimidine-2,8-diamine dihydrochloride |
BIBU 1361 dihydrochloride | 793726-84-8 | C22H27ClFN7.2HCl | 516.87 | N-(3-Chloro-4-fluorophenyl)-6-[4-[(diethylamino)methyl]-1-piperidinyl]-pyrimido[5,4-d]pyrimidin-4-amine dihydrochloride |
BIBS 39 | 133085-33-3 | C32H36N4O3 | 524.65 | Bibs 39; Bibs-39; CHEMBL130896; 2-[4-[[2-butyl-6-(cyclohexylcarbamoylamino)benzimidazol-1-yl]methyl]phenyl]benzoic acid; AC1L2ZGG |
BIBR 1532 | 321674-73-1 | C21H17NO3 | 331.36 | BIBR 1532 |
Bibenzonium bromide | 15585-70-3 | C19H26NO.Br | 364.324 | bibenzonium bromide; Bibenzonium; (2-(1,2-Diphenylethoxy)ethyltrimethyl)ammonium bromide; Bibenzonii bromidum; Bibenzonii bromidum [inn-latin]; Bibenzonio bromuro; Bibenzonio bromuro [dcit]; Bromure de bibenzonium |
BIBB 515 | 156635-05-1 | C22H21ClN2O2 | 380.9 | BIBB-515; BIBB515 |
Biapenem | 120410-24-4 | C15H18N4O4S | 350.39282 | (4R,5S,6S)-3-(6,7-dihydro-5H- pyrazolo[1,2-a][1,2,4]triazol-8- ium-6-ylsulfanyl)- 6-(1-hydroxyethyl)- 4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylate |
Bialaphos sodium - bar gene selective agent | 71048-99-2 | C11H21N3NaO6P | 345.27 | |
Bialaphos | 35597-43-4 | C11H22N3O6P | 323.28 | Bialaphos; Bialophos; Bilanafos |
Bialamicol hydrochloride | 3624-96-2 | C28H42Cl2N2O2 | 509.556 | CAM 807; 2-(diethylaminomethyl)-4-[3-(diethylaminomethyl)-4-hydroxy-5-prop-2-enylphenyl]-6-prop-2-enylphenol;dihydrochloride |
BIA10-2474 | 1233855-46-3 | C16H20N4O2 | 300.36 | N-cyclohexyl-N-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide;UNII-5AP1ZW859M; SCHEMBL427970; 5AP1ZW859M; GTPL9001; DOWVMJFBDGWVML-UHFFFAOYSA-N; |
BI-9564 | 1883429-22-8 | C20H23N3O3 | 353.42 | 4-(4-((dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one; BI-9564; BI 9564; BI9564. |
BI-44847 | 421592-30-5 | C21H29FN2O7 | 440.46 | beta-D-Glucopyranoside,4-((2-fluoro-4-methoxyphenyl)methyl)- 5-methyl-1-(1-methylethyl)-1H-pyrazol-3-yl; |
BI-3812 | 2166387-64-8 | C26H32ClN7O5 | 558.03 | |
BI-2536 | 755038-02-9 | C28H39N7O3 | 521.65 | BI2536 BI 2536. |
BG45 | 926259-99-6 | C11H10N4O | 214.22 | BG-45; BG 45. |
BI 78D3 | 883065-90-5 | C13H9N5O5S2 | 379.37 | JNK Inhibitor X; 4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-[(5-nitro-2-thiazolyl)thio]-3H-1,2,4-triazol-3-one |
BI 6015 | 93987-29-2 | C15H13N3O4S | 331.35 | 2-Methyl-1-[(2-methyl-5-nitrophenyl)sulfonyl]-1H-benzimidazole |
BI 224436 | 1155419-89-8 | C27H26N2O4 | 442.51 | |
BI 01383298 | 2227549-00-8 | C19H19Cl2FN2O3S | 445.34 | 1-[(3,5-Dichlorophenyl)sulfonyl]-N-[(4-fluorophenyl)methyl]-4-piperidinecarboxamide |
B-HT 958 dihydrochloride | 36085-44-6 | C14H16ClN3S.2HCl | 366.74 | 4H-Thiazolo(4,5-d)azepin-2-amine, 5,6,7,8-tetrahydro-6-((4-chlorophenyl)methyl)-, dihydrochloride; 2-Amino-6-(4-chlorobenzyl)-4,5,7,8-tetrahydro-6H-thiazolo(5,4-d)azepine dihydrochloride; 5,6,7,8-Tetrahydro-6-((4-chlorophenyl)methyl)-4H-thiazolo(4,5-d)aze |
B-HT 933 dihydrochloride | 36067-72-8 | C9H15N3O.2HCl | 254.16 | Azepexole hydrochloride; Azepexole dihydrochloride; 6-Ethyl-5,6,7,8-tetrahydro-4H-oxazolo[4,5-d]azepin-2-amine dihydrochloride |
B-HT 920 dihydrochloride | 36085-73-1 | 282.23 | Talipexole; 6-prop-2-enyl-4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepin-2-amine;dihydrochloride; 5,6,7,8-Tetrahydro-6-(2-propenyl)-4H-thiazolo[4,5-d]azepine-2-amine dihydrochloride, | |
BHPI | 56632-39-4 | C21H17NO3 | 331.4 | 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-7-methyl-2H-indol-2-one; |
BHHCT | 200862-70-0 | C30H15ClF14O6S | 804.93 | BHHCT |
BH3I-1 | 300817-68-9 | C15H14BrNO3S2 | 400.31 | 2-[(5E)-5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-methylbutanoic acid |
BGT226 (NVP-BGT226) | 1245537-68-1 | C28H25F3N6O2.C4H4O4 | 650.6 | N/A |
BGT226 | 915020-55-2 | C32H29F3N6O6 | 534.543 | BGT-226; NVP-BGT226. |
BGP-15 | 66611-37-8 | C20H40N4O3S3 | 351.272 | BGP-15; BGP15; BGP 15. |
b-Glucosylglycerol 2,3,4,6-tetraacetate | 157024-67-4 | C17H26O12 | 422.38 | 2-(Tetraacetylglucosido)glycerol; 2-Hydroxy-1-(hydroxymethyl)ethyl b-D-glucopyranoside 2,3,4,6-tetraacetate; 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl glycerol |
BGJ-398 | 872511-34-7 | C26H31Cl2N7O3 | 560.48 | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea; NVPBGJ398; NVPBGJ 398; NVPBGJ-398; BGJ398; BGJ-398; BG J398; Infigratinib |
b-Gentiobiose octaacetate | 4613-78-9 | C28H38O19 | 678.59 | 1,2,3,4-Tetra-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)-b-D-glucopyranose |
BGC-945 | 501332-69-0 | C32H33N5O10 | 647.641 | ONX 0801; BGC 945; BGC 945; CB 300945 (S). |
BGC-638 | 416852-27-2 | C32H33N5O9 | 631.642 | BGC 638; BGC638; CB300638. |
BGC 20-761 | 17375-63-2 | C19H22N2O | 294.39 | 5-Methoxy-N,N-dimethyl-2-phenyl-1H-indole-3-ethanamine; N,N-Dimethyl-2-(5-methoxy-2-phenylindol-3-yl)ethylamine |
BGC 20-1531 hydrochloride | 1962928-26-2 | C26H24N2O6S·HCl | 529 | BGC20-1531 HCl; BGC20-1531 hydrochloride; BGC20-1531; BGC 20-1531; BGC-20-1531; BGC201531; BGC 201531; BGC-201531; PGN 1531; PGN-1531; PGN1531 |
Bethanechol Chloride | 590-63-6 | C7H17ClN2O2 | 196.675 | |
BF 2649 | 903576-44-3 | C17H27Cl2NO | 332.309 | pitolisant hydrochloride; Wakix; 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine hydrochloride |
Bezafibrate-d6(dimethyl-d6) | 1219802-74-0 | C19H14D6ClNO4 | 367.86 | 2-[4-[2-(4-chlorobenzamido)ethyl]phenoxy]isobutyric acid |
Bezafibrate-d4 | 1189452-53-6 | C19H16ClNO4D4 | 365.85 | 2-{4-[2-(4-Chlorobenzamido-d4)ethyl]phenozy}-2-methylpropanoic Acid |
Bezafibrate Impurity D | 41859-58-9 | C21H24ClNO4 | 389.88 | Bezafibrate Ethyl Ester; 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic Acid Ethyl Ester; Ethyl 2-(4-(2-(4-Chlorobenzamido)ethyl)phenoxy)-2-methylpropanoate |
Bezafibrate | 41859-67-0 | C19H20ClNO4 | 361.82 | BM 15075; BM15075; BM-15075 |
BEZ235 Tosylate | 1028385-32-1 | C37H31N5O4S | 641.74 | NVP-BEZ235 |
Bexarotene | 153559-49-0 | C24H28O2 | 348.49 | Targretin; Targrexin; Targretyn; 4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid |
Bevonium methylsulfate | 5205-82-3 | C23H31NO7S | 465.561 | CG-201; Acabel; Piribenzil methosulfate. |
Bevirimat | 174022-42-5 | C36H56O6 | 584.83 | PA-457; MPC-4326; FH11327; YK FH312 |
Bevenopran | 676500-67-7 | C20H26N4O4 | 386.45 | 5-(2-Methoxy-4-(((2-(tetrahydro-2H-pyran-4-yl)ethyl)amino)methyl)phenoxy)pyrazine-2-carboxamide;CB-5945;CB5945;ADL-5945;ADL5945;MK2402;MK-2402 |
Bevantolol Hydrochloride | 42864-78-8 | C20H28ClNO4 | 381.89 | 2-Propanol,1-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-,hydrochloride; 1-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-2-propanol Hydrochloride; |
Bevacizumab | 216974-75-3 | C6638H10160N1720O2108S44 | 149146.82 | Avastin; Anti-vegf monoclonal antibody; Immunoglobulin G1, anti-(human vascular endothelial growth factor) (human-mouse monoclonal rhumab-vegf gamma1-chain), disulfide with human-mouse monoclonal rhumab-vegf light chain, dimer; Rhumab-vegf; Unii-2S9zzm9Q9 |
Betulonic acid | 4481-62-3 | C30H46O3 | 454.7 | Betulinonic acid; |
Betulinicaldehyde | 13159-28-9 | C30H48O2 | 440.7 | Betulinic aldehyde; Betunal |
Betulinic acid | 472-15-1 | C30H48O3 | 456.7 | ALS357; ALS 357; ALS-357; Mairin; Acronym: BA; Code name: ALS-357. |
Betulin palmitate | 582315-55-7 | C46H80O3 | 681.1 | |
Betulin caffeate | 89130-86-9 | C39H56O5 | 604.9 | 3-O-Caffeoyl-betulin |
Betulin | 473-98-3 | C30H50O2 | 442.7 | BETULINOL; BETULOL; LUP-20(29)-ENE-3,28-DIOL,(3B); LUP-20[29]-ENE3B,28-DIOL; LUP-20(29)-ENE-3BETA,28-DIOL; LUP-20(29)-EN-3,28-DIOL; TROCHOL |
Betulaprenol-7 | 32304-16-8 | C35H58O | 494.848 | (2E,6E,10E,14E,18E,22E)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-ol; Heptaprenol (all trans); SCHEMBL7944847; MFCD02259167; ZINC14677065 |
Betrixaban | 330942-05-7 | C23H22ClN5O3 | 451.91 | PRT054021; PRT 054021; PRT-054021; MK-4448; MK 4448; MK4448; PRT-021; PRT 021; PRT021; MLN-1021; MLN 1021; MLN1021; Bevyxxa; N-(5-chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide |
BETP | 1371569-69-5 | C20H17F3N2O2S | 406.42 | 2-(Ethylsulfinyl)-4-[3-(phenylmethoxy)phenyl]-6-(trifluoromethyl)pyrimidine |
BENZYL-N-VINYLCARBAMATE | 84713-20-2 | C10H11NO2 | 177.2 | BENZYL-N-VINYLCARBAMATE; O-Benzyl-N-vinylcarbamate; benzyl vinylcarbamate |
BENZYL-N,N-DIISOPROPYLCHLOROPHOSPHORAMIDITE | 128753-68-4 | C13H21ClNOP | 273.74 | BENZYL-N,N-DIISOPROPYLCHLOROPHOSPHORAMIDITE |
Benzylmalononitrile | 1867-37-4 | C10H8N2 | 156.187 | |
Benzyl malonate | 53439-79-5 | C10H10O4 | 194.18 | Benzyl malonate; Malonic acid methylphenyl ester |
benzyl L-prolinate | 41324-66-7 | C12H15NO2 | 205.253 | |
Benzyl L-histidinate dihydrochloride | 31321-62-7 | C13H15N3O2.2ClH | 318.19898 | benzyl(2S)-2-amino-3-(1H-imidazol-5-yl)propanoate; dihydrochloride; BenzylL-histidinatedihydrochloride; 31321-62-7; BenzylL-histidinateHCl; SCHEMBL9515682 |
Benzyl lactate | 2051-96-9 | C10H12O3 | 180.2 | 2-hydroxy-propanoicaciphenylmethylester; BENZYL LACTATE; Propanoic acid, 2-hydroxy-, phenylmethyl ester; 2-Hydroxypropionic acid benzyl ester; Ai3-15720; Einecs 218-136-6 |
Benzyl 2-acetamido-2-deoxy-D-glucopyranoside | 3055-51-4 | C15H21NO6 | 311.33 | Benzyl D-GlcNAc |
Benzyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 13343-67-4 | C15H21NO6 | 311.33 | |
Benzyl 2-acetamido-2-deoxy-a-D-glucopyranoside | 13343-62-9 | C15H21NO6 | 311.33 | Benzyl D-GlcNAc |
Benzyl 2-acetamido-2-deoxy-a-D-galactopyranoside | 3554-93-6 | C15H21NO6 | 311.33 | |
Benzyl 2-acetamido-2-deoxy-6-O-trityl-a-D-glucopyranoside | 33493-71-9 | C34H35NO6 | 553.64 | |
Benzyl 2-acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-b-D-glucopyranoside | 53167-38-7 | C21H31NO11 | 473.47 | |
Benzyl 2-acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-a-D-glucopyranoside | 81243-70-1 | C21H31NO11 | 473.47 | |
Benzyl 2-acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-a-D-galactopyranoside | 1373368-54-7 | C21H31NO11 | 473.47 | |
Benzyl 2-acetamido-2-deoxy-4-O-(b-D-galactofuranosyl)-a-D-glucopyranoside | 174866-45-6 | C21H31NO11 | 473.47 | |
Benzoic acid,2-nitro-5-(trifluoromethoxy)- | 189359-65-7 | C8H4 F3 N O5 | 0 | 2-Carboxy-4-(trifluoromethoxy)nitrobenzene |
Benzenepropanoic acid, 5-bromo-b-phenyl-2-(phenylmethoxy)-, methyl ester, (±)- | 156755-24-7 | C23H21BrO3 | 425.31504;g/mol | methyl3-(5-bromo-2-phenylmethoxyphenyl)-3-phenylpropanoate; SCHEMBL1355279; SXFFQILYKHDSIZ-UHFFFAOYSA-N; CS-B0083; KB-75242; S14-2411 |
Betoxycain | 3818-62-0 | C19H32N2O4 | 352.472 | Betoxycain; bethoxycaine; 2-[2-(Diethylamino)ethoxy]ethyl=3-amino-4-butoxybenzoate; 2-(2-diethylaminoethyloxy)ethyl 3-amino-4-butoxybenzoate; 2-(2-diethylaminoethyloxy)ethyl 3-azanyl-4-butoxy-benzoate; 3-amino-4-butoxy-benzoic acid 2-(2-diethylaminoethylo |
BET-IN-1 | 1422554-34-4 | C25H30N4O4 | 450.53 | 4-[8-methoxy-1-[(2R)-1-methoxypropan-2-yl]-2-(oxan-4-yl)imidazo[4,5-c]quinolin-7-yl]-3,5-dimethyl-1,2-oxazole BET-IN-1 SCHEMBL14698278 CS-5464 HY-19760 |
Bethoxazin | 163269-30-5 | C11H9NO2S2 | 251.32 | Bethogard; Bethoguard |
Bethanidine Sulfate | 114-85-2 | C20H32N6O4S | 452.57 | N,N'-Dimethyl-N''-(phenylmethyl)-guanidine Sulfate; 1-Benzyl-2,3-dimethyl-guanidine sulfate; 1-Benzyl-2,3-dimethylguanidine Sulfate; 1-Benzyl-2,3-dimethylguanidinium Sulfate; BW 467C60; Batel; Bendogen; Benzaidin; Benzanidin; Benzanidine; Betanidol; Betan |
BET-BAY 002 | 1588521-78-1 | C22H18ClN5O | 403.86 | 2-[[(4R)-6-(4-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-4-yl]methyl]-5-methyl-1,3,4-oxadiazole BET-BAY 002 SCHEMBL16963184 B4821 1588521-78-1 |
beta-Zearalanol | 42422-68-4 | C18H26O5 | 322.4 | Taleranol, β-Zearanol, β-Zeranol |
Betaxolol HCl | 63659-19-8 | C18H29NO3·HCl | 343.89 | BAY K 5552 |
beta-Tropisetron | 89565-68-4 | C17H20N2O2 | 284.35 | Navoban. ICS 205-930. (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 1methyl-indole-3-carboxylate. |
beta-Triglycidyl isocyanurate | 59653-74-6 | C12H15N3O6 | 297.26 | |
Betanidine | 55-73-2 | C18H16N2O8 | 177.2462;g/mol | 1-benzyl-2,3-dimethylguanidine;Betanidine;Bethanidine;1-BENZYL-2,3-DIMETHYLGUANIDINE;Esbatal;Betanidina |
Beta-Nicotyrine | 487-19-4 | C10H10N2 | 158.2 | 3-(1-Methyl-1H-pyrrol-2-yl)pyridine; 3-(1-Methylpyrrol-2-yl)pyridine; Nicotyrine; |
beta-Naphthyl stearate | 6343-74-4 | C28H42O2 | 410.63 | |
beta-NADPH-D | 74784-45-5 | C25H29ClO8 | 492.96 | Adenosine 5'-(trihydrogen diphosphate) 2'-(Dihydrogen Phosphate) P'-5'-Ester with (4S)-1,4-Dihydro-1--Beta-d-ribofuranosyl-3-pyridine-4-d-carboxamide; |
Betamipron | 3440-28-6 | C10H11NO3 | 193.20 | CS-443 |
Betamethasone-17-butyrate-21-propionate | 5534-02-1 | C29H39FO7 | 518.61 | [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate; betamethasone butyrate propionate |
Betamethasone Valerate Impurity C | 33755-46-3 | C27H37FO6 | 476.59 | 9-Fluoro-11b,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione 17-valerate; Dexamethasone Valerate; DV 17; Dexamethasone 17-valerate |
Betamethasone hydrochloride | 956901-32-9 | C22H30ClFO5 | 428.92 | |
Betamethasone EP Impurity D | 52619-05-3 | C25H33FO7 | 464.54 | |
Betamethasone Enol Aldehyde Z Isomer | 52647-06-0 | C22H27FO4 | 374.46 | |
Betamethasone Enol Aldehyde E Isomer | 52647-07-1 | C22H27FO4 | 374.46 | |
Betamethasone Dipropionate | 5593-20-4 | C28H37FO7 | 504.595 | Alphatrex; Beta-Val; Diprolene; Diprolene AF; Diprosone; Luxiq |
Betamethasone b-D-glucuronide | 744161-79-3 | C28H37FO11 | 568.60 | |
Betamethasone 9,11-Epoxide | 981-34-0 | C22H28O5 | 372.46 | DB 11; DB-11 |
Betamethasone 21-acetate | 987-24-6 | C24H31FO6 | 434.5 | |
Betamethasone 17-valerate | 2152-44-5 | C27H37FO6 | 476.58 | Betnovate, Celestone |
Betamethasone 17-benzoate | 22298-29-9 | C29H33FO6 | 496.57 | [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate; betamethasone 17-benzoate; betamethasone benzoate |
beta-IONYL ACETATE | 22030-19-9 | C15H24O2 | 236.35 | 3-Buten-2-ol, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, acetate, beta-IONYL ACETATE |
Betaines,C12-14-alkyldimethyl | 66455-29-6 | C16H33NO2 | 271.44 | LAURYL DIMETHYLAMINOACETIC ACID; DODECYL DIMETHYL BETAINE; EMPIGEN BB DETERGENT; EMPIGEN BB(R); EMPIGEN(R) BB; EMPIGEN(R) BB DETERGENT; 3-AZONIA-3,3-DIMETHYLPENTADECANOATE; N-DODECYL-N,N-DIMETHYLGLYCINE |
Betaine hydroxide | 17146-86-0 | C5H12NO2.HO | 135.163 | (Carboxymethyl)trimethylammonium hydroxide; Betaine, monohydrate; Methanaminium, 1-carboxy-N,N,N-trimethyl-, hydroxide |
Betaine hydrochloride | 590-46-5 | C5H12ClNO2 | 153.60 | (carboxymethyl)trimethyl-ammoniuchloride;1-carboxy-n,n,n-trimethyl-methanaminiuchloride;Achylin;Acidin;Acidine;Acidogeno;acidolhydrochloride;Acidol-Pepsin |
Betaine citrate | 17671-50-0 | C11H19NO9 | 309.27 | Betaine citrate; (Carboxymethyl)trimethylammoniumdihydrogencitrate |
betaine aldehyde | 7418-61-3 | C5H12 N O | 102.15500 | |
Betaine | 107-43-7 | C5H11NO2 | 117.15 | N-TRIMETHYLGLYCINE HYDROXIDE; OXYNEURINE; TRIMETHYLGLYCINE; TRIMETHYLGLYCOCOLL; (CARBOXYMETHYL)TRIMETHYLAMMONIUM HYDROXIDE ANHYDRIDE; (CARBOXYMETHYL)TRIMETHYLAMMONIUM HYDROXIDE INNER SALT; BET; BETAINE |
Beta-Hydroxylsovalerylshikonin | 7415-78-3 | C21H24O7 | 388.42 | 3'-Hydroxyisovalerylshikonin |